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Abstract 
Synthetic hydroxyapatite (HA) has been widely used for biomedical applications, in particular 
as a bone substitute and coating for implants, due to its similarity to the inorganic component 
of human bone. The aim of this study was to incorporate three divalent cations (silver, zinc and 
magnesium) into the hydroxyapatite structure via a wet chemical precipitation method to 
enhance its antibacterial properties, to avoid the need for the use of antibiotics.  Material 
characterisation techniques such as XRD and Raman Spectroscopy confirmed that these ions 
were substituted within the crystal structure of HA, though did not follow the expected reaction 
stoichiometry and substitution ratios. HA material properties, such as crystal size, crystallinity 
and solubility were shown to change after ion substitution. Metal-substituted HA showed 
varying strengths of antibacterial properties against two bacterial strains of E.coli and S. 
epidermidis, which was attributed to different type of ions and substitution ratios and also 
different release profiles from the solid phase to the culture medium. The results from cell 
biological studies confirmed that the rate of osteoblast cell proliferation and cell differentiation 
were improved after cells being incubated with disks of substituted HA.  
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CHAPTER 1 
INTRODUCTION 
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1 INTRODUCTION 
In recent years, healthcare systems have witnessed an unprecedented demand in the number of 
orthopaedic surgeries, in particular ones which include the use of implants and prostheses. The 
ageing population and increasing number of sport injuries are regarded as the main contributors 
for the growth in such operations. Since patients are living longer following the fitting of 
prosthetics and expect to retain normal levels of activity, there is now a significant increase in 
the physical demands placed on prostheses. Although most implants will last up to 20 years, 
there is a subset of patients who will need a revision surgery within 5 years after the procedure 
for both hip and knee replacements (1, 2). Most common problems associated with patients 
who require revision surgeries include instability, aseptic loosening, infection, wear, osteolysis 
and a failure of the bone to grow into the prosthetic (1, 3). 
Success of an orthopedic implants strongly relies on its interaction between its surface and the 
surrounding tissues after the implantation (4, 5).  A perfect orthopaedic implants are currently 
unachievable due to inadequate osseointegration, which increases the risk of implant failure. 
Efforts to improve host cell-implant interaction have resulted in enhanced osseointegration (6).  
Implant infections are responsible for the failure of approximately 2% of orthopedic implants 
worldwide (7). Infection at the implant site is the result of bacterial adhesion to the implant 
surface and subsequent formation of biofilm. If bacterial adhesion happens before tissue 
regeneration, the host defense system often cannot prevent colonization for certain bacterial 
species that are capable of forming a protective biofilm layer(8).  Since biofilm is extremely 
resistant to both immune system and antibiotics, it is critical to inhibit bacterial adhesion in 
order to prevent forthcoming infection. Skin is the most common source of the staphylococcus 
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species which is responsible for 60% of all prosthetic infections (9). To prevent infection during 
the surgery, applying prophylactic antibiotics has been shown to be most effective (9).  If 
infection does occur, the most common therapy is a two-stage implant exchange plus 6 weeks 
of intravenous antibiotic administration resulting in long periods of hospitalization(10) both 
steps are costly and not feasible(11) (12). 
Synthesized calcium phosphates (CaP), which are demonstrated biocompatibility for 
orthopaedic application and bioactive, have been widely used as orthopaedic implants. 
Hydroxyapatite (HA), which is a calcium phosphate, gained more attention due to its chemical 
and crystallographic similarities to the inorganic components of natural bone and other hard 
tissue in mammals(13). The three dimensional structure of HA shows great flexibility in 
accepting mixture of ions such as divalent ions (Mn2+, Sr2+, Cu2+, Co 2+, Zn2+, Mg2+), 
monovalent ions (Na+, K+, Ag+) and trivalent ions (Bi3+, Ln3+) in the calcium site. This ionic 
replacement can control the property and application of the HA in various subject such as 
catalysis (14), protein adsorption(15), ion exchangers(16)  and biomaterials. 
Studies have shown that synthesized HA, when compared to metallic or other ceramic 
biomaterials, can promote osteoblast (bone growth cells) and osteoclast (bone resorption cells) 
activity after implantation, and therefore improve osseointegration (direct structural and 
functional connection between living bone and the surface of HA implant). For this reason, 
synthesized HA has been widely used as implants materials in dentistry or orthopedics such as 
dental implants, periodontal treatment, alveolar ridge augmentation, maxillofacial surgery and 
otolaryngology(17). However, HA, due to its inherent characteristics of brittleness, poor tensile 
strength and low fracture, can only be used in none load bearing implants.  
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Since bacterial infection is major problem with orthopedic implant failures, over the years silver 
and zinc have been studied as an implant coating since they exhibit a broad range of 
antimicrobial activity and bacterial inactivation in vitro (18, 19) (20).  Moreover, zinc can 
promote osteoblastic cell proliferation and differentiation and is thought to possess a selective 
inhibitory effect on osteoclastic bone resorption in vivo (21, 22). Several studies confirmed that 
HA with zinc or silver accelerated osteoblast activity compared to pure HA.  
Magnesium is known to be an important trace element in bone and teeth and also during 
osteogenesis.  Magnesium can promote osteoblast proliferation (23), and its depletion causes 
bone fragility and bone loss (24). As a result, many studies have investigated the preparation of 
calcium phosphate implant materials containing of Mg, which has been shown to improve their 
bioactivity. 
Studying cytotoxicity is important factor to check biocompatibility before implantation. In vitro 
cytotoxicity is one of the recommended and appropriate tests for the biological assessment of 
the medical device (25).  The antimicrobial properties of silver, zinc and biological effect of 
magnesium have a high dependence on the release of the ions from calcium phosphate (26, 27). 
Based on previous studies, the replacement of calcium by silver, magnesium and zinc in HA is 
limited. This is related to the dissimilar size between candidate cations and Ca+2, which leads 
to strong distortions of the HA crystal and alter their solubility and biodegradability in 
physiological fluids. These changes have a direct impact on the properties of substituted 
hydroxyapatite,(13, 28-30). 
Introducing cations into hydroxyapatite structure has been studied for a long time in terms of 
reviewing the change in material characterization, interaction with microbiological culture and 
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cell biological behaviors. However, to date there has been no comprehensive studies of this and 
also measuring exact amount of substitution of cations (Ag, Zn, and Mg) in hydroxyapatite.  
In this research, Ions (Ag, Mg, Zn) substituted hydroxyapatite and samples were analyzed 
considering three aspects: 
1) Material characterization  
2) Microbiological effect of HA against two most common infection causing bacteria 
(E.coli and S.epidermidis) 
3) Proliferation and differentiation of osteoblast cells in contact to HA  
1.1 Aims and objectives 
The aim of this project was to study the effectiveness of silver, magnesium and zinc substituted 
hydroxyapatite as an improved formulation for orthopedic applications. It was critical to 
understand how the substituted ions will impact the chemical and crystal properties within the 
studied concentration range of the metal ions.  
While it is known that the metal ions in hydroxyapatite powders will manifest some 
antibacterial properties, a key objective in this study was to establish the optimum concentration 
range for the selected metal ions by measuring their antibacterial response individually for each 
sample against selected bacterial species and compare with other chemical and physical 
properties.   
In addition, this study will measure how the biological response and cell viability were affected 
versus selected cell lines in vitro and whether the metal ions have contributed to the 
osteoconductivity properties of the final powder.     
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2 Literature Review  
2.1 Biomaterials   
Biomedical material science or the science of understanding and developing “Biomaterials” has 
been an exciting and rewarding research area of materials science.  The most recent definition 
of biomaterials is: “ A biomaterial is a substance that has been engineered to take a form which, 
alone or as part of a complex system, is used to direct, by control of interactions with 
components of living systems, the course of any therapeutic or diagnostic procedure, in human 
or veterinary medicine” (31). In particular, in recent years, because of an increased ageing 
population, there has been a growing number of bone-related diseases and fractures which 
demand treatments, some by incorporating implants with or without complimentary 
functionality (e.g. incorporated antibacterial activity for infection control, growth hormones 
etc). To guarantee that an implant can provide the desired function, its longevity and its overall 
success, suitable selection of biomaterial fit for the proposed application is essential..  
Solid biomaterials can be classified as bimetals, biopolymers, bioceramics or biocomposites. 
The focus of this research is on the studying a new formulation of substituted hydroxyapatite 
with the enhanced antimicrobial activity. Hydroxyapatite is a calcium phosphate and a common 
bioceramic used mainly for its excellent osteo-conductive properties(32), , and its properties 
are reviewed in detail in section 2.3. 
2.2 Infections in prosthetics and implants 
Despite all the advances in the development of biomaterials, a significant number of implant 
procedures are affected by bacterial infection after implantation and revision surgeries as well 
as prolonged administration of antibiotics are required. Orthopaedic device-related infections 
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(ODRI) are responsible for the failure of 1-2% of orthopaedic implants worldwide (33). Implant 
joint infection is a relatively uncommon complication following hip and knee joint replacement 
and occurs approximately less than1 and 0.5%, respectively (34). These infections may require 
prolonged therapy and often removal of the affected prosthesis is necessary (35, 36).  
Infection may also occur early or late, from direct intra-operative inoculation, wound infection 
or haematogenous seeding. The most common infections are due to coagulase-negative 
staphylococci (CoNS) which are part of the normal flora of human skin such as S. epidermidis, 
the most common CoNS pathogen that accounts for about 74% to 92% of all hospital-acquired 
CoNS infections and S. haemolyticus, the second most common CoNS, often a pathogen in 
endocarditis, septicemia, peritonitis, urinary tract infections, osteomyelitis, and wound 
infections. Other common pathogens include S. aureus,enterococci, streptococci, 
corynebacteria, enterobacteriaceae and anaerobes (37). 
Infection occurs when bacteria are attached to the implant surface and biofilm, which is a 
resistant form of bacterial colony, starts to form. The biofilm develops through the following 
stages:  
(i) surface adhesion followed by  
(ii) multilayered cellular proliferation and  
(iii) intercellular adhesion in an extracellular polysaccharide matrix.  
Generally the body immune system cannot prohibit bacterial proliferation when a protective 
bacterial biofilm layer has been already formed (38). Hence, it is critical to prevent the initial 
colonisation and adhesion of bacteria in order to control infection.     
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Pathogenic microorganisms, particularly gram-positive S. aureus and S. epidermidis, have been 
found in approximately 90% of implants(7).  Gram-negative E.coli, Pseudomonas aeruginosa, 
and the pathogens from the Proteus group (e.g., P. mirabilis and P. vulgaris) have also been 
found in implant-associated infections (7).  
Implant infections are not only due to a poor surgical operation or host health factors (such as 
obesity or chronic diseases) but can also arise from the anatomical characteristics of the implant 
site and properties of the implanted device such as its size and shape (39).  
Another major concern in recent years has been the increasing occurrence of infections from 
antibiotic-resistant bacteria. In a large surveillance in surgical site infections after orthopaedic 
interventions, 59% of the infections were due to the isolated methicillin-resistant S. aureus 
(MRSA) strains (40, 41). The reported incidences of MRSA infection at the surgical site 
increased from 32% to 64% between 1992 and 2003 (42).  MRSA is associated with higher 
rates of patient morbidity and mortality than non-MRSA strains (43) and its control demands 
for new antibiotics or using alternative agents with minimum or no bacteria resistance (such as 
silver nanoparticles).  
Minimizing and inhibiting post-surgery infections, in particular for orthopaedic applications, is 
becoming more critical as the aging population increases meaning more people will need such 
treatments in coming years (7). 
The most common procedure to treat osteomyelitis (bone infection) is to remove the dead bone 
tissue from the infective site, irrigate the wound and administer systemically antibiotics for 
extended periods of time (44). The routine use of systemic antibiotic drugs for prophylaxis in 
post-operative complications is not appropriate for the alleviation of these ailments, due to poor 
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perfusion to the diseased ‘bone site’ as well as other antibiotic related symptoms such as allergic 
reactions, nephrotoxicity and ototoxicity (45). 
Hence, the local delivery of drugs to bones or infected implant site is becoming more popular 
for the treatment of post-operative complications. This to a large extent can be achieved by 
preloading implants with antimicrobial agents, which can reduce the systemic body burden of 
drugs. For example, bone cements are often preloaded with antibiotics as a standard practice 
(46). 
The delivery systems are certainly destined to play an important role in the fight against 
bacterial infections. In the treatment of orthopaedic infections, there are two main challenges 
faced by the surgeons when local delivery of antibiotics is followed as standard practice; 
avoiding antibiotic resistance and achieving antimicrobial activity without impairing peri-
implant bone growth (i.e. osseointegration) (47). 
 
2.2.1 Local Delivery for Treatment of Implant Infection  
All drug delivery systems in this case antibiotic loaded implants should provide a local and 
controlled release profile at the site of implantation.  Additionally, the release profile proven to 
be more effective is the one that allows burst release at the first hours after surgery (short time 
effect) followed by a sustainable therapeutic release over prolonged periods of time (long time 
effect) (48). Fast release provides high dose but short-term action. On the other hand, slow 
release may not reach the required antibiotic level. The release of antibiotics must occur before 
a protective biofilm layer forms protecting the bacterial colony. Bacteria protected by a biofilm 
can require 1000 times the antibiotic level necessary to combat bacteria in suspension.  
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Today, antibiotics can be loaded in two types of implants: 
1) Polymers such as polyurethane (PU), silicon rubber, poly L-lactic acid (PLA), poly (glycolic 
acid) (PGA), polyhydroxyalkanoates (PHA) and polymethylmethacrylate (PMMA)(non-
biodegradable), and 
2) inorganic coatings such as hydroxyapatite from different sources (48). 
Depending on the type of implant, the antibiotic release profile can be modulated in different 
forms. For instance in polymeric materials, the hydrophilic and hydrophobic chain ratios can 
be adjusted, or the right balance of biodegradability and biostability is set for.  
In contrast, self-setting apatite is transformed into hydroxyapatite, which has high compatibility 
with the natural hard tissue, sets within half an hour in-situ and is easy to use in a clinical setting 
(49). More importantly, there is no limitation in the use of thermos-sensitive antibiotics due to 
the non-exothermic setting reaction. On the other hand, certain care is also needed to investigate 
the antibiotic activity at different pH.  However, brittleness and poor strength of HAP has 
limited its use as an implant in loaded situations. Hence, HAP coated metal implant with 
sufficient mechanical strength has been proposed as an alternative (50). Although the load 
wearing capacity of HAP is low, in a recent report (51), gentamycin impregnated HAP cement 
was very effective to treat bone infection (e.g. osteomyelitis) in rats. It was showed that 
doxycycline is a broad-spectrum antibiotic with activity against a wide range of gram positive 
and gram-negative organisms (51).  
The following sections review the properties and applications of calcium phosphate ceramics, 
and in particular hydroxyapatite as well as metal ions as antibacterial agents.   
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2.3 Calcium Phosphates  
Calcium phosphates (CaP) are a group of minerals containing calcium ions (Ca2+) together with 
orthophosphates (PO43-), metaphosphates (P2O74-) and occasionally hydrogen or hydroxide ions 
(52) . Based on their composition, the vast majority of synthetic calcium phosphates are 
classified as 1. HA  (Ca10(PO4)6(OH)2); 2. α- and β-tricalcium phosphates (TCP) Ca3(PO4)2; 3. 
biphasic calcium phosphates (BCPs) which is a mixture of either α- or β-TCP with HA, and 4.  
amorphous calcium phosphates (53, 54) . 
CaP play a significant role in human bodies and other mammals as they represent the inorganic 
part of healthy bones and teeth as well as pathological calcified tissues (55). Hence, they are 
biocompatible and are not considered foreign materials when implanted. They are also safe, 
non-toxic and exhibit bioactive behaviour. (54). 
The first attempt to use calcium phosphates for clinical applications was as an artificial material 
to repair surgically bone defects in rabbits in 1920, but their use and introduction for 
orthopaedic applications in humans was not until the early 1970s (54). While trying to replace 
the dominant metallic materials, the main attention was to find how ceramic based materials 
could be improved in terms of bone integration, functionality, mechanical and chemical 
characteristics. Table 2.1 shows a list of known calcium orthophosphates and their major 
properties such as chemical formula, solubility and pH stability range. The ones which are 
stable around pH=7.0. 
In human body, ceramic materials are found in two forms, bioinert or bioactive. Bioinert 
materials does not stimulate body reaction in the surrounding environment and tissue after 
implantation while a bioactive material can lead to certain biological responses and reaction at 
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its surface and will promote the formation of links between the tissue and implant material.  
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Table 2. 1 Existing calcium orthophosphates and their major properties (54)   
Ca/P 
molar 
ratio 
Compound Formula pH stability range in aqueous solutions at 25°C Solubility at 
25 °C (g/l) 
0.5 Monocalcium phosphate 
monohydrate  
Ca2(H2PO4).H2O 0.0-2.0 ~18 
0.5 Monocalcium phosphate 
anhydrous 
Ca2(H2PO4) Stable at temperatures above 100 °C ~17 
1.0 Dicalcium phosphate 
dihydrate, mineral brushite 
CaHPO4.2H2O 2.5-6.0 ~0.088 
1.0 Dicalcium phosphate 
anhydrous, mineral monetite 
CaHP O4 Stable at temperatures above 100 °C ~0.048 
1.33 Octacalcium phosphate 
(OCP) 
Ca8(HPO4)2(PO4).5H2O 5.5-7.0 ~0.0081 
1.5 α-Tricalcium phosphate  
(α-TCP) 
α-Ca3(PO4)2 These compounds cannot be precipitated from 
aqueous solutions 
~0.0025 
1.5 β- Tricalcium phosphate  
(β-TCP) 
β-Ca3(PO4)2 These compounds cannot be precipitated from 
aqueous solutions 
~0.0005 
1.5-1.67 Calcium-deficient 
hydroxyapatite (CDHA) 
Ca10-x(HPO4)x.(PO4)6-x(OH)2- 6.5-9.5 ~0.0094 
1.67 Hydroxyapatite Ca10(PO4)6 (OH)2  ~0.0003 
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Calcium phosphates are formed through a process called sintering (1100-1300ºC) during which 
amorphous or crystalline structures are formed. The sintering conditions and stoichiometry of 
the reaction can dictate the type, structure and composition of the final CaP. For example, at 
Ca/P ratios of 1.5 from TCP while stoichiometric HA is obtained at Ca/P ratio of 1.67(56). By 
changing this ratio between these two ranges, the final obtained CaP can be a biphasic mixture 
of TCP and HA phases.   
Solubility of the formed CaP can also determine the type of application that it can be used for 
and depends whether a resorbable phase or and non-soluble phase is required(56). 
2.3.1 Tricalcium phosphate (TCP) 
Compared to HA, tri-calcium phosphate (TCP) with the formula of Ca3(PO4)2 , has lower Ca/P 
ratio, less stability and higher solubility. This phase is thermodynamically stable at very high 
temperatures (1000-1500º C) only.  
Both α- and β-TCP have identical chemical composition but have different crystallographic 
structure, which gives them slightly different properties.  α-TCP is a less stable phase and has 
higher solubility and degradation rates compared to β-TCP (57). 
 
2.3.2 Hydroxyapatite (HA) 
HA is a mineral from the apatite family with a general formula of M5(ZO4)3X, where M is a 
rare-earth metal, such as Ca2+, Cd2+, Sr2+, Ba2+, Pb2+, Zn2+, or Mg2+, ZO4 could be PO4, CO3 or 
SO4 and X is OH−, F−, Cl−, or CO32- (58). 
HA has a chemical formula of Ca5(PO4)3OH and is a naturally occurring CaP with the most 
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similar chemical composition to the mineral content of the bone(59, 60) . When compared to 
both α- and β-TCP, HA is a more stable and less soluble phase under physiological conditions 
and suitable for orthopaedic applications. In case of stoichiometric HA, the Ca/P ratio is 10:6 
(or 1.67) which is the pure stable phase of HA. When Ca/P ratio is in the range of 1.5-1.67, 
Calcium Deficient Hydroxyapatite (CDHA) will be formed. 
Due to its outstanding biological properties such as no inflammatory response, no toxicity and 
absence of fibrous or immunological reactions, HA is one of the most promising biomaterials 
for implant coating applications(61). HA exhibits a high degree of biocompatibility, mainly due 
to its identical chemical composition when compared with natural bone (62).  
HA has been widely used in orthopaedic and dental applications as well as in drug delivery 
vehicles(63, 64). 
The low solubility of HA makes it more suitable for long-term clinical and surgical applications, 
while its hard and brittle structure and faster setting time (in case of HA cements) makes it 
difficult to reshape and handle during operation(65) .  
Chemistry of HA 
Studies to investigate the exact composition of HA through chemical analysis were conducted 
as early as first half of 18th century but it was until a century later that the current concept of 
the presence of various CaP crystal phases was introduced (66). Understanding the exact 
chemical structure and composition of HA has made it possible to optimize the synthesis 
process during which improved functionality or tailored properties can be restored to the final 
product.  
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Two main crystal forms are identified for HA: monoclinic and hexagonal with the hexagonal 
form being more stable than the monoclinic one against the introduction of foreign ions (i.e. 
ions other than Ca2+, PO43– and OH– native to the HA structure) which makes it more practical 
for biomaterial applications(67, 68). 
In the hexagonal form, the ten calcium (Ca) atoms contained in the unit cell (as listed in Table 
2.2) are distributed between two different crystallographic Ca2+ sites, which are referred to as 
Ca(I) and Ca(II) as illustrated in Figure 2.1.  
Table 2. 2 Unit- cell positions of the HA lattice where; α=90°, β=90°, ϒ=120° (69) 
Atom x/a y/b z/c 
Ca(I) 1/3 2/3 0.0010 
Ca(II) 0.2464 0.9938 1/4 
P 0.3999 0.3698 1/4 
O(I) 0.3272 0.4837 1/4 
O(II) 0.5899 0.4666 1/4 
O(III) 0.3457 0.2595 0.0736 
OH 0.0000 0.0000 0.1930 
 
There are strong bonds between the four Ca atoms at the Ca(I) positions and six oxygen atoms 
with an additional weaker bonding influence from a further three oxygen atoms. Consequently, 
the Ca(I) ions will be tightly confined in columns along the c-axis and shape a hexagonal 
arrangement along c-axis. The HA crystal structure may be changed if there is any disruption 
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to the metal-oxygen interactions at the Ca(I) sites and therefore Ca(I) sites can only tolerate the 
substitution of ions which are smaller than Ca (or possibly slightly larger than Ca at low 
concentrations). The six Ca(II) atoms are staggered over consecutive planes cutting the c-axis 
and are surrounded by seven oxygen atoms, which belong to phosphate groups and  hydroxyl 
groups. The Ca(II) site under this arrangement can be subjected to local displacements by 
substitution with larger cations, while the overall crystal structure is not affected (68).  
 
 
 
Figure 2. 1: A view of the HA structure along the C-axis. Black line connect Ca(I) columns in hexagonal 
networks. Cyan and magenta triangles connect staggered Ca(II) atoms lying in the same plane, but at 
different height with respect to the C-axis. (68) 
 
HA as a coating for orthopaedic implants 
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HA is widely used solely or in combination with other implants to enhance the integration of 
medical implants and prosthetic components, in order to provide firm bonds to the host bone 
by ingrowth of new bone-like structure(70) . 
Most CaP ceramics (except stable stoichiometric HA) are classified as resorbable biomaterials 
as they can experience degrees of solubilisation at certain physiological conditions. The body 
can readily use and assimilate the dissolution products of CaP biomaterials. HA-coated implants 
have been widely used and shown to be effective by enhancing the durability stability of the 
implants, as a result of better osteoconductivity and integration of the implant with bone tissue 
(71) . 
When HA comes in contact with physiological fluids, a series of chemical reactions take place 
leading to the formation of new bones, in what is also called an osteoconductive process(61). 
The bioactive HA triggers a series of reformation processes at the surface of the material during 
which HA interaction with bone and the subsequent reactions, which lead to ion precipitation 
and generation of natural and biologically equivalent bone. As one of the noticeable effect of 
HA, it is able to improve bone formation between the gaps around the implant and also being 
capable of converting motion-induced fibrous membrane into a bony anchorage(72). 
At the bone-HA implant surface, the interaction with the bone tissue will form bonds other than 
fibrous tissue layer type, which is critical to guarantee the fixation and stabilisation of implants. 
This interface and the underlying interactions are very similar to the type of interface which is 
observed when natural tissue repairs itself as it is dynamic, time-dependent and a function of 
chemical reactivity of the ceramic(61).  
This is a clinical advantage for HA as its bioactivity can be modified by adjusting its synthesis 
37 
 
process, chemical composition, degree of crystallinity and its surface morphology(61). For 
example, smaller HA crystal sizes have been shown to be more soluble at the cost of reduced 
mechanical properties(73). HA, and generally all ceramics, are poor in terms of their 
mechanical properties and use for high load bearing applications while many of its 
crystallographic properties are similar to those of natural bone tissue (61). Hence, most clinical 
applications of HA are primarily as fillers, cements and coatings for orthopaedic implants.  
HA and other functional bioactive coatings can be successfully deposited on the surface of 
prosthetic implants using thermal spray process (74). While the actual spraying parameters can 
impact the success of deposition, Kweh et al. (62) showed that the quality of  HA coatings is 
also a function of the synthesized powder characteristics. These attributes are mainly the 
particle size, particle-size distribution and particle morphology, as they determine the flow 
characteristics and the subsequent melting behaviour of the HA particles in the plasma jet. In 
the same study, it was determined that spherical geometry and narrow size distribution can lead 
to better heat transfer and consistent melting profile which enhances the deposition of the 
coating powder and reduced porosity in the surface (62).  
2.4 Synthetic HA and Ion-Substitution  
The two main methods to synthesise HA are chemical synthesis (wet and dry) and biosynthesis, 
which is sourced from bacterial sources (75). 
Dry chemical methods include solid-state reaction and mechanical alloying method. 
In solid-state reaction, stoichiometric amounts of phosphate and carbonate salts are mixed and 
reacted following solid-state reaction principles, followed by calcification to obtain the crystal 
form chemical method(76).   
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Mechanical alloying is a repetitive cold welding, fracturing and re-welding of blended powders 
in a ball mill and is used for alloying elements which are difficult to combine by conventional 
melting methods. For mechanical alloying technique, reactants are mixed in water long milling 
times (up to 60h) have been employed in a dry environment without the need for heat 
treatment(76).  
HA can also be produced by different wet chemical techniques such as precipitation, sol-gel, 
hydrothermal and hydrolysis reactions. This section reviews the wet chemical precipitation 
route, as it is simple, well understood, requires low processing temperature and can be readily 
adjusted to achieve novel formulations.  
 
 
2.4.1 HA synthesis with chemical precipitation 
Chemical precipitation is the most common method for the preparation of HA. Main precursors 
or reactants for the reactions have been a combination of a phosphate donor (such as 
orthophosphoric acid or diammonium hydrogen phosphate), and a calcium salt (calcium nitrate, 
calcium hydroxide, calcium hydrogen phosphate hydrate). Critical factors which determine the 
purity and quality of the HA product in wet precipitation techniques are the stoichiometry of 
the reaction and the quality of the raw materials used for the reaction (77). 
The main underlying reaction during wet precipitation technique was proposed by Yogi and 
Aoki as is shown below(78) : 
10Ca (OH)2 + 6 H3PO4                                   Ca10 (PO4)6(OH)2 + 18 H2O            Eq 2.1 
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One of the main advantages of wet precipitation techniques is that the risk of contamination of 
the final product by the by-products is low because the main by-product is primarily water. As 
explained earlier, low processing costs and possible milder reaction conditions (temperature=90 
°C and pH ≈10) make this technique more attractive. However, a slight change in the reaction 
conditions (e.g. reaction addition rate, temperature, pH) can have a major effect on the resulting 
products, which can be a disadvantage when compared to a more stable dry processing (62, 69, 
79). 
HA synthesis through wet precipitation method can be carried out in high and low temperature 
conditions. During the high temperature method, mixed calcium and phosphate reactants with 
accurate stoichiometry need to be heated at around 1000 ºC but it is difficult to control the 
crystal size and in particular the reaction produces HA nanocrystals (58). In contrast, low 
temperature alternative technique can take place at temperatures of lower than 100 ºC, while 
ageing of precipitates from super saturated solution of calcium and phosphate salts takes place. 
It is more convenient to control the size of the final crystals through low temperature technique, 
however, the final product mostly consists of other intermediate calcium phosphate phases 
unless the synthesis conditions and ageing time are carefully controlled(58). 
Uskovovic et al. (58)  have outlined the detailed pathway of HA synthesis by precipitation from 
supersaturated solutions of calcium and phosphate salts. These steps can be briefly summarised 
in the following steps: 
(i) Nucleation of CaP clusters 
(ii) Formation of amorphous clusters,   
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(iii) Formation of chain-like structures and their growth, and 
(iv) Phase transformation through secondary precipitation. 
As HA structure starts to form, free OH ions are incorporated into the HA crystals and pH of 
the solution decreases. Generally, an alkaline solution with high pH of 9.00-10.00 (e.g. 
ammonium hydroxide) is added drop wise in order to provide enough free OH– ions for HA 
formation. Meanwhile, keeping the pH at alkaline levels ensures the balance of phosphate 
species to tip towards PO-34 and minimises the possibility of protonated HPO2–4, H2PO-14 and 
H3PO4 species to form which would make precipitation of HA less favourable(58). 
As the uptake of ions from the solution by the bulk solution decreases, the rate of pH drop also 
decreases. As the pH of the solution starts to stabilize, one may suggest that the solid phase is 
stable and the reaction is finished while the ions within the solid phase are still restructuring to 
form a more stable crystal structure. 
 
2.4.2 Ion substitution into HA 
The chemical composition and final structure of HA can be tailored by adjusting the chemical 
formulations and precursors of HA precipitation reaction.  The possibility of incorporating 
foreign ions in the chemical structure of hydroxyapatite may explain why bones also function 
as a highly effective ion storage area.  
HA in bone tissue is in the form of a calcium-deficient HA (CDHA), and incorporates a range 
of different ionic substitutions into its structure.  Examples of these ions are K+ (0.03-0.07 
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wt.%), Mg2+ (0.2-1.2 wt.%), Sr2+ (0.03-0.05 wt.%), Cl– (0.1-0.4 wt.%) and F– (0.01-0.07 wt.%) 
with further contributions from Zn, Fe, Cr, Co, Mn and Si ions in the ppm range (58, 68). The 
range of available ions, either incorporated into the crystal lattice or adsorbed on to the surface, 
represents the complex nature of the medium within which the hard tissue was mineralizing. It 
also denotes the flexibility of the apatite structure. The presence of these ions have been shown 
to act as a buffer in the bloodstream(80) or to influence the activity of osteoblast and osteoclast 
cells proliferation(81, 82).  
In recent years, many biologically active ions have been incorporated into ceramic implant 
formulations to enhance the regeneration of tissue around the implant, promote 
osseointegration, degree of structural order (i.e. crystallinity) and dissolution rate (83) (8, 81) . 
This section will consider the use of three ions, Ag, Zn and Mg substitution, as they are the 
ones who were studied in this project and are also the most prominent ones in the literature. 
The mechanisms of their incorporation into HA is reviewed and the resulting changes to the 
bulk material and in vitro and in vivo responses are provided. 
2.4.3 Methods of ion substitution in HA 
Ions, and in particular Ag, can be incorporated in the HA structure with either of the following 
methods: 
(i) Wet precipitation method, where all precursors are solubilized in water and precipitate at the 
same time (84) 
(ii) Ion exchange between the previously prepared pure HA and a metal salt solution by 
submerging HA in the salt solution(85), 
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(iii) Sol-gel method(86), by which a colloidal solution is formed from monomers and will 
act as the precursor for an integrated network of ions and ceramic crystals  
(iv) Ultrasonic spray pyrolysis (87), which is an aerosol synthetic method with deposition 
of metals on nanoparticles  
(v) The microwave method (88)  
Regardless of the technique used, the resulting material may be then subjected to heat treatment 
by sintering or drying which can affect the final structure or the crystal size(89). 
2.4.4 Mechanism of antibacterial/antimicrobial activity of metal ions 
Figure 2.2 illustrates a possible mechanism of antibacterial activity of ions, where the exact 
method of interactions is not fully determined. There are three mechanisms, which are thought 
to explain how ions can prohibit the growth of microorganisms (90-93): 
(i) Penetration of ions through the cell membrane and change the regulation of ATP production 
and DNA replication, 
(ii) Ion attachment to the cell membranes with electrostatic forces, which disrupts the integrity 
of the cell and also affects the free transportation of protons and other molecules in and out of 
cell, and  
(iii) Induction of an oxygen stress by formation of free radicals (also called reactive oxygen 
species: ROS) which interfere in the normal function and can irreversibly damage bacteria (e.g. 
their membranes, DNA and mitochondria), resulting in bacterial death(94). 
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Figure 2. 2: Antibacterial mechanisms of nanoparticles and their ions, adopted from(94) 
            
 
 
Further studies have also reviewed other possible interactions of metal ions with bacterial cells 
to explain their antibacterial activity. Kandile et al. (95) proposed that heavy metals can react 
with proteins via thiol (SH) groups leading to inactivation of proteins, but as explained earlier, 
the general concept is that silver nanoparticles follow mainly the mechanisms discussed above.  
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Ag substituted HA (Ag-HA) 
The inhibitory and antimicrobial properties of silver against gram-positive and gram-negative 
bacteria, viruses, and fungi have long been known(96-98) Silver is effective at even very low 
concentrations (35 ppb) without having any negative cytotoxic effect on mammalian cells (99, 
100). Another advantage of silver, and other metal ions in general, is that microorganisms have 
a relatively poor ability to develop immunity to silver. Silver as an infection control agent has 
been used in catheters and coatings of implants and dental materials (92, 101). Due to its large 
spectrum of antimicrobial activity and high efficiency, silver-doped HA has been one of the 
most studied ion substituted HA materials(102, 103).  
Silver can interact with cells and show its antimicrobial activity through two mechanisms: (i) 
Direct interaction of silver ions on the surface of HA with the cell wall of microorganisms. (ii) 
Release of silver ions to the medium from the internal structure of HA surrounding the 
microorganism and then exerting its antibacterial activity(84). 
Although silver has an established antimicrobial effect, it is toxic if its concentration in coatings 
is very high. It is necessary to establish the threshold of silver percentage in HA in order to 
optimize the antibacterial effects while avoiding cytotoxicity. However, there is discrepancy 
for optimum concentration due to the different substitution methods and biological test 
methodologies. 
In a study of in vitro bacterial adhesion to Ag-HA prepared by Sol-gel process, a significantly 
reduced number of Staphylococcus epidermidis (S.epidermidis) and Staphylococcus aureus 
(S.aureus) on both 1 wt.% and 1.5 wt.% Ag-HA surfaces were observed and compared to the 
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surface of HA without Ag (19). In addition, significantly reduced adhesion of viable S. aureus 
was observed on 1 wt.% Ag-HA coating surface when compared to 1.5 wt.% Ag-HA surface 
after 3 hours of bacteria culture(19).  
As far as cytotoxicity is concerned, no significant change in cell proliferation (by measuring 
double stranded DNA amount) was observed for 1 and 1.5 wt.% Ag-HA and HA without Ag 
(19). No difference of Alkaline phosphatase (ALP) specific activity between HA and 1 wt.% 
Ag-HA were observed over time, while a significantly less ALP specific activity was observed 
on 1.5 wt.% Ag-HA surface after 12 and 15 day culture (19). It was concluded that 1 wt.% Ag-
HA has similar biological activity as HA, with respect to bone cell proliferation and 
differentiation, and Ag-HA can minimize the initial bacterial adhesion on its surface (19).   
Ag-HA coating processed by co-sputtering has also been studied for its anti-bacterial and 
biological properties(19). In vitro bacterial adhesion study indicated a significantly reduced 
number of S.epidermidis and S. aureus on 2.05 ± 0.55 wt.% Ag-HA coating surface when 
compared to blank Ti and HA surface after 3 hours of bacteria culture (104). No significant 
cytotoxicity was reported for these coatings after incubation with human embryonic palatal 
mesenchymal cells for 24 hours (104). 
Feng and co-workers used an ion exchange technique to prepare Ag-HA coatings and measured 
the antibacterial effect. HA coating was prepared by ion-beam-assisted deposition (IBAD) and 
was immersed in a 20 ppm AgNO3 solution to carry out ion exchange reaction between Ag+ and 
Ca+ in HA (85). In this study, the treated samples showed antimicrobial activity versus 
Escherichia coli(E.coli), Pseudomonas aeruginosa, S. aureus, and S. epidermidis compared to 
untreated samples. The minimum inhibitory concentration of AgNO3 was determined to be 
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1.302 µg/ml (ppm). The amount of silver ions released in simulated body fluid (SBF) solution 
was shown to be the function of time, indicating an initial fast release of ions while reached a 
constant levels after 24 h (85) .  
In another study by Feng and co-workers, they used the same material to evaluate the 
cytotoxicity of Ag coatings using murine macrophage, cell lines (RAW264.7) and human 
osteosarcoma osteoblast-like cells, (MG63)(105) . The results indicated that the number of 
macrophages in the coating treated with up to 20 ppm AgNO3  solution did not change 
significantly when compared to Ag free coating, indicating Ag-HA coating with limited silver 
ions could effectively inhibit the bacterial growth without significant cytotoxicity (105).  
Karlov and co-workers used silver concentration of up to 15 wt.% of Ag ions in coatings, which 
showed both antibacterial and cytotoxicity activity, while concentration of 5 wt.% had no 
inhibitory effect on bacterial growth. The optimum concentration of 7 wt.% was suggested as 
exhibiting a balanced ratio of antibacterial effect and minimum cytotoxicity(106). Oh et al. (87) 
also showed that a HA coating with 15 mol.% of Ag exhibited mild cytoxicity but this was also 
affected the shape of particles and the choice of synthesis route.  
 
The release profile of silver ion is very critical for its biological activity as a sustained 
concentration of ions available in the environment depends upon it. Shirkhanzadeh et al. (107) 
studied the release of Ag ions from Ag-micro porous HA coating into SBF solution. It was 
reported, that 50% of Ag was released within the first 24 hours. The silver ions release was 
gradually decreased until the end of the experiment at day 7. Chen et al. (108) also prepared 
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Ag-doped HA powders of up to 5 %wt. and observed similar release profile while the maximum 
concentration of Ag in the medium was only 2.27 ppm after 14 days. 
 
Ag-HA has also been used for bone cement applications, in addition to implant coatings. It has 
been shown, that HA cements with 1% metallico silver nanoparticles in the range of of 5- 50 
nm in diameter, can have effective antibacterial activity against S.epidermidis, methicillin-
resistant S.epidermidis (MRSE), and methicillin-resistant S.aureus (MRSA), where no 
significant cytotoxicity on fibroblasts and osteoblasts was observed with the use of the above 
ion concentrations(109).The microbiological effect of silver when incorporated in amorphous 
calcium phosphate has also been reviewed and antibacterial activity was observed at 
concentrations of 3 to 6 wt. % of Ag against E. Coli, S.aureus, P. aeroginosa, C. diphteroides 
and C. albicans (110). 
 
Mg substituted HA (Mg-HA) 
Magnesium (Mg) plays a key role in bone growth and metabolism by modulating osteoblast 
and osteoclast activity in biological apatite. Its level increases as calcification progresses and 
decreases as calcifications takes places (68).  
Mg is one of the essential metals in biological apatite with concentrations of 0.44, 1.23, and 
0.72 wt.% in enamel, dentin and bone, respectively (111).  Although research on the role of Mg 
on bone health is still on going, most studies report a positive effect on all stages of skeletal 
metabolism and bone health, particularly in the process of osteoporosis(112),(28). Belluci et al. 
(113) demonstrated that Mg deficiency has a negative effect on bone metabolism and new bone 
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tissue formation around implant sites. 
Mg-HA have been used in numerous orthopaedic and dental prosthetic examples (114). Zhao 
et al.(115) reported that Mg substituted HA surfaces promoted osteogenic differentiation of pre-
osteoblasts and might improve implant osseointegration during the early stages of implantation. 
Bonfield and Gibson prepared bone mimetic HA ceramics with the co-incorporation of Mg2+ 
and CO32- in a content of up to 0.5 and 1 wt.%, respectively by using a precipitation method. 
They expected, that the resulted materials would exhibit better bioactivity over pure HA, which 
was applied in the commercial application, such as bone implant fabrication(116). Mg 
concentration of up to 25.4 wt.% was used in odontostomatologic applications (117). 
Mg has a smaller ionic radius (0.065nm) to calcium (0.099nm) which could allow it to 
substitutes either of Ca I and II positions (see section 2.3.1 HA chemistry); there is a preference 
for the Ca (II) position which is possibly due to the greater flexibility of the ions geometry at 
the this position(68). Solid state Nuclear Magnetic Resonance (NMR) studies have also 
confirmed that Mg ion can be substituted for Ca (II) position by up to 10% molar ratio of Mg 
(118).  
Mg can also inhibit the nucleation and growth of HA crystals resulting in the reduction of HA 
crystallinity(119), while stabilizes the more acidic calcium phosphate intermediate phases 
during synthesis(120) . 
Chiranjeevirao et al.(121) reported that Mg-HA solid solutions in the whole range of 
compositions were prepared by using calcium nitrate, magnesium nitrate, and ammonium 
dehydrate phosphate in an aqueous medium at pH=9.0. Similar work was carried out by Patel 
et al.(122) who prepared similar Mg-HA solid solutions using same reactants, but was 
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synthesized at more alkaline pH values, which was above 11. However, other researchers could 
not reproduce the results presented in that study (13, 123). Bigi et al.(13) showed that Mg 
exhibited similar effect as Zn ions inhibiting the crystallization of HA. It was reported that the 
unique crystalline apatite phase was only achieved with Mg concentrations in the range of 0 to 
30 atom % (13). At Mg concentrations of 35 to 50 atom %, the structure became  fully 
amorphous and other phases such as  Mg3(PO4)2·8H2O, and NH4MgPO4·H2O started to form. 
The same research group also reported, that the crystal size, degree of crystallinity, and the 
(Ca+Mg)/P ratio was decreased with increasing Mg concentration(13). 
The opposite effects of Mg substitution for Ca on the crystal size and degree of crystallinity of 
apatite was reported by Yasukawa et al. (124) who prepared Mg-HA solid solutions with a 
Mg/(Mg + Ca) molar ratio ranging from 0 to 0.5 by a wet precipitation method, using 
Mg(NO3)2·6H2O, Ca(OH)2, and H3PO4 as reagent. The crystal size of the apatite phase was 
increased and a more porous structure was formed with increasing  Mg/(Mg + Ca) ratio from 0 
to 0. 31 (124). When the ratio reached 0.38, an amorphous structure was formed. Fadeev et al. 
(33) followed a similar wet precipitation method using Ca(NO3)2, Mg(NO3)2, and (NH4)2HPO4 
( 33 ) and reported that Mg had a destabilizing effect on the apatite structure. 
Other studies showed that a maximum Mg concentration of 5.7%wt was substituted in the 
apatite crystal lattice for calcium with excess of Mg to be in the form of an additional 
amorphous phase (68) or adsorbed on the HA surface (119).  
The effects of free magnesium ions on early bone formation have been exploited through the 
production of Mg-HA as bone defect fillers. Mg ions helped to increase osteoconductivity in a 
rabbit femoral defect filled with Mg-HA granules (125). While there are no specific studies 
50 
 
which isolate the role of Mg ions in adjusting material dissolution properties, there is evidence 
that Mg ions association with calcium phosphates may influence the surface structure in a way 
that implies increased solubility (126). 
Zn substituted HA (Zn-HA) 
Zinc (Zn) is the most abundant trace metal in bone mineral (ranging from 0.0126 to 0.0217 
wt.%) and plays a key role in various body functions such as regulating nucleic acid 
metabolism, maintenance of membrane structure, hormonal activity and is an enzyme cofactor 
in more than 300 enzymes involved in bone metabolismjonna (68, 83, 89, 127). Zn also 
stimulates bone formation and mineralisation by inhibiting osteoclast differentiation and 
enhancing osteoblast activity (128), while it has been also shown that it can stimulate bone 
resorption at higher concentrations (129).  
Ion substitution via wet precipitation has been a common technique for the preparation of Zn-
substituted HA (Zn-HA) with varying ratios of Zn substitutions (126, 130-132). Zinc is well 
known for its inhibitory effect on HA crystal growth, but it has been shown that it can be 
quantitatively substituted in the HA lattice at concentrations of up to 20 atom. %. (133) .The 
smaller ionic radius of Zn (0.075nm compared to 0.099nm Ca) can result in a reduction in the 
lattice parameters of the apatite crystal (131). Tripathy et al. (134) reported that they could 
produce Zn-HA with a chemical formula of Zn10(PO4)6(OH)2 using a co-precipitation method 
in aqueous media. However, other studies suggested that because of the inhibitory effect of Zn 
on the crystallization of HA, the synthesis of Zn-HA over the entire compositional range was 
impossible (127, 132, 135). 
Bigi et al. (127) performed a synthetic reaction using different concentrations of Zn in solution 
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(ranging from 0 to 100 atom%); however, the unique crystalline phase was only obtained with 
Zn concentrations of only up to approximately 25 atom%. With increasing Zn concentration 
above 25 atom% the XRD analysis showed the presence of an amorphous structure and the 
evaluation was hindered because of the peak broadening effect (127).  
Li et al. (135) reported the synthesis of 20 mol% of Zn-HA by using Ca(NO3)2, (NH4)3HPO4, 
and Zn(NO3)2 via a hydrothermal method  and showed that the degree of crystallinity and 
crystal size of Zn-HA samples decreased with increasing Zn concentrations while the numbers 
of the Zn-HA crystals formed were increased (135). 
In another study by Miyaji et al. (132) the limits of Zn substitution in the apatite structure was 
estimated to be 15 mol%.They used alternative reagents (Ca(CH3COO)2·H2O, 
Zn(CH3COO)2·2H2O, and (NH4)2HPO4 ) to avoid the incorporation of NO3 -2 or Cl- into the 
apatite structure. The maximum concentration of 15% mol was reported which was a slightly 
lower value compared with the one reported by Li et al, who suggested that the small difference 
on the substituting limit value was attributed to the consequence of using a different synthesis 
method (135). These authors indicated that the Zn-HA samples were more difficult to prepare 
by using a precipitation method rather than using a hydrothermal method (135). 
Chemical analysis confirmed that both Ca/P and (Ca+Zn)/P ratios decreased as Zn content 
increased resulting in a change in the stoichiometry of HA, loss of crystallinity and formation 
of irregular shapes of Zn apatite structures (133). Within the substituting limits, Miyaji et al. 
(132) found that the crystal size and degree of crystallinity was decreased with increasing Zn 
substitution. This was in good agreement with results reported Li et al. (135) . Furthermore, 
Miyaji et al. (132) suggested, that the order of the produced phases with increasing Zn 
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substitution was Zn substituted apatite, amorphous phase, and amorphous phase + parascholzite 
(CaZn2(PO4)2·2H2O). Zn inhibits the crystal growth of apatite by being adsorbed onto the active 
growth sites which is why the (Ca+Zn)/P ratio and stoichiometry cannot be maintained (68, 
119, 132).  
Whether there is an actual substitution within the HA lattice, however, is not fully clear. There 
is much debate over the mechanism of Zn incorporation into HA. Some theoretical studies 
reported that ion substitution is not energetically favoured and that Zn occupation at Ca 
vacancies (particularly at the Ca (II) site) is probable with significant local structural distortion. 
Contrarily, Tang et al. (136) reported that Zn ions may favour the substitution at Ca (II) position, 
but also highlighted that Zn ions could be entrapped and act as a defect site given the fast 
crystallisation kinetics of precipitation.  
Measuring ion adsorption values have shown high amounts of Zn ions being associated with 
HA particles, which is higher than what is expected to be normally substituted. Wang et al. 
(137) reported that Zn ions have a high affinity to adsorb on HA crystals at concentrations 
above 1wt%. They presented a Langmuir type adsorption isotherm for Zn and Mg ions on the 
active growth sites on the HA crystals. Two possible explanations are the formation of zinc-
phosphate complexes at the surface and the ability of the surface bound Zn species to undergo 
hydrolysis and potentially block multiple active growth sites (119).  
The mechanism of the antibacterial activity of HA with zinc ions is again not yet fully 
understood. It is proposed that Zn ions form strong bonds with thiolic, imidazole, amine, and 
carboxylic groups of proteins, causing structural changes and also affects the membrane 
permeability and transport resulting in cell death (138, 139) . It is also shown that Zn ions can 
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damage the enzymatic activity and DNA and RNA of bacteria with similar results (140). 
In addition to its role as an antimicrobial agent, Zn-HA ceramics are used to regulate other 
biological functions. Kawamura et al. (141) used composite ceramics of Zn-TCP/HA as 
implants in the femor of New Zealand White rabbits for 4 weeks and reported increasing rates 
of bone formation at concentrations of 0.316 wt.%.   
Grandjean-Laquerriere et al. (142) reported, that the addition of Zn-HA decreased the 
inflammatory reaction following the implantation of HA based prosthesis by increasing the 
production of cytokines. Li et al. (135) suggested that Zn substituted HA could consist of a new 
generation of biomaterials for bone tissue engineering. 
 
2.5 Bone: A Solid Structure and Living Tissue 
2.5.1 The chemical Composition of the Human Bone Mineral 
Natural bone consists of organic and inorganic chemicals. The majority of the organic structure 
is formed of Collagen (90-95%) and calcium and phosphate form the most part of inorganic 
chemicals (143). 
The inorganic phase of bone is primarily made of apatite crystal structure of which resembles 
and the mineral phase consists of a continuous cellular backbone.  
HA is the main mineral available in bone, dentin and teeth (143). Bone is made of 25 wt.% 
water, 43 wt.% mineral, 29 wt.% collagen and 3 wt.% of non-collagenous organic molecules 
(144). The inorganic part of bone is also made of calcium, phosphate and hydroxyl ions in the 
ratio of the chemical formula, Ca10(PO4)6(OH)2. It is important to note that natural bone apatite 
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is slightly different from the stoichiometric HA in terms of stoichiometry, crystal dimensions 
and a relative crystallinity of 33-37% with the degree of crystallinity of the stoichiomettric  HA 
is assumed to be 100% (68, 133, 145). 
The organic part of the bone is made of type I collagen which is a fibrillar protein composed of 
three protein chains, bound together in a triple helix by secondary hydrogen bonds.. 
2.5.2 Hierarchical Structure 
The natural human bone is a complex network of living cells within a hard and dense connective 
structures with different arrangements and scales. Bone is a living tissue and with its 
microstructure is continuously evolving. The main role of the bone is to form the main 
supportive structure of the body as the skeleton, protect the organs, generate healing cells and 
carry out the homeostasis mineral ions (146). 
Knowing the physical, chemical, and mechanical characteristics of human bone is vital in 
making of similar structures for medical applications.  
To understand the bone architecture, it is critical to consider the involved scales and understand 
the structural relationship between them. The following section provides a detailed overview 
of bone structure and discusses how it can define the final structure of bone.  
Figure 2.3 shows different classes of entities in bone in terms of their scale. These levels can 
be indicated as the continuum level (macro-structure), tissue level (meso-structure), cellular 
level and molecular level (microstructure)(147).  
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Figure 2. 3: Hierarchical structural organization of bone (a) cortical and trabecular bone (a) Cortical and 
trabecular bone;  (b) Osteons with Haversian systems; (c) Lamellae; (d) collagen fiber assemblies of collagen 
fibrils; (e) bone mineral crystals, collagen molecules, and non-collagenous proteins(148) 
 
  
A more detailed structure of bone can be seen as a well-defined hierarchically organized matrix, 
consisting of further entities at different scales which also define the structural-function in bone 
(149) The most detailed structural classification of bone was provided by Weiner and Wagner, 
who concluded that there are  seven structural levels of hierarchy in the adult human bone (150) 
as illustrated in Figure 2.4. 
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Figure 2. 4: The 7 hierarchical levels of the bone (150). 
Macrostructure 
The macrostructure or continuum level of the bone defines its overall shape i.e. the shape and 
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form of mature and grown bone (e.g. femur) and can measure between 3-750 mm.  
Mature bones are made of either cortical (compact) bone on the outer surface of most bones 
and cancellous (spongy or trabecular) bone found near the ends of long bones and at the centre 
of flat bones (e.g. ribs) (148). These two types of bones are very similar in terms of 
compositions but each has different degree of porosity and ratio of organic to inorganic 
compounds.   
Cortical bone is denser than trabecular bone, is formed from cylindrical lamellae and has a 
porosity of between 5 and 10%.  Cancellous or trabecular bone are more porous (can have a 
porosity of up to 95%) and is made of trabecular struts with non-mineralized spaces filled within 
cancellous bone contain bone marrow (151). Cortical bone is denser than forms the outer shell 
around the trabecular bone in joints and in vertebrae and can account for about 80% if the total 
skeletal mass, while trabecular bone can form around 70% of the skeletal volume (144).   
Microstructure and Sub-microstructure 
At this scale (5 to 500 µm), the main components are osteons, Harvesian canals and lamellae. 
Osteons are large hollow fibers of lamellae and as Figure 2.5 shows, that are made of Harvesian 
canals (or secondary osteons) and contains blood cells (149). Harvesian canals are 100-200 µm 
in diameter and are surrounded by cement lines, which bind them to the bone matrix.  
The sub-microstructure of bone consists of lamellae, which are fibrils consisting of calcium 
phosphate and collagen cells and are 3-7 µm thick. 
Two main types of bone microstructure can be found at this level: 
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a) Woven bone, which is usually a transient tissue type and is composed of poorly organized 
mineralized collagen fibril bundles without a set pattern and can be used as a scaffold for further 
bone structure development or fracture healing (149) 
b) Lamellar bone (Figure 2.5), which is a highly organized bone tissue and is composed of a 
series of lamellae (each lamella is in the range of 3 to 7 µm as discussed above). The lamellae 
are bands or bundles of mineral crystals and collagen fibers. The spaces between these arrays 
are filled with disordered materials (152). 
As bone grows, the woven bone is replaced by lamellar bone or become highly mineralized 
having improved pattern and organization (144) .  
 
Nanostructure and Sub-nanostructure  
Collagen fibres are the most dominant structure at this scale (100 nm-1 µm) and with apatite 
can make up to 95% of the dry weight of bone. Collagen is the most abundant protein in the 
body and it accounts for 70-90% of non-mineralised component of bone (153). Type-1 collagen 
is the most abundant protein in mature bone. Collagen is responsible for the flexibility and 
tensile strength of bone.  
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Figure 2. 5: Lamellar bone (154).  
 
Other than collagen proteins are non-collagenous (NCP) and proteoglycans such as osteocalcin, 
alkaline phosphatase osteopontin and bone sialoproteins  that are responsible for regulating 
bone mineralisation and bone formation (149).  
At the smallest scale, bone minerals are present at molecular levels which are mainly comprised 
of apatite crystals. The mineral phase is in the form of thin plate like structure which are 
between 1.5-4 nm thick (155).  
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2.5.3 Bone Physiology 
The bone cellular structure is composed of three functionally distinct cell types; osteocytes, 
osteoblasts, and osteoclasts. The overall function of these cells is to determines how the bone 
is remodelled.  
Osteoclasts 
Osteoclasts are giant multi-nucleated cells, typically 20 to 100 µm in size that are responsible 
for resorbing old bone by secreting acids and enzymes (156). Osteoclasts are active during bone 
remodeling and are generally more related to macrophages rather than osteocytes or osteoblasts 
(156).  
Osteocytes 
Osteocytes are small inactive cells, that form about 90% of all cells in human skeleton. These 
cells are derived from osteoblasts and regulate the extracellular concentration of calcium and 
phosphate ions through the release of calcitonin and parathyroid hormones. Osteocytes interact 
with osteoblasts and other osteocytes via canals within the bone matrix called canaliculi (157).  
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Osteoblasts 
Osteoblasts (bone-forming cells) are small mononuclear cuboidal cells, which are derived from 
bone marrow mesenchymal stem cells and play a key role in bone matrix synthesis(157). 
Osteoblasts release alkaline phosphatase during their activity that catalyses the hydrolysis of 
pyrophosphates and polyphosphate ions releasing inorganic phosphates (158, 159). Calcium 
salts precipitate from the body fluids and bond with osteoids resulting in the formation of new 
bone tissue. 
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CHAPTER 3 
MATERIALS AND METHODS 
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3 Materials and Methods 
 
This chapter outlines the detailed experimental procedures employed for: 
• The preparation of cation-substituted hydroxyapatite (Ag, Zn, and Mg/ HAp)  
• The analytical techniques that were used to characterise and study the chemical and 
physical properties of substituted apatites. 
• In order to understand and model the biological activity and cellular response to the ion 
substituted HA samples and their impact on cell viability, cell proliferation and cell 
differentiation, animal cell lines were developed and analysed with all the synthesised 
samples. The results from these assays enabled us to establish the behaviour of 
hydroxyapatite and the addition of selected ions and predict their in vivo responses.  
• To investigate the bactericidal effect, two types of tests (spread plate method and agar 
diffusion test) were developed using two pathogens associated with implant infection 
and failure.  
 
The following techniques were used for the chemical and structural analysis: 
1) X-ray diffraction (XRD) was employed to ascertain phase purity, degree of crystallinity, 
crystal size and lattice parameters of apatite and substituted apatites. 
2) Fourier transform infrared spectroscopy (FT-IR,) Raman Spectroscopy and X-ray 
fluorescence (XRF) techniques were used to identify the chemical composition of the materials. 
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3) Thermogravimetric analysis (TGA) was employed to understand the thermal decomposition 
profile of the prepared samples and explain the behaviour of ceramics at sintering temperatures 
and subsequent chemical conversion (decomposition).   
4) Inductively-Coupled Plasma-Mass Spectrometry (ICP-MS) was used to measure the 
concentration of soluble ions in the liquid phase.  
 
3.1 Synthesis of ion substituted hydroxyapatite (wet precipitation technique) 
Reagents 
The reagents used for substituted HA synthesis were Diammonium hydrogen phosphate 
(NH4)2HPO4 and Calcium Nitrate Tetrahydrate Ca(NO3)2.4H2O plus either of Silver nitrate 
Ag(NO3)2 for Ag-HA, Zinc nitrate ZnNO3 for Zn/HA and Magnesium nitrate Mg(NO3)2.H2O 
for Mg/HA). These chemicals were introduced to the reaction in form of two separate solutions 
(A and B). Solution A was prepared by dissolving a calculated amount of Ca(NO3)2·4H2O (for 
Ca-HA) and Ag(NO3)2 (for Ca-Ag-HA) in 200 ml deionised water (deionised water was used 
for all the experiments to minimise any side reaction of other interfering ions with the 
reactants). The amount of reactants was calculated by adjusting the concentration of 
Ca(NO3)2·4H2O in order to keep the (Ca + x)/P ratio (x= substituted cation) constant at 1.8. The 
(Ca+2 + x)/P ratio of 1.8 for this study used by the method developed by Bigi et al (83). The 
amount (weight) of the added cation (x) to the total cation (x / Ca+2 + x) was variable and was 
set to obtain a 1, 5, and 10 wt.%. Tables 3.1, 3.2, and 2.3 show the weights of each reagents for 
a 200 ml solution A. 
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Solution B was prepared by dissolving (NH4)2HPO4 in 200 ml of deionised water and was 
identical for all of the samples.  
Pure HA was prepared and used in all the experiments as the control sample. 
 
All chemicals and reagents were supplied by Sigma-Aldrich and had the following grades: 
 AgNO3: (BioXtra, ≥ 99%) 
 MgNO3 : ( BioXtra, ≥ 98%) 
 ZnNO3: (crystallized, ≥ 99%) 
 Ca(NO3)2·4H2O: ( ≥ 99.0%) 
 (NH4)2.HPO4 : (ACS reagent  ≥98%) 
 NH4OH: (ACS reagent, 28.0-30% NH3 basis) 
 
Deionised water was generated in a lab based deionisation water PURELAB Chorus 2 
generation system. 
 
Table 3. 1: Weights of reactants in chemical precipitation method to make Ag substituted HA (based on 200 
ml of 1M solution of Ca+Ag ions) (unit) 
Ag (%) Ca(NO3)2·4H2O Ag(NO3)2 (NH4)2HPO4 
0 47.20 0 14.66 
1 46.73 0.34 14.66 
5 44.84 1.70 14.66 
10 42.48 3.40 14.66 
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Table 3. 2: Weights of reactants in chemical precipitation method to make Mg substituted HA (based on 
200 ml of 1M solution of Ca+Mg ions) 
Mg (%) Ca(NO3)2·4H2O Mg(NO3)2 (NH4)2HPO4 
0 47.20 0 14.66 
1 46.73 0.512 14.66 
5 44.84 2.56 14.66 
10 42.48 5.12 14.66 
 
Table 3. 3: Weights of reactants in chemical precipitation method to make Zn substituted HA (based on 200 
ml of 1M solution of Ca+Zn ions) 
Zn (%) Ca(NO3)2·4H2O Zn(NO3)2 (NH4)2HPO4 
0 47.20 0 14.66 
1 46.73 0.59 14.66 
5 44.84 2.97 14.66 
10 42.48 5.95 14.66 
 
Apatite synthesis reaction  
HA samples were prepared by using an adopted chemical precipitation method developed by 
Bigi et al. (83). 400 ml of solution A was transferred into a three-neck flask (Figure 4.1) and 
was heated and maintained at 90°C. 400 ml of solution B was heated in a separate container 
and was carefully poured into solution A from the top of the condenser. The pH values of the 
solution A and B were maintained at 11 by gradual addition of NH4OH solution with a 5 ml 
pipette. The mixed Solution A and Solution B was kept agitated and heated to 90°C using a hot 
plate/magnetic stirrer for 5 hours. The temperature of the mixture was measured with a 
thermometer fixed on the neck of the flask. Heating was stopped at the end of the reaction and 
the suspension was allowed to cool. In order to obtain the precipitate, the solution was 
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centrifuged for 13 minutes at 10000 rpm at room temperature with a Beckman Coulter model 
J6-MI Centrifuge. The supernatant was collected and its pH checked. The HA precipitate was 
re-suspended with deionised water up to 5 times until the pH of the supernatant reached 7.0. 
Finally, the washed precipitate was dried overnight in an oven at 37°C. For any subsequent 
material characterisation, the dried HA precipitate was grounded into a uniform fine powder 
using a pestle and mortar.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. 1: Schematic diagram of the experimental setup for HA preparation taken with permission from 
Jiangling et al. (76) 
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Preparation of HA discs and sintering 
For the microbiological and cell biological assays, HA samples were prepared in discs. For 
doing so 0.5 g of the sample powder was pressed at 155 Nm-2 force using a mechanically 
operated press machine (Instron 5582) and metallic dyes specially designed for making dense 
discs of 13mm diameter and 2mm thickness (Specac Ltd., Kent, UK). 
All the discs were sintered in a furnace at 1100°C. The temperature of the furnace was set to 
increase at a rate of 5°C/min up to the set plateau temperature (1100°C) and it was remained at 
this temperature for 2 hours after which it was reduced to 26°C at the rate of 10°C/min (Figure 
3.2). The calcination time was limited to 2 hours to prevent further decomposition of HA to 
TCP. These sintered powders (not disc) were used for all subsequent material characterisation 
assays.  
 
 
 
 
 
 
 
 
 
 
 
Figure 3. 2: Discs of Hydroxyapatite                                                      
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To obtain a smooth surface for biological assays, sample disks were polished with a fine sand 
paper and washed in an ultrasonic bath in water before being sterilised. The sintered discs were 
placed in sealed autoclave tubes and heat sterilised at 120°C for 20 minutes. 
 
3.1.1 X-Ray Diffraction 
X-ray diffraction (XRD) is a versatile, non-destructive instrument that is used for determination 
of atomic arrangement within a material, giving the crystalline phases from the atomic spacing 
and symmetry (160). In this technique, X-rays of a known wavelength are passed through a 
sample to fully investigate its crystalline structure. The wave nature of the X-rays means that 
the lattice of the crystal gives a unique diffraction, which results in pattern of peaks of 
‘reflections’ at varying angles and with different intensities. The diffracted beams from atoms 
in successive planes cancel unless they are in phase, and the condition for this is given by the 
Bragg’s law (161-163): 
 
 = 2. . sin 																																																																																																																															 .		3.1 
 
where; λ is the wavelength of the X-rays, d is the distance between different plane of atoms in 
the crystal lattice and θ is the angle of diffraction. 
 Figure 3.3 shows the X-ray detector moves around the sample and measures the intensity of 
these peaks and the position of these peaks (diffraction angle 2 θ). The highest peak is defined 
as the 100% peak and the intensity of all the other peaks are reported as percentage. 
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Prior to XRD analysis, the samples were ground using a marble mortar and pestle before 
distributing 200mg of the ground sample powder over a 10mm diameter circular area of 25mm 
Magic® tape (Scotch Magic Tape, 3M, France) which was in turn folded over the sample and 
attached to the sample holder. 
 The prepared HA samples were analysed by XRD using a high resolution Powder Bruker D8 
Diffractometer (Bruker ASX Gmbh, Karlsruhe, Germany, Figure 3.4), with CuKα 
monochromated beam (wavelength=0.154056 nm) produced at 40 kV and 40 mA. The scanning 
range 2θ was performed from 20° to 60° using a step size of 0.05° and step duration of 1 
second. 
 
Figure 3 3: Incident and diffracted X-rays are in phase 
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Figure 3. 4: Powder X-ray diffraction machine (Bruker D8 Diffractometer) 
                 
                    
The sample was rotated about its axis during the entire measurement to minimise the influence 
of preferential crystal orientation. Baseline correct of the diffraction patterns was implemented 
using the Bruker DIFFRAC.SUITE software (Bruker ASX GMBH, Karlsruhe, Germany). 
 The XRD data was used to identify the phases, the crystallinity (what ratio of the ceramic is 
amorphous or crystallised), the purity of the HA powders as well as the details of their 
crystallographic properties (such as crystal size and lattice parameters).  
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Phase Identification 
For the phase identification step, the X-ray diffraction patterns were directly compared to the 
files for HA from the Joint Committee for Powder Diffraction Standards (JCPDS, Card No. 09-
432) as was supplied by the International Centre for Diffraction Data (ICDD).  
The most common phases present within calcium phosphate based powders, such as a-TCP 
(09-348), β-TCP (09-169), DCPA (09- 80), DCPD (09-77), OCP (26-1056), TTCP (25-1137) 
were used. Similarly, the most comparable phases for Ag, silver phosphate (06-0505), silver 
metallic (04-0783), for Mg, Mg-β- TCP (01-70-1787), Brucite [Mg(OH)2] (07- 0239) 
magnesium oxide (00-04683) and for Zn Parascholzite. (35-.0495), zinc oxide (36-1451) were 
identified and reported in the Results section. 
Crystallinity 
The crystallinity of the HA samples was measured by comparing the ratio of peak-to-
background of the real samples to the one for a fully crystalline reference sample (163). The 
percentage of crystallinity was based on the XRD patterns obtained between 10° to 60°(2θ) and 
was calculated using the following equation (163): 
 
% =  −   ×	100																																																																																											. 3.2 
 
where I300 is the intensity of (300) diffraction peak and V112/300 is the intensity of the hollow 
between 112 and 300 diffraction peaks of HA. 
 
3.1.2 Crystal size (L002 reflection plane) 
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The crystal size, of the precipitates was estimated from XRD pattern using the Scherrer’s 
formula (163). According to this equation, a single crystal dimension perpendicular to the (h k 
l) plane (D h k l ) (nm) can be estimated from the peak broadening as: 
 
   
 = !"#$%&. cos	 																																																																																																																									. 3.3 
 
where D is the crystal size in nm; K is the Scherrer constant (0.9 for hexagonal HA), α is the 
wavelength of the monochromatic X-ray beam (0.15418 nm); FWHM is the experimental Full 
Width at Half Maximum intensity of the diffraction peak under the consideration peak; θ is the 
diffraction angle (°). In samples with apatite structures, the line broadening of the (002) 
reflection was used to evaluate the mean crystal size, which corresponds to the c 
crystallographic axis. 
 
Lattice Parameters Determination 
The spacing of the lattice points in a crystal is an important quantitative aspect of its structure 
and its investigation by X-ray diffraction. In case of the hexagonal crystal structure of HA, the 
lattice parameters were denoted by (a=b), and c and were determined from the relationship 
between the distance (d) of two adjacent planes and the (h k l) Miller Indices by using the  
equation below (163):   
1
 =
ℎ +	+
, +
-
. 																																																																																																																									. 3.4 
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where d is determined by Bragg’s law (E 4.1) by knowing the wavelength (λ) and  diffraction 
angle (2θ). In this method, for each (hkl) XRD peak, lattice spacing of the (hkl) planes can be 
calculated by: 
0123 			 4567	8 																																																																																																																																		. 3.5  
 
where θ is obtained from the XRD pattern. C axis parameter can be calculated from the 
(00l) peaks, once the c-axis parameter is calculated, a-axis parameter can be calculated 
by considering any (hkl) peaks. However, since any error in measuring the exact value 
of θ produces errors in sinθ and subsequently in the calculated lattice parameter, it is 
important to choose the peaks which minimize this error. For the function of sinθ, the 
error in sinθ would be the minimum if θ is close to 90°. Therefore, it is more accurate 
to use peaks near θ=90° to minimize the errors in sinθ. If there are more than one peak 
near θ=90°, all the peaks are considered and the average value for the lattice parameters 
are reported.  
 
 
For this study, hexagonal unit cells (as in HA crystals) will result in the following equation for 
distance (d): 
1
ℎ+- = [
4
3 ℎ +	+ + ℎ+ +	- ;
,
.<
-
, 																																																																														. 3.6 
 
 
 
The following data were used for the analysis. 
a=b, α=β=90°, and γ=120°, space group: P63/m 
3.1.3 X-ray fluorescence 
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X-ray fluorescence (XRF) is an elemental analysis technique to understand the chemical 
composition of the samples and is based on measuring the emitted X-ray beams specific form 
each element after an X-ray beam is directed from an external source inside the X-Ray machine 
(164). 
Samples were dried and powdered as described for XRD analysis. 1g of powder sample was 
evenly distributed over 2μm thick Mylar film held taut over a loose powder sample holder. 
 The atomic concentrations of Ca, P, Ag, Zn, and Mg in the precipitates were determined by 
Bruker S8 Tiger (Bruker ASX Gmbh, Karlsruhe, Germany). 
Three replicates were carried out for each sample and the mean value was calculated. The 
reference samples of each ion was prepared by mixing known amount of cation (Nitrate salt) 
solid in the pure HA powder and using the mixed powder in the XRF machine to create a 
reference response for a known amount of cation. Standard curves were created by measuring 
the XRF response for 5 different concentrations of each cation (0.5%, 2%, 3% 4% and 12% 
wt% of AgNO3, ZnNO3 and MgNO3 in pure HA) and used to calculate the accurate 
concentration of each component in the synthesized ion-substituted HA samples. 
 
 
 
3.1.4 Fourier Transform Infrared Spectroscopy  
Fourier transform infrared spectroscopy (FT-IR) is a chemical analysis technique that generates 
a molecular fingerprint of the samples. It is based on the vibrations of the atoms, which are 
subjected to a passing infrared radiation and measures the ratio of the incident radiation is 
absorbed at a particular energy (165).  As the sample is exposed to different wavelengths of 
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infrared light, transitions between vibrational energy levels of various chemical bonds are 
detected, allowing for the functional groups within the molecules of the sample to be identified. 
The resulting spectra, which are a characteristic of infrared absorption/emission at different 
wavelength, can be used to define the chemical composition of the sample. 
In this study, FT-IR was used for further confirmation of the chemical composition of the 
samples.  FT-IR spectroscopy was carried out by a Nicolet nexus 470 FT-IR using a smart orbit 
diamond attenuated total reflectance (ATR) to confirm the presence of chemical group OH and 
PO4.  Sample preparation was consisted of mixing 2mg of each sample with 300mg of 
Potassium bromide (KBr), compressed to form a tablet and then placed on the diamond ATR 
specimen holder and analysed them from 400 to 4000cm-1 at 4 cm-1 resolution averaging 100 
scans. Four spectra reading were done for each synthesised sample and absorbance spectrum 
were considered. A background reading was taken before collecting spectra from the samples 
and was subtracted from the sample spectra. 
 
 
3.1.5 Raman Spectrometry  
Raman spectroscopy is another non-destructive spectroscopic technique to obtain information 
about the structure and chemical composition of materials. Similar to FT-IR, a radiation source 
(such as UV light, near infrared beam) is used to excite the molecules through the absorption 
of a photon and measures the vibrational and rotational transition of the molecules and 
functional groups (166)(Figure 3.5). Raman spectroscopy is based on the change of polarisation 
of the molecule during the vibration while FT-IR technique relies on dipole moment change of 
the molecule. Hence, Raman spectroscopy can be used to analyse the molecules, which are 
symmetrical and have no dipole moment (like O2). 
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Raman spectra of powdered samples (without any treatment) were obtained using a Renishaw 
InVia Raman microscope (Renishaw plc., Gloucestershire, UK) using a 532nm laser line at 
10% power delivered to the sample via a x50 Plan-N objective lens with the detection range set 
to 300-1200cm-1. The scan time was set to 10 seconds and 5 scans were gained and summed to 
produce the final spectrum for analysis using the Wire 3.0 software (Renishaw plc, 
Gloucestershire, UK.) 
 
 
 
Figure 3.5: Adapted schematic diagram of Raman Spectroscopy taken from Department of Chemistry and 
Biochemistry website, University of Maryland. 
 
3.1.6 Thermogravimetry (TG) 
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TG is used to study the change in mass of a sample as the temperature is varied. By controlling 
the atmosphere e.g. with O2 or N2, it may be possible to encourage or suppress oxidation 
reactions, thus controlling to some extent the nature of the thermal events occurring (167). 
When heated to 1000°C, many materials undergo weight changes giving characteristic curves. 
Where the changes can be linked to the particular thermal events, such as oxidation, or loss of 
water of crystallisation, the size of the step in the curve can be used for the quantitative analysis.  
TG analysis was carried out in a NETZSCH-TG209 system under air atmosphere with the 
heating rate of 10°C/minute.  100mg of dried samples were grinded to make a fine powder. 
The percentage weight loss is recorded and plotted as a function of time (in second) and 
temperature. The baseline values were corrected by carrying out a blank run and subtracting 
this from the plot obtained from the same machine.   
 
3.1.7 Inductively coupled plasma mass spectrometry 
Inductively coupled plasma mass spectrometry (ICP-MS) is a widely used analytical technique 
and is commonly applied for trace elemental analysis (168). ICP-MS operates on the basis of 
decomposing (ionising) the sample into neutral elements using a high temperature argon 
plasma, and separation and detection of the generated elements according to their mass to 
charge ratio (168). Samples are firstly converted to aerosols and then passed into a torch body 
and mixed with heated argon gas, producing an argon plasma flame. This produces atomised 
and ionised sample are transferred into a pumped vacuum system through a quadruple mass 
filter and are directed to a mass spectrometer, with a typical detection limit of 0.1 µg-1.  
For this study, an ICP-MS technique was used to measure the amount of released cations (Ag, 
Zn, and Mg) into the liquid phase. The solubilised cations were measured under two conditions:  
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a) Solubilised cations from the solid HA precipitates during washing, resuspension and 
centrifugation process. 5 ml of each supernatant was collected after each centrifugation step 
and the cations were measured by ICP-MS. The results from this section were used to carry out 
an accurate mass balance for the cations and determine how much of the cation were remained 
in the solid phase. 
b) Release profile from the prepared disk samples after being placed in PBS buffer up to 21 
days. This experiment was developed to measure the release profile of the cations and was used 
to better describe the concentration of the ions in the liquid phase and compare it to their 
antibacterial activity. Each disk sample (0.5 g of the powder was pressed at 155 Nm-2 force 
using a mechanically operated press machine and metallic dyes specially designed for making 
dense discs of 13 x 2 mm) of HA (as control) and of (Ag, Zn, and Mg)/HA composite were 
placed in polypropylene bottles and were filled with 20ml of potassium hydrogen phosphate 
buffer solution (pH=7.2) at time zero. The bottles were stayed stationary and incubated steadily 
at 37°C and 10 ml of the solution was collected after 3h, 6h, 12h, 24h, 48h, 72 h, 15 days and 
21 days. 10 ml of fresh phosphate buffer was added to the bottle and gently mixed.  
 
 
3.2 Cell culture  
To assess the effect of ions on the proliferation and differentiation of cells well-characterised 
mouse osteoblast cell lines (2T3) were chosen. The main reasons for using these cells were that: 
• 2T3 cells are easier to transfect than primary osteoblasts, which give very low 
transfection efficiencies, and 
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• They more closely resemble primary osteoblasts in terms of in vitro responses to various 
stimuli than many of the available human and murine cell lines (169). 
Maintenance of osteoblast cells 
Mouse osteoblast cell lines (2T3) were obtained from Professor Sabokbar’s research group at 
University of Oxford. Cells used for the experiments were used from stocks passaged up to 
passage 21. These cells were in stored in cryogenic storage (-180°C) and whenever required 
were defrosted in a 37°C water bath before use. The vials (exterior) were wiped clean with 70% 
ethanol solution to remove any contamination and the content of the vial was then transferred 
with a sterile pipette into a 150
 
cm2
 tissue culture flask (T150) (BD Bio-Sciences, UK). Fifteen 
ml of culture medium1 was added to the cells which were incubated afterwards in a humidified 
incubator at 37°C and 5% CO2. The growth medium was changed every 3 days until cells were 
confluent and ready for sub-culturing. 
In Vitro cell Sub-Culture of 2T3 cells 
In order to sub-culture the cells, adherent confluent 2T3 cells had to be removed from the 
surface of T150 culture flasks. The most common approach for undertaking this task is by use 
of Trypsin/EDTA solution which is routinely used in in vitro tissue cell culture studies.  
Firstly the culture media from flasks were discarded followed by the addition of 10 ml of 0.5% 
trypsin and 0.02 % ethylene diamine triacetic acid (EDTA) (Life Technologies, UK). After 5 
minutes incubation at 37°C the flask was gently rotated to remove the ensure all the cells were 
                                                 
1
 Osteoblast-like cells were cultured in Dulbecco's Modified Eagle's Medium (DMEM)- (Invitrogen Inc.) 
supplemented with 10% foetal bovine serum (FBS, Invitrogen) and 1% v/v antibiotics; penicillin & 
streptomycin (Invitrogen Inc.). 
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detached from the flask.  The resultant cell suspension was then gently aspirated with a sterile 
pipette before being mixed with 10 ml of culture media, the addition of which (due to the 
presence of FBS) stops the trypsin/EDTA activity as long term exposure of any cells to 
trypsin/EDTA can result cell death. The cell suspension was then transferred to a sterile 
universal and centrifuged at 1000 rpm for 5 minutes at room temperature. The supernatant was 
discarded and the resultant cell pellet was re-suspended in 4 ml of pre-warmed culture media. 
These cell suspension were either used to “passage/re-seed” further culture flasks or utilised for 
setting up the necessary experiments by counting the 2T3 cells.  
Counting Viable Cells 
When required, the suspended 2T3 cells (as described above) were used to set the necessary in 
vitro experiments using Trypan blue exclusion test. Firstly the number of viable cells was 
determined by adding 20µl of 2T3 cell suspension to 20µl of 0.4% (w/v) trypan blue solution 
which was homogenously mixed2. 
About 10 µl of stained cell suspension was transferred to the haemocytometer (Figure 3.6) and 
a microscope was used to view the viable cells for counting. The full grid on a haemocytometer 
contains 9 squares, each of which is 1 mm square and a chamber depth of 0.1 mm.  Each square 
has a total volume of 0.1 mm3 or 104 cm3.  The central square is divided into 25 small squares 
with triple lines and four corner squares are divided into 16 small squares. Each large square 
                                                 
2
 The dye exclusion test is used to determine the number of viable cells present in a cell suspension. It 
is based on the principle that live cells possess intact cell membranes that exclude certain dyes, such as 
trypan blue, whereas dead cells do not. In this test, a cell suspension is simply mixed with dye and then 
visually examined to determine whether cells take up or exclude dye. A viable cell will have a clear 
cytoplasm whereas a nonviable cell will have a blue cytoplasm(170)  
 
82 
 
has a surface area of 1.0mm2, and the depth of the chamber is 0.1mm.  As there are 1000 mm3 
per ml, each large square represents a volume of 0.0001ml, so that it is equal to 1/ 0.0001ml = 
10,000 = (104). So the total numbers of cells per ml were calculated using the following 
equation: 
Cells per ml = Average count per square x dilution factor x 10,000 
 Large cells are counted using the four large corner squares (and the middle one). Each is 
divided into nine 1mm2 squares. 
Thereafter 1x105 viable 2T3 cells were added in culture media to previously autoclaved HA 
discs (both ion substituted and non ion substituted) which had been placed in sterile 24-well 
cell culture plates containing media for 2 hours. Cells on HA discs were incubated in 5% CO2 
at 37°C for a period of 7 days, during which the samples were removed on a daily basis (1-7 
days) to assess the effect of HA ± cations on 2T3 cells’ cellular activity. 
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Figure 3.6: Haemocytometer used for the cell counting(171)  
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3.2.1 Osteoblast cellular activity in response to (Ag, Mg, and Zn)/HA  
Osteoblast differentiation in vitro can be characterised in three stages: (a) cell proliferation, (b) 
matrix maturation, and (c) matrix mineralisation. In vitro matrix maturation and mineralisation 
are usually enhanced by growing the cells to complete confluency and by adding specific 
osteogenic factors. During proliferation stage (a), several extracellular matrix proteins 
(procollagen I, TGF-β, and fibronectin) can be detected. The matrix maturation phase (b) is 
characterised by maximal expression of alkaline phosphatase (ALP). Finally, at the beginning 
of matrix mineralisation (c), genes for proteins such as osteocalcin and osteopontins are 
expressed and once mineralization is completed, calcium deposition can be visualized using 
adequate staining methods. For the purpose of the current investigation, cell proliferation and 
matrix maturation of the 2T3 were assessed. 
 
Cell Proliferation  
The gold standard cell proliferation assay is 3H-thymidine DNA incorporation during cell 
division (172). However, due to the high cost of the purchase of tritium and handling radio-
labelled materials, it was decided to use the, Alamar BlueTM technique as an alternative for 
assessing the cell viability/proliferation (173). This approach is based on redox-sensitive 
growth indicator which quantitatively measures cell viability and proliferation using fluorescent 
or colourimetric detection strategies. The Alamar BlueTM reagent is a non-toxic, water-soluble 
that on its own is non-fluorescent, but it is effectively reduced by cytochrome-b5 reductase to 
a red fluorescence colour (resorufin) in the mitochondria of metabolically active cells and the 
dye is released into the cell medium (174) . 
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This approach is much more appropriate than 3H as cell viability can be monitored in real time 
and the cells can be re-used for subsequent experimentations. For the present investigation 2T3 
cells’ proliferation was investigated using Alamar BlueTM (AbD Serotec, Oxford, UK) assay 
according to the manufacturer’s instruction. Briefly, after 1 to 7 days cell culture incubation, 
the culture media from the 24-plates containing NS-HA or/and (Ag, Mg, and Zn) substituted 
hydroxyapatite were removed and the samples were washed three times with PBS. 500 µl of 
10% Alamar BlueTM (at room temperature) was added to each well and incubated at 37°C and 
5% CO2 for 180 minutes. 100 µl of the Alamar BlueTM from each was then transferred to a 
sterile 96-well plate. Cells in the 24-well plates were then washed carefully with phosphate 
buffer saline to remove any excess the Alamar BlueTM and replaced with fresh culture media 
and returned back in the incubator for completion of the experiment. 
The fluorescence level in the 96 well plate corresponding to the HA samples in 24-well plates 
was measured at 540 nm excitation and 590 nm emission using a FluorStar Optima plate reader. 
The measurement was repeated twice for each sample and thrice for individual experiment.  
The background control fluorescence reading was assessed with the same number and type of 
cells but in the absence of any HA discs. Another set of cell-containing plates were used with 
control samples (NS-HA) and their absorbance were normalised against the mentioned 
background readings. Normalised control samples were compared with the ion-substituted 
samples to measure the efficacy of ions on the studied cells. 
Standard curve were used as described by the assay kit supplier to convert te absorbance 
readings and concentration of ALP enzyme activity (coloured p-Nitrophenol). 
In summary, two readings were taken from each of the three samples in each group – giving a 
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total of six readings per group. Also reading from an Alamar BlueTM only (blank) was measured 
and subtracted from all the reading values to obtain the real measurement of cell proliferation. 
This process was repeated for each measurement at each time point (days 1 to 7) and the Alamar 
BlueTM reduction for each cell density was obtained. For all cell densities, the relative 
fluorescence unit of Alamar BlueTM reduction was plotted against duration of the cell cultures.  
3.2.2 Alkaline Phosphatase Activity Assay 
Alkaline phosphatase is a non-specific de-phosphorylation metalloenzyme (Zn and Mg) which 
hydrolyses phosphate compounds at basic pH. It is found in all body tissues and is responsible 
to catalyse the splitting the organic phosphate esters to inorganic phosphates (175). ALP 
activity is regarded as a measurement of enzyme kinetics for transformation of p-
nitrophenylphosphate into p-nitrophenol. ALP enzyme is known to be localised on the surface 
of osteoblast cells and secreted into the matrix in order to generate a basic medium for the 
formation of new bone (175). The activity of ALP enzyme has been shown to indicate the 
osteoblast maturation and its level maximises up to the mineralisation phase (176).  
Osteoblastic phenotype was examined by the cell’s response to BMP-2. Osteoblast- like cells 
typically up-regulate ALP and other phenotypic markers in response to BMP-2 when cultured 
and assessed in vitro. Osteoblast like cells 2T3 (7500) cells were seeded in triplicates in 24 well 
plates and treated with murine recombinant BMP-2 (100 ng/ml) over 2, 3 and 4 days. Plates 
were removed from incubators, media were aspirated and cells were washed with PBS and 
lysed in radioimmunoprecipitation lysis buffer (RIPPA) in 2% ready to use mammalian 
protease inhibitor cocktail (PI) on ice. Cell lysates were collected in labelled microfuge tubes, 
sonicated for 5 seconds, and centrifuged at 12000 rpm for 20 minutes. Supernatant was 
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collected and total protein content was measured by PIERCE BCATM protein assay kit (Fisher 
Scientific-UK). ALP was measured by 4-methylumbelliferyl (4MU) substrate kit (Sigma-
Aldrich). Briefly, 10µl of cell lysates were incubated with 100µl of freshly made 4MU (0.16mM 
in 50mM Tris pH= 6) in white 96 well plates (Fisher Scientific, UK) for 45 minutes in the dark 
at 37°C, following an addition of 100µl of 0.6M Na2CO3 to stop the reaction. Fluorescence was 
measured at 360 nm excitation, 450 nm emission and 435 nm cut off using a BMG Optima 
FluorSTAR® plate reader. ALP activities were calculated by preparing a standard curve of 0-
20,000 pmol 4-methylumbelliferone (4MU) on the same plate and normalised to the total 
protein content of each relevant well. Murine 2T3 cells (1×104) were plated into 24 well plates 
in replicates in their culture growth medium to reach confluence. Differentiation was then 
induced (day zero) by osteogenic differentiation medium. 2T3 osteoblasts were maintained in 
osteogenic differentiation medium for 3 days, with media being changed twice on day zero and 
day two. Cultures were stopped at 12 hours intervals for the assessment of ALP activity.  
3.3 Antibacterial Measurements 
3.3.1 Agar diffusion study - Zone of Inhibition (ZI) 
Ag and Zn substituted hydroxyapatite disks were prepared following the same procedure 
described in section 2.1. Under sterile conditions, a single colony of S. epidermidis 11047 
(Fisher Scientific, UK) was cultured in 10ml Trypton Soya Broth (TSB) at 37 °C for 24 hours. 
This resulted in a bacterial suspension of ~108 cells/ml which was serially diluted to produce 
another suspension of ~105 cells/ml. 25 µl of this suspension was then spread across a Tryptone 
Soya Agar (TSA) (Oxoid, Hamps, England) plate using a sterile swab to form a lawn of bacteria 
covering the agar surface. Each disc samples placed in the center of the plate on the top surface 
of TSA agar medium. The plates were placed in a 37°C incubator for further 24 hours. The 
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same procedure was carried out to prepare E. Coli ATCC 4352 (Fisher Scientific, UK. 
The Trypton Soya Broth (TSB) was prepared by addition of 18.5 g of TSB powder to 500 ml 
of deionized water and was sterilized by autoclaving at 121°C for 15 minutes to prepare a 
sterilized medium. 
The Trypton Soy Agar (TSA), solid culture media, was used for cultivation of candidate 
bacteria. 40 g of powdered agar was added to 1 liter of distilled water and dissolved. The 
dissolved medium was sterilized by autoclaving at 121°C for 15 minutes. 
The zone of inhibition (reported values are the diameter of zone) was measured and recorded 
for each plate at different times and results are summarized and compared for ach sample and 
bacteria strain. 
3.3.2 Film adhering method (Quantitative) 
In this technique, a known number of bacterial cell were cultivated on top of a sample disk (and 
control) for varying time intervals (hours) and then the whole disk was washed to remove and 
disperse any viable cells from the surface of the disk. Samples from the suspension were 
transferred to fresh agar plate to quantitatively measure the colony formation unit (CFU) and 
the effectiveness of antibacterial agent in the disk. Cultures of E.coli ATCC 4352(Fisher 
Scientific, UK) and S.epidermidis 11047 (Fisher Scientific, UK) were prepared by using freeze-
dried ampoule of each bacteria (obtained from the Fisher Scientific, UK). Ampoules were 
broken open and the bacterial pellet revived by re-suspending in 500 µl of Trypton Soya Broth 
(TSB) (Oxoid, UK) and incubated at 37°C with 5% CO2 overnight. 
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A method described by Kashani et al. was used for this measurement (177) . Cells were 
collected from a plate and were suspended in sterile TSB (5 ml). To prepare starter cultures for 
future experiments, 1 ml aliquots where stored at -80°C and used daily to inoculate 5 ml of 
fresh TSB. Growth was also measured by a spectrophotometer (Jenway, UK) using 1 ml 
cuvettes at 600 nm. 
 
The OD at 600 nm of the E.coli  and S.epidermidis was measured and adjusted using fresh 
solution to 0.05 ± 0.01 in 1 ml. The original bacterial suspension, adjusted to ~107 cells/ml, was 
added to the specimens. 
To measure count cells, 20 µl of the test suspension was diluted ten-fold six times (10-6) of the 
in phosphate buffered saline (PBS).  When dilutions with each colony could be measured, the 
colony forming units (CFUs) per ml of original sample was calculated. 
The samples then were transferred to 10 ml of sterile PBS after a set time, before dispersing the 
cover slips and suspend surviving bacteria in vortex. 100 ml of final suspension was pipetted 
into TSA, which was previously divided into three quadrants with different Dilution factors 
(DFs), such as 10-2, 10-4 and 10-6. Form each DF, three 20 µl spots were evenly spaced and 
CFUs were counted following 24 h incubation at 37 °C.  
TO calculate the reduction, following formula was used:  
                           Reduction % (CFU/ml) = [(αt−α0)/α0] × 100%                    
Where αt= mean CFU/ml for the treated coupon after the designated contact time and α0 = mean 
CFU/ml for the untreated coupon after the designated contact time. 
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3.3.3 Statistical Analysis 
All biological experiments were carried out in triplicates unless otherwise stated. Data were 
statistically tested for significance difference using parametric one-way analysis of variance 
(ANOVA) and Student’s T-tests. Microsoft Excel 2003 was used for this purpose and the 
significant level (p) was set at p<0.05 unless otherwise stated. 
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CHAPTER 4 
RESULTS 
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4 Results  
4.1 X-ray Diffraction analysis 
4.1.1 X-ray diffraction analysis of Non-Substituted Hydroxyapatite (NS-HA) 
In order to understand the effect of ion substitution on the hydroxyapatite structure and the 
chemical and physical attributes, a sample of non-substituted hydroxyapatite (NS-HA) was 
prepared (using the same preparation method) and was used as the HA reference sample 
throughout this study. This non-substituted hydroxyapatite sample was analysed using all the 
analytical techniques described in Chapter 2.  
As discussed earlier in Materials and Methods (Chapter 3), XRD was used for phase 
identification, measurement of the degree of crystallinity, crystal size and lattice parameters. 
Phase Identification of NS-HA 
The XRD patterns of NS-HA samples both sintered and non-sintered are shown in Figure 4.1 
and provide an overview of the HA structure prepared by wet precipitation.  
The overall diffraction patterns were in agreement with the current literature (62, 66, 178, 179) 
and showed the characteristic peaks of HA (66). Table 4.1 lists and compares the significant 
peaks of the synthesised HA sample with the Joint Committee on Powder Diffraction Standards 
(JCPDS), no. 09-0432 for stoichiometric HA. 
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Figure 4. 1: The XRD diffraction patterns of sintered (1100 °C) and non-sintered hydroxyapatite. 
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Table 4. 1: Characteristic peaks of synthesised HA (non-substituted) and comparison with 
stoichiometric HA used as a reference. 
Data from the X-Ray diffraction of  
NS-HA (Experimental results) 
Stoichiometric HA Card  
No. 09-0432  
2Θ (°) d (Å) 
Miller Index of the 
Corresponding Reflection d (Å) 
Miller Index of the 
Corresponding Reflection 
16.84 5.26 (101) 5.25 (101) 
18.78 4.72 (110) 4.72 (110) 
21.6 4.1 (200) 4.07 (200) 
22.97 3.87 (111) 3.88 (111) 
25.9 3.44 (002) 3.51 (201) 
28.22 3.16 (102 3.44 (002) 
29.14 3.06 (210) 3.17 (102) 
31.86 2.8 (211) 3.08 (210) 
32.2 2.78 (112) 2.814 (211) 
32.9 2.72 (300) 2.778 (112) 
34.22 2.62 (202) 2.72 (300) 
35.51 2.52 (301) 2.631 (202) 
39.26 2.28 (212) 2.528 (301) 
39.86 2.26 (310) 2.296 (212) 
42.1 2.14 (311) 2.262 (310) 
43.8 2.07 (113) 2.228 (221) 
45.32 1.99 (203) 2.148 (311) 
46.69 1.94 (222) 2.134 (302) 
48.16 1.88 (312) 2.065 (113) 
48.59 1.87 (320) 2.04 (400) 
49.51 1.83 (213) 2 (203) 
50.53 1.8 (321) 1.943 (222) 
51.33 1.78 (410) 1.89 (312) 
52.24 1.75 (402) 1.871 (320) 
53.27 1.72 (004) 1.841 (213) 
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Data from the X-Ray diffraction of  
NS-HA (Experimental results) 
Stoichiometric HA Card  
No. 09-0432  
2Θ (°) d (Å) 
Miller Index of the 
Corresponding Reflection d (Å) 
Miller Index of the 
Corresponding Reflection 
54.45 1.68 (104) 1.806 (321) 
55.87 1.64 (322) 1.78 (410) 
57.15 1.61 (313) 1.754 (402), (303) 
58.17 1.58 (501) 1.722 (004), (411) 
 
The prepared NS-HA samples in this study were sintered at 1100 °C, as described in the 
Materials and Methods section 3.1. As results suggest, slight HA decomposition to β-TCP was 
observed in samples (indicated by a small β-TCP peak at 2θ= 13.71 (104), 14.21 (006), 17.13 
(110), 18.61 (113) and 34.37 (220) (JCPDS no. 09-0169 and JCPDS no. 09-0432)). 
Table 4. 2: Present phases, crystallinity and crystal size for NS-HA. 
HA Powder Phase Present Crystallinity 
(%) 
Crystal Size 
(nm) 
Commercial HA 
(Sigma Aldrich) HA 100  
NS-HA HA, β-TCP 88.8±4.6 73±4.1 
Non-sintered NS-HA HA, β-TCP 61.75±5.3 88.76±4.8 
 
Crystallinity and crystal size of NS-HA 
The degree of crystallinity was measured using the formula provided in Materials and Methods 
sections 3.1.1 and 3.1.2. The effect of sintering on crystallinity is summarised in Table 4.2 
where the sintering of HA samples at 1100°C resulted in a considerable increase in crystallinity. 
This is evidenced through a substantial increase in peak heights and an associated drop in peak 
widths. Non-sintered NS-HA exhibited a crystallinity of 61.75 ±5.3 %, while sintered HA 
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exhibited crystallinity of 88.8 ±4.6 %; demonstrating that sintering increased crystallinity by 
27 %. 
 
Lattice parameters and crystal size of NS-HA 
In order to determine the unit cell parameters of the substituted HA samples, the models 
previously reported by Dickens et al. (180) and Sudarsanan (181) were used as the starting 
conditions for the Rietveld refinement. It should be noted, that the Rietveld refinement 
technique was not sensitive enough to determine the ion concentration in each phase.  Hence, 
only the unit cell parameters for both phases of HA (180) and β-TCP (181) were considered 
and compared against the values from the NS-HA sample. 
Table 4.3 presents the lattice parameters of the powders, which were calculated using refined 
values for the NS-HA sample consisted of a mixture of HA and β-TCP phases. These values 
showed an excellent match to those input from the literature references.  
Table 4. 3: Lattice parameters of HA and β-TCP in sintered (1100 °C) NS-HA. 
 a-axis(Å) c--axis(Å) 
NS-HA 9.415±0.001 6.879±0.009 
NS-β-TCP 10.439±0.005 37.399±0.008 
 
For the sintered NS-HA sample, all the refined lattice data for the HA phase confirmed the 
presence of a hexagonal structure (space group P63/m) and the measured values were in good 
agreement with the crystal data for a single HA phase (a = b = 9.424 Å, c = 6.879 Å, α = β = 
90°, and γ = 120°) (182). A typical rhombohedral β-TCP structure (space group R3c) was 
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confirmed by the refined lattice data. The calculated values were very similar to those which 
are reported by Dickens et al. (180) for a single phase crystalline β-TCP (a = b = 10.439 Å, c = 
37.375 Å, α = β = 90°, and γ = 120°). The slight difference in the lattice parameters may be due 
to a possible deviation from stoichiometry, which is often the case for precipitated apatitic salts. 
When the lattice parameter for the a-axis was compared to the ones for the stoichiometric HA 
(Ca/P=1.67) sample, which was used as reference, the precipitated HA exhibited a higher value 
for this crystal axis. This could be as a consequence of the higher Ca2+ for the HA reported here 
(Ca/P=1.8). This has previously been reported by Aizawa et al. (183), who suggested that the 
crystal planes of HA could be controlled by changing the Ca/P ratio during synthesis.   
4.1.2 X-ray diffraction analysis of Silver-Substituted Hydroxyapatite (Ag-HA) 
Phase Identification of Ag-HA 
The XRD patterns of all silver substituted hydroxyapatite (1%, 5% and 10 % Ag-HA) samples 
are shown in Figure 4.2 and 4.3. The XRD patterns of all samples were very similar to that of 
NS-HA and in accordance with JCPDS no. 09-0432. However, two sharp peaks at 2θ = 33.29° 
and 36.58° and a small peak at 27.16°, present in the X-ray diffraction pattern of 1% Ag-HA 
sample were in good agreement with (210), (211) and (110), crystal planes of the body centred 
cubic Ag3PO4, respectively. When the silver concentration increased to 5%, an additional peak 
at 2θ= 20.82 ° was present. This peak was associated with the (119) crystal plane of Ag3PO4.  
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Figure 4. 2: The XRD diffraction patterns for sintered (1100 °C) silver substituted hydroxyapatite with different Ag concentrations.  :
99 
 
 
Figure 4. 3: The XRD patterns for non-sintered silver substituted hydroxyapatite with different Ag concentrations. 
 
Silver phosphate (Ag3PO4 ) was observed in all silver added hydroxyapatite samples. It is worth 
mentioning, that with increasing silver content, the presence of Ag3PO4 is more pronounced as 
the peaks at 2θ= 33.29° and 36.58° become sharper especially in the case of 10% Ag-HA 
(Figure 3.2).  A slight shift to a higher 2θ was also observed at 2θ = 33.29° and 36.58° with 
increasing silver from 5 to 10 wt.%.  
In addition, two small peaks at 2θ = 40.30° and 45.31° may be associated with the hexagonal 
crystal planes of metal silver (102) and (103), respectively. These small peaks are present in 5 
and 10 wt% silver concentrations and have also been reported in previous studies (184, 185).  
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Crystallinity and crystal size of Ag-HA 
 As the XRD patterns in Figure 4.2 showed, by introducing silver to hydroxyapatite in 
concentrations of 0 to 10 %, crystallinity marginally decreased. As presented in Figure 4.4, and 
Table 4.4, the crystallinity degree was about 88.8%±4.6 for NS-HA, and 85.85%±10.1, 
86.72%±4.2 and 86.61±3.6 for Ag-HA 1 %, 5 %, and 10 % respectively (all sintered samples).  
 
 
Table 4. 4: Present phases, crystallinity and crystal size for sintered (1100 °C) Ag-HA. 
HA Powder Phase Present Crystallinity 
(%) 
Crystal Size 
(nm) 
NS-HA HA, β-TCP 88.8±4.6 73±4.1 
Ag-HA 1% HA, β-TCP, Silver Phosphate 85.85±10.1 74±5.3 
Ag-HA 5% HA, β-TCP, Silver Phosphate, Silver 
Metal 
86.72±4.2 78.31± 3.6 
Ag-HA 10% HA, β-TCP, Silver Phosphate, Silver 
Metal 
89.31±3.6 79.1±6.1 
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Figure 4. 4: Crystal size (top) and Degree of crystallinity (bottom) for silver substituted hydroxyapatites 
with different concentrations. 
 
Lattice parameters of Ag-HA 
The unit cell parameters of all Ag-HA samples are presented in Figure 4.5. The lattice 
parameters a and c increased with an increasing quantity of silver ions in the HA and β-TCP 
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phase, which suggested that Ag ions contributed to the change of the lattice parameters. It is 
not clear in what way silver ions can change the lattice parameters. Considering that silver ions 
are monovalent, it is difficult to say that silver ions can directly replace the divalent calcium 
ions as this would result to a charge unbalance within the crystal lattice.  
 
 
Figure 4. 5: Lattice parameters of HA crystal (top) and β-TCP crystal (bottom) in silver substituted 
hydroxyapatites with different concentrations. 
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Lattice parameters of both HA and β-TCP have changed, which may indicate Ag ions have 
replaced Ca+2 sites in both phases. The observed changes in the cell parameters also confirm 
that silver with the size of 0.128 nm has substituted the calcium (with the size of 0.099 nm) in 
the HA lattice. 
 
4.1.3 X-ray diffraction analysis of Magnesium-Substituted Hydroxyapatite (Mg-HA) 
Phase Identification of Mg-HA 
The XRD patterns of all magnesium substituted hydroxyapatite (1%, 5% and 10 % Mg-HA) 
samples are shown in Figure 4.6 and Figure 4.7. 
When Mg ions were added to HA, the XRD pattern was shifted clearly lower 2θ values 
comparing to NS-HA. In addition, a β-TCP phase was observed and also shifted to lower 2θ 
values. 
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Figure 4. 6: The XRD diffraction patterns for sintered (1100 °C) magnesium substituted hydroxyapatite with different Mg concentrations. 
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Figure 4. 7: XRD patterns for non-sintered magnesium substituted hydroxyapatite with different Mg 
concentrations. 
 
All peaks became broader with increasing Mg substitution compared to NS-HA samples. Thus, 
it can be concluded that Mg ions which were engaged in the HA structure caused significant 
deformations in the crystal lattice. Also, the absence of unreacted MgO (JCPDS no. 00-04683) 
and Brucite (Mg(OH)2) (JCPDS no.07- 0239) in all Mg-HA pattern may suggest that Mg ions 
were substituted in the HA and most likely replaced calcium ions in the crystal lattice. The 
location of the substitution is very difficult to observe from these data. When Mg concentration 
was increased to 5% and 10%, a new single Mg-Whitlockite (Ca9Mg(PO4) 6(PO3)OH)  phase , 
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also called Mg-β-TCP (JCPDS no. 01-70-1787) was formed with representing peaks at 2θ= 
31.30° in addition to the existing HA phases and β-TCP. In fact, one of the main characteristic 
planes, which is present at 31.81° (112) was shifted to a lower degree and converted to most 
characteristic Whitlockite phase at 30.00° (0210).  
Table 4. 5: Present phases, crystallinity and crystal size for sintered (1100 °C) Mg-HA 
HA Powder Phase Present Crystallinity 
(%) 
Crystal Size 
(nm) 
NS-HA HA, β-TCP 88.8±4.6 73±4.1 
Mg-HA 1% HA, β-TCP, 83.2±7.8 68.5±4.6 
Mg-HA 5% HA, β-TCP, 
Whitlockite 
64.8±10.2 49.3±5.4 
Mg-HA 10% HA, β-TCP, 
Whitlockite 
63.5±4.31 43.6±4.31 
 
A consistent shift to higher 2θ range was observed for the (0210) β-TCP plane with increasing 
Mg substitution. This shift is representative of a reduction in β-TCP lattice parameters. As 
explained earlier, the lattice contraction is due to the substitution of Ca2+ ions by the smaller 
Mg2+ ions.  
Crystallinity and crystal size of Mg-HA 
The XRD experimental data indicated that Mg could affect the crystallinity and crystal size of 
HA as reported in Figure 4.8. While there was a crystallized biphasic structure (β-TCP + HA) 
in the NS-HA samples, the peaks of HA and β-TCP became wider and their intensity reduced 
by introducing Mg ions, especially in the 2θ range between 28° to 32° and 45° to 55°. As  
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Figure 4. 8: Crystal size (top) and Degree of crystallinity (bottom) for magnesium substituted 
hydroxyapatites with different concentrations. 
detailed earlier, the crystallinity degree was about 88.8% for NS-HA, and 83.2%, 64.8% and 
63.5%, for Mg-HA 1 %, 5 %, and 10 %, respectively (all sintered samples). The results for the 
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degree of crystallinity and crystal size measurements of Mg-HA suggested that magnesium ions 
affected the crystal size by inhibiting the growth of the HA crystals (111).  
Lattice parameters of Mg-HA 
As shown in Figure 4.9, comparing the lattice parameter data obtained from Mg-HA samples 
with NS-HA indicated a decreasing trend in the values of a and c-axis parameter with the 
introduction of Mg 2+ in both β-TCP and HA phases.  
 
Figure 4. 9: Lattice parameters of HA crystal (top) and β-TCP crystal (bottom) in magnesium-substituted 
hydroxyapatites with different concentrations. 
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This suggested that there was a contraction of the cell volume after Mg 2+ addition. The volume 
contraction was more pronounced in the case of the β-TCP phase, and therefore it might suggest 
higher concentration of Mg 2+ in this phase. The reason for the observed contraction in both a 
and c axis could be explained by the substitution of the smaller ionic radii Mg 2+ (0.072 nm) for 
Ca 2+ ion (0.099 nm).  
A comparison between the cell parameter values in samples with different Mg concentration 
indicated that at Mg 1 %, Whitlockite phase was not present suggesting that the majority of the 
Mg ions were accumulated in the HA phase. Another explanation could be that the range of 
Whitlockite was below the detectable range for XRD technique. As Mg concentration increased 
to (5 and 10 %), Whitlockite was detectable suggesting that Mg2+ ions were substituting Ca2+ 
ions in the β-TCP phase.  
As described earlier, the a and c-axis parameter values decreased in the magnesium substituted 
HA phase for all Mg2+ ion concentrations. For the β-TCP phase, however, the a axis parameter 
decreased in the case of 1 % Mg but no further change was observed when more Mg2+  ions 
ware added. On the other hand, the c-axis parameter decreased in all magnesium substituted 
samples. This changing of the cell parameters may be due to the limited replacement capacity 
of Mg ions into the β-TCP crystal lattice. 
4.1.4 X-ray diffraction analysis of Zinc-Substituted Hydroxyapatite (Zn-HA) 
Phase Identification of Zn-HA 
The XRD patterns of all zinc substituted hydroxyapatite (1%, 5% and 10 % Zn-HA) samples 
are shown in Figure 4.10 and Figure 4.11. The broad diffraction peaks in all Zn-HA samples 
suggest the formation of smaller apatite crystals than NS-HA. The peaks of β-TCP and HA 
110 
 
could be detected in Zn-HA 1% similar to NS-HA. However, HA and β-TCP peeks have been 
shifted to lower 2θ degree. 
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Figure 4. 10: The XRD diffraction patterns for sintered (1100 °C) zinc substituted hydroxyapatite with different Zn concentrations. 
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Figure 4. 11: XRD patterns for non-sintered zinc substituted hydroxyapatite with different Zn 
concentrations. 
 
As shown in Figure 4.10 a new phase was identified at Zn concentration of 5 % associated 
with the presence of calcium zinc phosphate hydrate or Parascholzite. Parascholzite 
(CaZn2(PO4)2.2H2O) is a Zn-substituted TCP and its more pronounced  in the case of  Zn-
HA 10% sample. More β-TCP phase at higher Zn concentrations suggested that more HA 
has been transformed to β-TCP in the form of Parascholizite at 1100 °C.  
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Table 4. 6: Present phases, crystallinity and crystal size for sintered (1100 °C) Zn-HA. 
HA Powder Phase Present Crystallinity 
(%) 
Crystal Size 
(nm) 
NS-HA HA, β-TCP 88.8±4.6 73±4.1 
Zn-HA 1% HA, β-TCP 85.12±8.6 72±4.9 
Zn-HA 5% HA, β-TCP, Parascholzite, 70.2±7.4 61.31±5.4 
Zn-HA 10 % HA, β-TCP, Parascholzite, 67.3±11.3 52.29±5.2 
 
Crystallinity and crystal size of Zn-HA 
As the XRD patterns in Figure 4.12 show, when Zn ions were added to hydroxyapatite, 
the patterns became broader suggesting that crystallinity and crystal size were decreased 
compared to NS-HA. The degree crystallinity was about 88.8% for NS-HA, and 85.12%, 
70.2% and 67.3% for Zn-HA 1 %, 5 %, and 10 %, respectively (all sintered samples) 
(Table 4.6).  
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Figure 4. 12: Crystal size (top) and degree of crystallinity (bottom) for zinc-substituted 
hydroxyapatites with different concentrations. 
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the degree of crystallinity and crystal size measurements of Zn-HA may indicate that zinc 
ions affected the crystal size by inhibiting the growth of the HA crystals. 
Lattice parameters of Zn-HA 
As Figure 4.13 which compares the lattice parameter data obtained from Zn-HA samples 
with NS-HA, indicates, there was decreasing trend in a and c-axis parameter values was 
observed with the introduction of Zn 2+ in both β-TCP and HA phases.  
 
 
Figure 4. 13: Lattice parameters of HA crystal (top) and β-TCP crystal (bottom) in zinc-substituted 
hydroxyapatites with different concentrations. 
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Therefore, a contraction of calculated cell volumes was evident. A reason for this 
contraction in cell parameters can be the lower ionic radius of Zn2+ (0.0745 nm) when 
compared to Ca2+ ions (57, 186, 187). 
 
4.2 Fourier transform infrared spectroscopy (FT-IR) 
FT-IR is a versatile technique in analytical chemistry, which is based on the principles of 
molecular spectroscopy. This analytical tool detects the absorbance (or transmittance) of 
light energy, which is emitted on molecules at specific wavelengths (known as their 
resonance frequencies).   
4.2.1 FT-IR for NS-HA  
The FT-IR spectra for NS-HA samples are shown in Figure 4.14. The absorption band 
positions and their assignments are summarized in Table 4.7. 
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Figure 4. 14: FT-IR spectra of sintered Hydroxyapatite 
 
As shown in Figure 4.14, the presence of apatite phase in the prepared powder can be 
proven by the presence of the fundamental vibrational modes of PO43-
 
group at 574, 609, 
966 and 1020-1120 cm-1. The bands at 630 and 3570 cm-1 are representative of OH1- 
groups in the apatite phase and adsorbed water, respectively. The latter can be seen in the 
region around 3300-3600 cm-1 which is indicative of the “bound” water or hydration layer 
associated with HA crystals. It is known that this hydration layer contains high 
concentrations of calcium and phosphate ions (188).  
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While carbonate ions were not expected to be present in HA, a small peak of carbonate 
at 1430 cm-1 was formed due to the solubilisation of CO2 in air in water and incorporation 
of resulting carbonate ions into the crystal lattice.  
A small broad peak observed at 1422.6cm-1 is a characteristics peak for NH4+ groups and 
can be attributed to the ammonium residues which were still present in the sample after 
synthesis (189). There was no presence of nitrate ions indicated by the absence of 
characteristic peaks in the region between 1320 and 1480 cm-1. 
The studied experiments also confirmed that partially carbonated hydroxyapatites were 
formed. This was based on the observation of carbonate-specific bands in the range of 
1460–1410 cm-1 and likely were incorporated from the carbonate groups present during 
the synthesis process. 
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Table 4. 7: Assignments of main bands observes in the Infrared absorption spectra of HA. 
4.2.2 FT-IR for Ag-HA 
Peak (cm-1) Assignment References 
3572 Stretching mode, νs,  of hydroxyl groups  OH
-
 (190), (191) 
2000 Harmonic overtone 2. ν3 or combination band ν1 + ν3b (192), (193), (194) 
1630 Adsorbed water (195) 
1430 Stretching mode, ν3, of B-type CO3
2-
  (196) 
1087 
Triply degenerated asymmetric stretching mode, ν3a, 
of the P−O bond of phosphate groups PO43- (197), (198) 
1046 
Triply degenerated asymmetric stretching mode, ν3b, 
of the P−O bond of phosphate groups PO43- (193) 
1032 
(shoulder) 
Triply degenerated asymmetric stretching mode, ν3c, 
of the P−O bond of phosphate groups PO43 
(193), (194), 
(197) 
962 
Non degenerated symmetric stretching mode, ν1, of the 
P−O bonds in phosphate groups PO43- 
(192), (193), 
(197), (198) 
880 Characteristic bending mode of A-type CO3
2-
 (196) 
631 Librational mode, νL, of hydroxyl groups  OH
-
 (199) 
602 
Triply degenerated bending mode, ν4a, of the O−P−O 
bonds in phosphate groups PO43- 
(193), (194), 
(198) 
574 
(shoulder) 
Triply degenerated bending mode, ν4b, of the O−P−O 
bonds in phosphate groups PO43- 
(193), (194), 
(198) 
561 
Triply degenerated bending mode, ν4c, of the O−P−O 
bonds of the phosphate group 
(193), (194), 
(198) 
472 
Double degenerated bending mode, ν2a, of the O−P−O 
bonds in phosphate groups PO43- (193), (198) 
462 
Double degenerated bending mode, ν2b, of the O−P−O 
bonds in phosphate groups PO43- (193), (198) 
355 
(shoulder) 
Translational mode, νT, of hydroxyl groups OH
-
 (193) 
342 
(shoulder) 
Translational mode, νT, of hydroxyl groups OH
-
  (ν3) (193), (199) 
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The FT-IR spectra of the silver (0 to 10%)-substituted hydroxyapatite samples are shown 
in Figure 4.15. The absorption band positions and their assignments are summarized in 
Table 4.7.   
 
 
 
Figure 4. 15: FT-IR Spectra of Silver Substituted Hydroxyapatite with different Ag ions 
concentrations. 
 
 
The characteristic HA peaks appeared in all apatite samples at 963, 1029, 1095 and 561-
601 cm-1(for PO4-3) and are in good agreement with previous studies (200, 201) (195). 
Similarly, characteristic OH- peak at 3571 cm-1 was observed and was also in good 
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agreement with previous published work (200, 202, 203).The vibration band 
corresponding to the silver phosphate (bulk Ag3PO4 frequency 975 cm-1 and nano Ag3PO4 
frequency 1017 cm-1) which was reported by Thomas et al. (204) was not detected in the 
Ag-HA spectrum. However, the vibration around 1070 cm-1 was observed. The intense 
phosphate band of HA (1034 cm-1) might be responsible for the obstruction of Ag3PO4 
band. 
The absorption bands at 873, 1300–1650 cm-1 of the Ag-HA are again attributed to the 
carbonate substitution in the HA lattice. In case of hydroxyl stretching band, they became 
more distinct at 3569 cm-1 in the Ag-HA 5% while the broad moisture peak was reduced 
significantly. 
 
4.2.3 FT-IR for Mg-HA 
Figure 4.16 shows the FT-IR spectra of HA samples with different Mg concentrations (1, 
5 and 10 %).  
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Figure 4. 16: FT-IR Spectra of magnesium substituted Hydroxyapatite with different Mg ion 
concentrations. 
 
Introducing 1% Mg to HA, all the FT-IR absorption bands were present at similar 
positions to the ones in non-ion substituted HA. However, the bands associated with OH- 
and N-H groups became broader. This indicates that Mg-HA 1 % substitution did not 
induce any significant changes in the apatite structure of HA. The same representative 
bands for PO4-3
 
groups (574, 609, 966 and 1020–1120 cm-1) and OH- groups (around 
3570 cm-1) of apatite phase are still present in all the Mg-HA samples. Adsorbed water 
could also be identified in the same region (around 3300–3600 cm-1) as well as carbonates 
(CO2- 3) (around 1660 cm-1), which is more pronounced in 5 and 10 % samples. Nitrates 
(NO1- 3) were also present around 1320–1480 cm-1 resulting from the residual species in 
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the reaction (NO3 -1, NH4  +). Additionally, a peak at 1424 cm-1 can be attributed to CO3 -
2
 groups, which are common for the powders synthesised in the presence of air.  
Increasing the Mg concentration to 5%, the FT-IR bands assigned to the four PO4-3 modes 
appeared at similar wavenumbers as in HA. However, a reduction in the resolution at 
around 634 cm-1 can be assigned to OH- liberation mode (83, 200, 203). In addition, the 
PO4 -3 peaks, which are present at around 1029 and 1059 cm-1 were, gradually merged 
into a broad peak centred at around 1062 cm-1. These changes impled that the phase 
transformation from Mg substituted apatite to Mg substituted  
β-TCP (Whitlockite) was at its most when Mg content reached to 10 %. 
At 10% Mg-HA, the FT-IR spectrum showed a similar pattern to that of 5 % sample but 
exhibited poorer resolution. In addition, the peak broadening was more significant when 
Mg concentration increased suggesting that the apatite structure was possibly distorted 
(114). The FT-IR spectra for samples with Mg substitution of 10% revealed a phosphate 
peak (range 1550–1450 cm-1) that became broader with increasing magnesium content.  
4.2.4 FT-IR for Zn-HA 
Figure 4.17 shows the FT-IR spectra for the Zn substituted HA powder at different Zn 
concentrations.  
Zn-HA samples at concentration of 1% showed a water broad peak, between 3155 and 
3037 cm-1, associated with water adsorption. No other significant changes were observed. 
It has also been reported that the CO3 -2 which is present in the region of 1570-1410 cm-
1(205) might have overlapped with the band in the region of 1575-1279 cm-1, which was 
already ascribed to the presence of residual nitrates (206, 207), as described above.  
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Figure 4. 17: FT-IR spectra of zinc substituted hydroxyapatite with different Zn concentrations. 
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By increasing Zn concentration from 1 to 5%, the PO4 -3 bending bands appeared at 562 and 
600 cm-1 whilst the PO4 -3 stretching bands were centred at 1037 and 1089 cm -1. The broad 
band between 3300 and 3700 cm-1 can be attributed to the presence of water molecules. 
Overlapping is possible in this region especially at 3571 cm-1 associated with the presence of 
OH- groups. Also, carbonate CO3 -2 bands can be seen at 1414 and 1641 cm-1 similar to other 
prepared samples described earlier. 
4.3 Raman spectroscopy  
Complementary information can be obtained from FT-Raman spectroscopy. In addition to FT-
IR, Raman analysis was also used to further explore the chemical structure of the prepared 
samples. 
4.3.1 Raman analysis for NS-HA 
Figure 4.18 shows the Raman spectra of sintered HA samples. The Raman peak positions and 
their assignments are summarized in Table 4.8. 
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Figure 4. 18: Raman spectra of sintered NS- hydroxyapatite. 
 
 An intense peak was detected at around 960 cm-1 which can be assigned to PO43-(v1) and is 
believed to be the characteristic peak of HA present in 963 and 961 cm-1 (208, 209). 
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Table 4. 8: Characteristic Raman peaks of HA observed in the Raman spectra and assignment. 
Peak (cm-1) Assignment References 
1076, 1054, 1046, 1030 Triply degenerated 
asymmetric stretching mode 
(ν3) of the PO3-4 groups (P−O 
bond) 
(210), (211), (212), (213) 
961 Totally symmetric stretching 
mode (ν 1) of the tetrahedral 
PO3-4  groups (P−O bond) 
(212, 214),(215) 
620, 610, 594, 582 Triply degenerated bending 
mode (ν 4) of the PO3-4  group 
(O−P−O bond) 
(211), (212),(215) 
447, 433 Doubly degenerated 
bending mode (ν 2) of the 
PO3-4  group (O−P−O bond) 
(210), (211), (212), (215) 
 
The Raman spectrum clearly indicated that the peak with the highest intensity was associated 
with OH- in HA. In addition, three other PO43- modes were present in the regions of 447-430 
cm-1 (PO43-, v2), 1076-1030-1048 and 1054 cm-1 (PO43-, v3), and 610-620-578 and 594 cm-1 
(PO43-, v4). 
The Raman peak at around 1076 cm-1 observed in all HA samples can be assigned to both PO43-
- v3 mode (208, 209). 
 
4.3.2 Raman analysis for Ag-HA 
Figure 4.19 shows the Raman spectra of HA samples with different Ag concentrations (1,5 and 
10 %). 
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Figure 4. 19: Raman spectra of silver substituted hydroxyapatite with different Ag ion concentrations 
 
Similar to the NS-HA sample, the symmetric stretching for P-O bonds (ν1) was detected at (960 
cm-1). The vibrational bands at 429 cm-1 (ν2) and 450 cm-1 (ν2) were attributed to O-P-O bending 
modes. Both peaks at 1046 cm-1 (ν3) and 1074 cm-1 (ν3) were assigned to asymmetric ν3 (P-O) 
stretching. As silver concentration increased to 5 %, the intensity of phosphate groups reduced.  
It is worth noting, that pure metallic Ag is neither IR or Raman active and the formation of AgO 
and Ag2O are not thermodynamically feasible up to the maximum sintering temperature of 
(1300°C) (216).  
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4.3.3 Raman analysis for Mg-HA 
Figure 4.20 shows the Raman spectra of HA samples with different Mg concentrations (1, 5 
and 10%). The Raman peak positions and their assignments are summarised in Table 4.9. The 
Raman spectra peaks in Mg-HA 1% sample were very similar to those observed in the NS-HA. 
Peaks at 1075 and 1046 cm-1 in the spectrum were believed to correspond to asymmetric 
stretching (ν3) of the P–O bond in phosphate groups. The peak around 962 cm-1 corresponds to 
the symmetric stretching mode (ν1) of the P–O bond in phosphate groups. This peak, however, 
is normally expected to be present at 961 cm-1 in hydroxyapatite (209). The small shift observed 
could be caused by the incorporation of the magnesium ions in the HA lattice.  
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Table 4. 9: Raman shifts observed and assignment for Mg-HA 
Assignment 
        NS-HA Mg-HA 1wt.% Mg-HA 5wt.% Mg-HA 10 wt.% 
Peak (cm-1) Ref Peak(cm-1) Ref Peak (cm-1) Ref Peak(cm-1) Ref 
Triply degenerate asymmetric 
stretching mode (ν3) of the PO4 
group (P−O bond) 
1075(w), 
 
1046(m) 
(210), 
(211),  
1075(w), 
1046(m), 
1028(vw) 
(210), 
(211), 
(212),  
1073(w), 
1046(m), 
1029(vw) 
(210), 
(211), 
(212),  
1073(w), 
1046(m), 
1030(vw) 
(210), 
(211), 
(212),  Totally symmetric stretching 
mode (ν 1) of the tetrahedral PO4 
group (P−O bond) 
958(vs) (215) 96 (vs),  ( 5) 971(vs) ( 6) 971(vs) ( 6) 
Triply degenerate bending mode 
(ν 4) of the PO4 group (O−P−O 
bond) 
610(w), 
587(m) 
(211), 
(215) 
610(w), 
588(m) 
(211), 
(215) 
612(w),59
1(m) 
(211), 
(215) 
612(w), 
599(m) 
(211), 
(215) 
Bending mode (ν  4) of the 
HPO-2 4 group 
    555(w) (212) 555(w) (212) 
P−O and O−P−O stretching and 
bending modes (ν 4) of the PO4 
group 
    633(w) (215) 633(w) (216) 
Doubly degenerate bending 
mode (ν 2) of the PO4 group 
(O−P−O bond) 
447(w),43
3(m) 
(210), 
(211) 
442(w), 
432(m) 
(210), 
(211) 
442(w), 
433(m) 
(210), 
(211) 
442(w), 
433(m) 
(210), 
(211) 
v: very, w: weak, m: medium, s: strong, Ref: references 
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Figure 4. 20: Raman spectra for magnesium substituted hydroxyapatite with different Mg ion 
concentrations. 
 
 
Peaks at around 610 cm-1 and 587 cm-1 correspond to the (ν4 ). Peaks at around 442 cm-1  and 
432 cm-1  correspond to the  (ν2 ) bending of the O–P–O linkage in phosphates in HA. The small 
shift observed in (ν4 ) and (ν3) in the  spectra of Mg-HA 5 % and Mg-HA 10 %, which could be 
caused by the incorporation of the magnesium ions in the HA lattice and formation of TCP. 
Also Mg-HA 5% and Mg-HA 10 % samples each reveal a peak at 555 cm-1 and 633 cm-1 which 
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were associated with the bending modes of the O–P–O linkages in phosphates (e.g., 
Whitlockite).  
 
4.3.4 Raman analysis for Zn-HA 
Figure 4.21 shows the Raman spectra of HA samples with different Zn concentration (1, 5 and 
10%). The Raman peak positions and their assignments are also summarized in Table 4.10  
Similar to previous samples, the spectra for Zn-HA 1% were very similar to those observed for 
NS-HA. The asymmetric stretching peaks (ν3) of the P–O bond in the phosphate group PO43- 
were at 1076, 1055 and 1029 cm-1. However, stretching peaks (ν3) of P-O band of phosphate in 
1030 cm-1 become more pronounced by adding Zn to the HA. The peak around 962 cm-1 was 
associated with the symmetric stretching mode (ν1) of the P–O bond of the phosphate group 
PO43-.  
As discussed earlier, this peak is generally expected to be present at around 961 cm-1 in pure 
HA (209). Similarly, the shift could be due to the introduction of Zn into the HA lattice.  
Peaks at around 610 cm-1 and 587 cm-1 correspond to the (ν4). Peaks at around 447 cm-1 and 
433 cm-1 correspond to the (ν2) bending of the O–P–O linkages in phosphate in HA. The small 
shift observed in (ν4) and (ν3) in the spectra of Zn-HA 5 % and Zn-HA 10 %, which could be 
caused by the incorporation of the zinc ions in the HA lattice and formation of TCP. Also, Zn-
HA 5 % and 10 % samples each reveal a peak at 555 cm-1, which are corresponding to the 
bending modes of the O–P–O linkage in phosphate. 
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Table 4. 10: Raman shifts observed and assignment for Zn-HA 
 
Assignment 
        NS-HA Zn-HA 1wt.% Zn-HA 5wt.% Zn-HA 10 wt.% 
Peak (cm-1) Ref Peak (cm-1) Ref Peak (cm-1) Ref Peak (cm-1) Ref 
Triply degenerate asymmetric 
stretching mode (ν3) of the PO4 
group (P−O bond) 
1075(w), 
 
1046(m) 
(211), 
(212) 
1076(w), 
1048(m), 
1029(vw) 
(211), 
(212), 
(213) 
1077(w), 
1046(m), 
1030(vw) 
(211), 
(212), 
(213) 
1078(w), 
1045(m), 
1030(vw) 
(211), 
(212), 
(213) 
Totally symmetric stretching 
mode (ν 1) of the tetrahedral PO4 
group (P−O bond) 
958(vs) (215) 962(vs) (215) 970(vs) (216) 971(vs) (216) 
Triply degenerate bending mode 
(ν 4) of the PO4 group (O−P−O 
bond) 
610(w),  
 
587(m) 
(212),  
 
(216) 
610(w),  
 
588(m) 
(212),  
 
(216) 
611(w), 
 
597(m) 
(212),  
 
(216) 
612(w),  
 
599(m) 
(212),  
 
(216) 
Bending mode (ν  4) of the 
HPO-2 4 group 
    555(w) (213) 555(w) (216) 
Doubly degenerate bending 
mode (ν 2) of the PO4 group 
(O−P−O bond) 
447(w),43
3(m) 
(211), 
(212) 
442(w), 
433(m) 
(211), 
(212) 
440(w), 
428(m) 
(211), 
(212) 
442(w), 
433(m) 
(211), 
(212) 
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Figure 4. 21: Raman spectra of zinc substituted hydroxyapatite with different Zn ion concentrations. 
 
4.4 Thermal Stability Analysis  
This section provides information regarding the change in physical and chemical properties of 
apatite structure due to the sintering process at 1100 °C.  
4.4.1 Thermogravimetric analysis of NS-HA 
The thermogravimetric analysis (TGA) of the HA powder (NS-HA) was carried out between 
the room temperature and 1100°C (sintering temperature in this study) in order to understand 
the phase transformation within the sintered samples.  
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The TGA results for NS-HA sample are shown in Figure 4.22. The weight loss at the beginning 
of the TG plot from 25°C to 200°C corresponded to the removal of adsorbed water. At higher 
temperatures, the weight of NS-HA sample gradually decreased from 200 °C to 500 °C 
associated with the removal of water in the lattice. The weight loss trend continued (at a slower 
rate) from 500°C to 800°C and was associated to the transformation of HA to TCP.  
The total weight loss was about 2.5 wt.% for NS-H sample. For comparison, a pure 
stoichiometric HA sample prepared by others show a weight loss of about 1.7 wt.% (217), and 
the difference is expected to be because of difference in both physical (initial adsorbed water) 
and chemical properties (different ratio of water in the HA structure) between the experiments. 
4.4.2 Thermogravimetric analysis of Ag-HA 
Figure 4.22 shows the TGA graph for the silver substituted hydroxyapatite with different 
concentrations (1, 5 and 10 %). Table 4.11, also shows all the weight loss data. The temperature 
where the weight loss peak (or slope change) appeared between 700-850 °C is a representation 
of how much the HA phase is stable. Similar to NS-HA samples, there are three stages of weight 
loss based on different temperature range. Up to 200 °C is the region where the adsorbed surface 
water is evaporated and normally the biggest weight loss can be observed. In case of Ag-HA 
sample, they all showed a sharp peak in this region. 
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Figure 4. 22: TGA analysis of silver substituted hydroxyapatite with different Ag ion concentrations. 
 
Table 4. 11 Weight loss for NS-HA and Ag ions substituted HA up to 1100 °C. 
Sample Decomposition temperature 
(°C) 
Total weight loss (%) 
NS-HA 688 2.5±1.4 
Ag-HA 1 wt.% Not determined 0.9± 0.1 
Ag-HA 5 wt.% Not determined 1±0.1 
Ag-HA 10 wt.% Not determined 1.2±0.2 
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The most prominent change indicates the stability of the sample is the weight loss between 600 
and 1000°C. While it was difficult to measure and determine the decomposition temperatures 
from the results, based on the general profile of the curves, it was expected that the 
decomposition temperature are higher than NS-HA when Ag concentration increased. The total 
weight loss for the Ag substituted HA in the range of 25–1100 °C was about 7.9 wt.%. As 
expected, the residual weight slightly increased with the addition of Ag in the HA sample, as 
shown in Figure 4.22 
4.4.3 Thermogravimetric analysis of Mg-HA 
Figure 4.23 shows the TGA graph for the magnesium substituted hydroxyapatite with different 
concentrations (1, 5,10 %). Table 4.12 also shows all the weight loss data. 
 
Table 4. 12: Weight loss for NS-HA and Mg ions substituted HA up to 1100 °C. 
Sample Decomposition temperature 
(°C) 
Total weight loss (%) 
NS-HA 688 2.5±1.4 
Mg-HA 1 wt.% 750-810 7.3±2.9 
Mg-HA 5 wt.% 735-798 10.5±3.0 
Mg-HA 10 wt.% 720-791 11.4±4.1 
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A significant weight loss was observed for all magnesium substituted hydroxyapatite samples. 
In the temperature range between 25 and 400 oC the weight loss is similar to NS-HA for all 
samples 
 
Figure 4. 23 : TGA analysis for magnesium substituted hydroxyapatite with different Mg ion 
concentrations. 
 
The weight loss near the 690–800°C region was probably due to the loss of OH during the 
decomposition of HA to β-TCP. A decrease in the decomposition temperature with Mg content 
was indicated in the TG curves.  
The total weight loss increased with increasing Mg concentration. Mg-HA 10 wt.% showed the 
highest weight loss 11.4%±4.1%. Three different thermal profiles for Mg-HA were observed. 
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The Mg-HA with 5% showed a sudden weight loss between 735.3°C to 798. 4°C which might 
indicate the decomposition into whitlockite (total weight loss about 10.5% ±3.00%). On the 
other hand, the Mg-HA sample with 10 % showed a weight loss at 720°C. As a conclusion, the 
thermal stability of Mg-substituted hydroxyapatite decreased by increasing the content of Mg 
into hydroxyapatite products and also Mg-HA partially transformed to Mg-substituted β-TCP 
or whitlockite. 
 
4.4.4 Thermogravimetric analysis of Zn-HA 
Figure 4.24 shows the TGA graph for the zinc substituted hydroxyapatite with different 
concentrations (1, 5 and 10 %). Table 4.13 shows all the weight loss data. 
 
Table 4. 13: Weight loss for NS-HA and Zn ions substituted HA up to 1100 °C. 
Sample Decomposition temperature 
(°C) 
Total weight loss (%) 
NS-HA 688 2.5±1.4 
Zn-HA 1wt.% 790-830 6.7± 0.5 
Zn-HA 5wt.% 740-810 9.3±2.3 
Zn-HA 10wt.% 735-790 10.5±4.9 
 
There was a continuous weight loss of the samples with increasing the temperature. Again, the 
early weight loss between 25°C to 200°C was attributed to the adsorbed and bound (lattice) 
water while at higher temperatures, the weight loss was mainly due to the dehydroxylation of 
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hydroxyapatite (about 400 °C to 800°C) (218). The weight loss increased as the amount of zinc 
in the samples increased which might be linked to the formation of phases that include zinc or 
removal of a volatile species of zinc. As expected, the decomposition starting temperature at 
this concentration is about 790°C, which is very similar to NS-HA. However by increasing the 
Zn concentration, the decomposition temperatures drops to about 740 °C suggesting its lower 
thermal stability. The TG profile for different Zn concentrations showed, that the weight loss 
was more significant in samples with higher Zn concentrations (total weigh loss about 10.5% 
±4.9). The amounts of both the adsorbed and lattice water increased with increasing Zn 
substitution. For the samples with higher Zn concentration, the effect of increasing lattice water 
might overcome that of the substitution by Zn with smaller ionic radius (132). 
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Figure 4. 24: TGA analysis of Zinc substituted hydroxyapatite with different Zn ions concentrations 
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4.5 ICP-MS Analysis 
Analytical techniques such as XRD and FT-IR can only be used to obtain qualitative 
measurements and to confirm the inclusion of ions in the solid apatite structure. These 
techniques cannot give quantifying information about the degree of substitution in substituted 
apatite. Hence, Inductively Coupled Plasma-Mass Spectroscopy (ICP-MS) and X-Ray 
Fluorescence (XRF) methods were selected as two powerful tools to measure the substitution 
levels in the solid hydroxyapatite samples.  
ICP-MS in particular can provide accurate measurement of ion concentration in the liquid 
phase, while it can also be used to indirectly determine the remaining ions in the solid phase 
knowing the initial concentration of ions in the starting reaction medium.  
For all measurements, 3 samples for each case were used and each measurement was repeated 
3 times using the ICP-MS machine. An average value was calculated and is presented here 
together with the standard deviation.  
In order to find out the degree of substitution in the solid substituted hydroxyapatite samples 
(Ix, substituted), the mass balance equation below was used: (Equation 1). 
  
Ix, substituted = Ix, substrate - (Ix, sup-1+ Ix, sup-2 + Ix, sup-3)                                       Eq. 3.1 
 
Where Ix, substrate is the concentration of ions present in the initial reaction solution, Ix, sup-1  is the 
concentration of residual ions in the first supernatant of the centrifugation step, Ix, sup-2 is the 
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concentration of the residual ions after the first wash and Ix, sup-3 is the concentration of residual 
ions after the second wash.  
It was assumed, that the subsequent washing steps will remove any non-substituted or 
physically adsorbed ions, hence the difference will be the amount of substituted ions. As 
discussed in Section 3.2 (Materials and Methods), each measurement was performed using 10 
ml samples taken from each step. The actual weigh of the available ions in each sample of Ag-
HA, Mg-HA and Zn-HA was obtained and listed in Table 4. 15 and 4.16 respectively.  
 
Table 4. 14: Ag ions concentration in silver substituted hydroxyapatite samples 
Sample Ag-HA 1% 
Ag-HA 
5% 
Ag-HA 
10% 
Ix, substrate (mg) 71.2 355.9 711.9 
Ag not substituted (mg) (Ix, sup-1+ Ix, sup-2 + Ix, sup-3) 16.6 160.8 506.3 
% of Ag which substituted in HA 76.6 54.8 28.9 
wt. % of Ag in the final powder 0.99 3.4 3.6 
 
Table 4. 15 Mg ions concentration in magnesium substituted hydroxyapatite samples. 
Sample Mg-HA 1% 
Mg-HA 
5% 
Mg-HA 
10% 
Ix, substrate (mg) 48.1 240.6 481.3 
Mg not substituted (mg) (Ix, sup-1+ Ix, sup-2 + Ix, sup-3) 4.0 8.6 91.5 
% of Mg which substituted in HA 91.7 96.4 81.0 
wt. % of Mg in the final powder 0.3 1.7 2.19 
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Table 4. 16 Zn ions concentration in magnesium substituted hydroxyapatite samples. 
Sample Zn-HA 1% 
Zn-HA 
5% 
Zn-HA 
10% 
Ix, substrate (mg) 129.8 653.4 1309 
Zn not substituted (mg) (Ix, sup-1+ Ix, sup-2 + Ix, sup-3) 15 24.5 119.2 
% of Zn which substituted in HA 88.4 96.2 90.9 
wt. % of Zn in the final powder 1.7 3.4 5.3 
 
As discussed in the Materials and Methods section, the ion percentage used to differentiate each 
sample indicates the ion molar ratio of the selected ion to Ca, while the obtained values from 
the ICP-MS analysis shows the actual weight (and its ratio to the total weight of the powder) 
for each sample. 
In the case of Ag-HA, the weight percentage of Ag ions in the 1% Ag-HA was almost 1 wt.%, 
for Ag-HA 5% it increased to 3.4 wt.% and for Ag-HA 10% it was 3.6 wt. %. In case of Mg-
HA, the weight percentage of the Mg ion in the 1% Mg-HA was almost 0.28 wt.%, for Mg-HA 
5% increased to 1.66 wt.% and for Mg-HA 10% was 2.2 wt. %. For Zn-HA, the weight 
percentage of the Zn ion in the 1% Zn-HA is almost 1.7 wt.%, for Zn-HA 5% that increases to 
3.4 wt.% and for Zn-HA 10% that increases to 5.3 wt. %.  
4.5.1 Release profile of substituted metal ions  
ICP-MS analysis was also used to measure the amount of released ions from the disks placed 
in a liquid medium (PBS solution). The purpose of this study was to measure how much of the 
ions diffuse and solubilise in the liquid medium to almost resemble their release behaviour in 
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biological studies and human body. PBS buffer solution has a similar pH to human body =7.2 
and the specimen was kept stationary (no stirring) to avoid any force mass transfer and 
dissolution of the samples. Stationary conditions also ensured the solid structure of the samples 
remained intact and were not disrupted through manipulation.   
Release profile data are presented in two sections; a) Concentration (ppm) of the ion in the 
solution at each time interval b) Concentration (%) of the ion released as a ratio of the total ion 
available in the solid sample (disk). The total amount of ions was calculated based on the results 
presented in section 3.5.1. 
Silver release profile from Ag-HA 
Figure 4.25, shows the amount of released Ag ion (ppm and percentage of total Ag available in 
the solid) from Ag-HA samples after being submerged in PBS solution for up to 21 days.  
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Ag ions were detected as soon as few hours (3 hours) after the solid samples were submerged 
in liquid phase. The results confirmed that there was a direct relationship between the amount 
of silver in the solid and the amount of ions released in the liquid phase. Ag ions were shown 
to be released to the medium gradually until they reached a peak concentration after 24-48 hours 
in all of the samples. For Ag-HA 1%, this value was 0.22 ppm (with slight increase to 0.24 ppm 
after 14 days). A similar profile was observed for Ag-HA 5% sample showing a concentration 
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Figure 4. 25: Ag release profile from Ag-HA sample based on total Ag ion concentration in 
solution (top) and percentage of Ag in the powder which is released (bottom) 
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of 0.23 ppm in the medium after 48 hours. For Ag-HA 10%, there was a maximum 
concentration of 0.40 ppm and it increased to 0.45 ppm after 14 days.  
While Ag-HA 1% and Ag-HA 5% show an almost gradual release profile in the first 48 hours, 
a relatively burst release was observed for Ag-HA 10% sample. The concentration of Ag in the 
medium varied between 0.4 and 1.2 % of the total silver available in the solid for Ag-HA 10% 
and Ag-HA 1% respectively.  
Magnesium release profile from Mg-HA 
Figure 4.26, shows the amount of released Mg ions (ppm and percentage of total Mg available 
in the solid) from Mg-HA after being submerged in PBS solution for up to 21 days.  
Similar to silver ions in Ag-HA samples, magnesium ion concentration was relative to its 
concentration in the solid samples and ions started to release as soon as the solid was submerged 
(3 hours) in PBS. As Figure 4.26 shows, a maximum 10 ppm of Mg2+ ions was released about 
200 µg in 20 ml sample which was more  compared to what was observed for Ag-HA samples 
and was equivalent of about 18% of the total Mg2+ ions available in Mg-HA 1%. 
Similarly to Ag1+ ions, Mg2+ ions release followed a maximum release in the first days before 
it reached its highest concentration after 48 hours (4 days) 168 hours (7 days). The release 
profile for Mg2+ ions suggested that a burst release of Mg2+ ions was occurred in all samples 
showing that most of Mg2+ ions migrated from the surface of the solid particles and were 
transported into the liquid phase (PBS). Not much of Mg2+ ions were released at extended times, 
confirming that only very small amount of ions would diffuse through the solid (internal mass 
transfer), to the surface and then to PBS. 
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The concentration of solubilised Mg2+ ions was considerably higher than the ones observed for 
Ag ions. The highest concentration of Mg2+ ions was measured to be 8.79 ppm in the case of 
Mg-HA 1%, while in the case of Mg-HA 5% and  10% , the concentration was 9.64 and 10.35 
ppm, respectively.  
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Figure 4. 26: Release profile of magnesium in magnesium substituted hydroxyapatite based on total Mg2+ 
ions concentration in PBS (top) and percentage of released Mg2+ ions from the samples (bottom). 
Zinc release profile from Zn-HA 
Figure 4.27, shows the amount of released Zn2+ ions (ppm and percentage of total Zn available 
in the solid) from Zn-HA samples after being submerged in the PBS solution for up to 21 days.  
150 
 
Similarly, to silver and magnesium ions, zinc concentration in liquid was changing relative to 
its concentration in solid sample. As Figure 4.27 shows, maximum 0.06 ppm of Zn was released 
(or 1.2 µg in 20 ml sample) which is less than what was observed in Ag-HA and Mg-HA 
samples. This was equivalent to about 0.007 % of total Zn substituted in Zn-HA 5% which is 
significantly lower than what was observed in Ag-HA and in particular Mg-HA samples. 
Zinc concentration in liquid phase reached the maximum concentration after 24 hours for Zn-
HA 1% and Zn-HA 10% and 48 hours for Zn-HA 5% hence showed a faster rate of release. 
The release profile for Zn ions (reaching its max level after 24 hours) and lower concentration 
of released Zn suggest that the release is mainly governed by the migration of the surface 
adsorbed ions. The concentration of solubilised Zn did not change after 48 hours, which again 
confirms the negligible mass transfer from the bulk material to the liquid phase.  
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Figure 4. 27: Release profile of zinc in zinc substituted hydroxyapatite based on total Zn2+ ions concentration 
in PBS (top) and percentage of released Zn2+ ions from the samples (bottom). 
4.6 X-ray Fluorescence Spectroscopy (XRF) 
4.6.1 Characteristaion of Ag-HA by XRF 
Table 4.17, shows the Ag ions content, Ca/P, (Ca+Ag)/P (as a ratio of total cations to 
phosphorus) and Ag/Ag+Ca (as ion substitution ratio) in Ag-HA samples measured by XRF.   
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Table 4. 17: XRF measurement for Ag-HA samples. 
Sample Pure HA Ag-HA 1% Ag-HA 5% Ag-HA 10% 
Ag (wt.%)-measured 0.0 0.57 2.89 4.23 
Ca/P molar ratio 1.85 2.00 1.97 1.93 
Ca+Ag/P   molar ratio 1.85 2.01 2.02 2.01 
Ag/Ag+Ca 0.0 0.48 2.53 3.68 
 
The ratio of Ca/P in NS-HA and Ca+X/P (where X is cation substituted for Ca in HA) was set 
to 1.8. Ca/P ratio. The stoichiometric HA is 1.67, but as discussed in chapter 3 (section 3.1) the 
ratio of 1.8 was selected to obtain a higher calcium content in the HA with better bone-implant 
interaction. 
The Ca/P ratio in the prepared NS-HA (1.85) was similar to the ratio in the reactants (1.8) and 
the slight increase could be due to the replacement of phosphorus with carbonate ions as a result 
of atmosphereic CO2 solubilised in the aqueous reaction medium. 
In the Ag-HA samples, the total substitution was 0.57, 2.89 and 4.23 wt.% in the solid HA 
which was almost in the same range as the values obtained from the ICP measurements in 
section 4.5.  
Silver substitution, or the amount of silver replacing calcium ions in Ag-HA 1, 5 and 10 wt.% 
was 0.48, 2.53 and 3.68 %, respectively.  
The Ca+Ag/P ratio increased from 1.85 in NS-HA to about 2 when Ag1+ ions were introduced 
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to the structure.  
4.6.2 Characterisation of Mg-HA by XRF 
Table 4.18, shows the XRF measurements of the Mg content in solid Mg-HA and also the 
calculated values for Ca/P ratio, Ca+Mg/P (as a ratio of total cations to phosphorus) and 
Mg/Mg+Ca (as a measure of Mg substitution).    
 
Table 4. 18: XRF measurement for Mg-HA samples. 
Sample Pure HA Mg-HA 1% Mg-HA 5% Mg-HA 10% 
Mg (wt.%) 
incorporated 
0.0 0.22 0.99 2.55 
Ca/P molar ratio 1.85 1.9 1.95 1.88 
Ca+Mg/P   molar ratio 1.85 1.91 2.02 2.07 
Mg/Mg+Ca 0.0 0.88 3.61 9.07 
 
In case of Mg-HA samples, the XRF analysis showed that the total concentration of Mg in Mg-
HA was 0.26, 1.11 and 2.86 wt.% in Mg-HA 1, 5 and 10% samples, which was again similar 
to wt.% ratios of Mg which was obtained from ICP measurements. Magnesium substitution, or 
the amount of Mg ion which has replaced and substituted Ca in HA structure was 1.02, 4 and 
9.92% for Mg-HA 1, 5 and 10% samples.  These results suggest that Mg substitution in HA 
structure was very similar to the stoichiometric values which was calculated for the amount of 
chemicals as reactants.   Ca+Mg/P ratio increased from 1.85 to about 2 when Mg was introduced 
to the HA structure, which can be explained with similar effects discussed for Ag-HA above.  
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4.6.3 Characterisation of Zn-HA by XRF 
Table 4.19, shows the XRF measurements of the Zn content in solid Zn-HA and also the 
calculated values for Ca/P ratio, Ca+Zn/P (as a ratio of total cations to phosphorus) and 
Zn/Zn+Ca (as a measure of Zn substitution).    
Table 4. 19:  XRF measurement for Zn-HA samples. 
Sample Pure HA Zn-HA 1% Zn-HA 5% Zn-HA 10% 
Zn (wt%) measured 0.0 0.56 2.80 4.23 
Ca/P molar ratio 1.85 1.93 1.85 1.87 
Ca+Zn/P   molar ratio 1.85 1.94 1.92 1.99 
Zn/Zn+Ca  0.0 0.77 3.96 5.90 
 
For Zn-HA samples, XRF measurement shows that total concentration of Zn in Zn-HA was 
0.56, 2.8 and 4.23 wt. % in Zn-HA 1, 5 and 10% samples, which was again similar to wt.% 
ratios of Zn which was calculated from ICP measurements. Zinc substitution, or the amount of 
Zn ion which has replaced and substituted Ca in HA structure was 0.77, 3.96 and 5.9 % for Zn-
HA 1, 5 and 10 % samples.  As Table 4.16 shows,  Zn substitution in HA structure was 5.9 % 
(in Zn-HA 10% sample) even when there was excess Zn available in the medium. Ca+Zn/P 
ratio increased slightly from 1.85 to 1.92 when Zn was introduced. 
 
4.7 Cell Biology  
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In order to ascertain the biological activity and cellular responses to the ion-substituted HA 
samples animal cell lines were employed to investigate their impact on cell viability, cell 
proliferation and cell differentiation. The results from these assays enabled us to establish the 
behaviour of HA selected ions and potentially elucidate their responses in vivo. The in vitro cell 
investigation is well established and commonly used in biomaterial testing as indicated in 
following section. 
4.7.1 Cell Proliferation results  
Cell proliferation can be directly attributed to the level of cell growth and multiplication and 
when negatively impacted, can also be representative of the chemical toxicity(219). 
Comparison with NS-HA samples show the effect of addition of ions on the studied tests. All 
the results in this section are normalised for response of NS-HA of 100.  
Proliferation results are presented using absorbance values which are directly related to the 
number of living cell. As absorbance values increases, more number of cells are formed.   
Cell Proliferation on NS-HA samples 
Figure 4.28 illustrate the changes in osteoblast cell proliferation on samples of NS-HA during 
6 days of incubation in culture media. As results indicated, there was a steady increase in 2T3 
proliferation from 2 days to 6 days in culture conditions in the presence of NS-HA discs. Cell 
proliferation was significantly (p<0.05) increased by 20%, 38% and 52% in day 2, 4 and 6 
respectively. These preliminary results, represent a favourable response by the studied cells 
with hydroxyapatite disks. 
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Figure 4. 28: Cell growth (mouse osteoblast cell lines (2T3)) vs. time (over 6 days culture) from the 
AlamarBlue assay (blank wells is control). Mean values (±standard error values) from 3 independent 
experiments. * (p<0.05). 
 
Cell Proliferation on Ag-HA samples 
Figure 4.29 shows the changes in osteoblast cell proliferation on Ag-HA at three different ratio 
(1, 5 and 10%) samples during 6 days of incubation in culture media. Ag-HA samples, as 
prepared following the method described in Section 3, were used to investigate the effect of 
silver substitution on cell proliferation.  In case of 1 % Ag-HA, proliferation increased by 10% 
cell when compared to NS-HA 2 days incubation. However, cell proliferation increased by 18% 
in these cultures after 4-days incubation and this difference reached significance (p<0.05). A 
similar pattern of significant increase (p<0.01) was noted after 6 days incubation with a 19% 
increase in the extent of cell proliferation as compared to control cultures.  
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For Ag-HA 5 % samples, cell proliferation rate was almost similar to Ag-HA 1% samples. 
Hence, 8% cell proliferation increase was observed up to day 2 when compared with NS-HA 
sample. Although cell proliferation on Ag-HA 5 % was slightly lower than the results obtained 
from incubation of Ag-HA 1 % at days 4 and 6, cell proliferation increased by 17%% and 18% 
in these cultures after 4 and 6 days incubation respectively compared to NS-HA and this 
difference reached significance (p<0.05).  
Cell proliferation on Ag-HA 10 %, was significantly lower than the NS-HA (P<0.05), Ag-HA 
1% (p<0.05) and Ag-HA 5% (p<0.05) during all days. Cell proliferation on Ag-HA 10% 
decreased by 34%, 35% and 38% in these cultures after 2, 4 and 6 days respectively compared 
to NS-HA and this difference reached significance (p<0.01). 
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Figure 4. 29: Cell growth (mouse osteoblast cell lines (2T3)) vs. time (over 6 day culture) from the 
AlamarBlue assay for Ag-HA (NS-HA is control). Mean values (±standard error values) from 3 
independent experiments *(p<0.05) and **(p<0.01). 
 
As shown in section 4.5.2 (release profile measurement), the total concentration of Ag ion 
which is present in the medium after 6 days are as table below: 
 
Table 4. 20: Concentration of Ag ions due to unassisted release (ppm) over period of 2, 4 and 6 days. 
 Day 2 Day4 Day6 
Ag-HA 1% 0.21 0.30 0.31 
Ag-HA 5% 0.23 0.30 0.31 
Ag-HA 10% 0.40 0.45 0.46 
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Based on the values presented in Table 4.20 and the results from cell proliferation assessment, 
when the concentration of Ag ion increases to more than (between 3 and 4) ppm (which 
corresponds to 10% Ag sample) cell proliferation is negatively affected and cell proliferation 
reduced.  
Cell Proliferation on Mg-HA samples 
Figure 4.30 presents the results of the osteoblast proliferation assay for on Mg-HA (1, 5 and 10 
%) samples versus the NS-HA control sample.  
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Figure 4. 30: Cell growth (mouse osteoblast cell lines (2T3)) vs. time (over 6 days culture) from the 
AlamarBlue assay for Mg-HA (NS-HA is control). Mean values (±standard error values) from 3 
independent experiments *(p<0.05) and **(p<0.01). 
 
 
Mg-HA 1% samples increased cellular activity in terms of cell proliferation by 10% on day 2 
compared to NS-HA sample. Although proliferation rate slightly decreased on day 4 and 6, it 
was still higher than control by 5% and 4% respectively. In case of Mg-HA 5 and 10% cell 
proliferation have showed sharp decrease in all time pointed. For Mg-HA 5%, cell proliferations 
decreased significantly by 31%, 52% and 54% in day 2, 4 and 6 respectively. A similar pattern 
was observed for Mg-HA 10 wt.% with a significant decline (p<0.01) by 56%, 57% and 58% 
in day 2, 4 and 6 respectively.  
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Based on the release profile values presented in Table 4.21 and the results from cell 
proliferation assessment, when concentration of Mg ion increases to more than 8 ppm (which 
corresponds to 5% Mg sample) cell proliferation was negatively affected and cell proliferation 
reduced. 
 
Table 4. 21: Concentration of Mg ions due to unassisted release (ppm) over period of 2, 4 and 6 days. 
 Day 2 Day4 Day6 
Mg-HA 1% 6.22 8.01 8.03 
Mg-HA 5 % 7.06 9.05 9.02 
Mg-HA10 % 8.02 10.03 10.05 
 
Cell Proliferation on Zn-HA samples 
Figure 4.31 shows the osteoblast cell proliferation on NS-HA and Zn-HA (1, 5 and 10 %) 
samples during 6 days of incubation in culture media. On day 2, proliferation on the surface of 
Zn-HA 1% increased but the difference was not statically significant. However, on the same 
day, osteoblast cell proliferation with Zn-HA 5 % and 10 % were 5% and 17% higher than the 
one for NS-HA respectively. On day 4, cell proliferation on the surface of Zn-HA 1% was 5% 
higher than the NS-HA sample. On the same day, Zn-HA 5 and 10 % samples showed 15% and 
37% increase in cell proliferation respectively (p<0.05). On day 6, cell proliferation increased 
by 9%, 21% and 41% with Zn-HA 1, 5 and 10 % respectively.  
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Figure 4. 31: Cell growth (mouse osteoblast cell lines (2T3)) vs. time (over 6 day culture) from the 
AlamarBlue assay for Zn-HA (NS-HA is control). Mean values (±standard error values) from 3 
independent experiments *(p<0.05). 
 
Based on the values presented in Table 4.22 and the results from cell proliferation assessment, 
all selected Zn concentration (with maximum 0.08 ppm concentration) can enhance cell 
proliferation. 
Table 4. 22: Concentration of Zn ions due to unassisted release (ppm) over period of 2, 4 and 6 days. 
 Day 2 Day4 Day6 
Zn-HA 1% 0.02 0.03 0.03 
Zn-HA 5 % 0.05 0.07 0.08 
Zn-HA10 % 0.06 0.08 0.08 
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4.7.2 Alkaline Phosphatase (ALP) Activity quantification 
When studying the biocompatibility of the implants, cell proliferation may not provide 
conclusive result to assess the suitability of the implants. A new set of measurement based on 
ALP activity was designed to investigate the effect of ion substitution on the cell differentiation. 
ALP is a hydrolyse enzyme secreted by osteoblasts, and is responsible for removing phosphate 
groups from nucleotides, proteins, and alkaloids. Therefore, ALP is a useful marker for 
osteoblast activity. 
ALP Activity on Ag-HA samples 
The level of ALP protein expression by 2T3 cell cultured on HA and Ag-HA (1, 5, and 10 %) 
samples are illustrated in Figure 4.32. The onset of ALP activity for all samples was observed 
at day 7 of incubation.  
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Figure 4. 32: ALP/ Protein values representing osteogenic differentiation of 2T3 cells after subsequent 
culture at day 7 for NS-HA and Ag-HA. Mean values (±standard error values) from 3 independent 
experiments. *(p<0.05). 
 
 
 
A steady increase in the ALP activity at the time points was observed for 2T3 cell cultured on 
Ag-HA 1 and 5 % when compared with NS-HA, by 27% and 31% respectively.  In case of Ag-
HA 1 wt.%, ALP activity was more distributed. The activity for Ag-HA 10% decreased by 5%.  
ALP activity produced by 2T3 cultured on Ag-HA 5 % was statistically the highest whilst for 
Ag-HA 10 wt.%, it showed the lowest activity on day 7. This suggests that the incorporation of 
silver of more than 5 % did not affect the bone differentiation of 2T3. 
ALP Activity on Mg-HA samples 
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The level of ALP protein expression by 2T3 cell cultured on NS-HA and Mg-HA (1, 5, and 10 
%) samples are illustrated in Figure 4.33. 
 
 
Figure 4. 33: ALP/ Protein values representing osteogenic differentiation of 2T3 cells after subsequent 
culture at day 7 for NS-HA and Mg-HA. Mean values (±standard error values) from 3 independent 
experiments.  
 
 
A gradual increase in the ALP activity was observed on day 7 by increasing Mg concentration 
from 0 to 1 wt.%. For Mg-HA 5 %, the activity was the lowest while for Mg-HA 1 % it showed 
the highest on day 7. In other words, incorporating magnesium in hydroxyapatite by more than 
1 wt.% can decrease differentiation by 15% and 12% in Mg-HA 5 and 10 % respectively. While 
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the difference between 1% sample and 5% and 10% sample were more pronounce, the 
difference between ALP activity for Mg-HA 10 % and 5 % was not significantly higher. It can 
be concluded that the substitution of Mg has a relatively positive effect on bone differentiation 
of 2T3 but is dose-dependent. This slight increase is believed to be the result of Mg and Ca ions 
release from Mg-HA into the cell culture medium.  
ALP Activity on Zn-HA samples 
The level of ALP protein expression by 2T3 cell cultured on NS-HA and Zn-HA (1, 5, and 10 
%) samples are illustrated in Figure 4.34. 
 
Figure 4. 34: ALP/ Protein values representing osteogenic differentiation of 2T3 cells after subsequent 
culture at day 7 for NS-HA and Zn-HA. Mean values (±standard error values) from 3 independent 
experiments. *(p<0.05). 
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A gradual increase in the ALP activity was observed for 2T3 cell cultured with Zn-HA samples 
as the concentration of Zn increased. ALP activity for Zn-HA 1 % sample increased only by 
25% while for Zn-HA 5 % it increased by 33% and for Zn-HA 10% it increased by 32%. The 
difference between ALP activity of Zn-HA 5 % and 10 % was not significantly different (p> 
0.10) . This suggests that the incorporation of Zn positively affect the bone differentiation of 
2T3 cell culture at the levels studied.  
 
4.8 Antimicrobial efficacy tests 
4.8.1 Agar diffusion study (Zone of Inhibition (ZI)) 
Agar diffusion study with Ag-HA 
Figure 4.35 shows the change in the size of the zone of inhibition (ZI) against time and different 
concentrations of loaded silver samples in two bacterial cultures. Bacterial growth was inhibited 
in all Ag-HA samples, suggesting that solid disks exhibit antibacterial properties when 
compared to the NS-HA (control) sample. The size of the ZI increased with times suggesting 
that the release profile of silver (Ag) ions was not fast and sudden under such conditions.  
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Agar diffusion study with Zn-HA 
The diameter of the ZI is larger against Escherichia coli (E.coli) than Staphylococcus 
epidermidis (S.epidermidis) in all Ag concentrations. By increasing the Ag concentration, larger 
ZI (p < 0.05) was observed against both bacteria. Figure 4.36 shows the size of the ZI in agar 
plates obtained with Zn-HA samples and confirms bacterial inhibition in 5% and 10% Zn-HA 
0
5
10
15
20
25
30
35
NS-HA Ag-HA 1% Ag-HA 5% Ag-HA 10%
Z
o
n
e
 o
f 
in
h
ib
it
io
n
 (
m
m
)
Ag-HA Samples
24h
48h
0
5
10
15
20
25
30
35
40
45
NS-HA Ag-HA 1% Ag-HA 5% Ag-HA 10%
Z
o
n
e
 o
f 
in
h
ib
it
io
n
 (
m
m
)
Ag-HA Samples
24h
48h
 
Figure 4. 35: Zone of inhibition of Ag-HA samples against S.epidermidis (top) and E.coli (bottom). 
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when compared to the NS-HA (control) sample. However, the results showed no significant 
difference in 1% Zn-HA in two cultures after 24 hours. 
The diameter of the ZI was larger against S.epidermidis than in E.coli in all zinc (Zn) 
concentrations. When the Zn concentration increased, larger ZI (p<0.05) was obtained against 
both microorganisms. However, no significant difference was observed in the diameters of the 
ZI for 5% and 10% Zn-HA samples in 24 hours against S.epidermidis (p>0.1). However, 
antibacterial activity recovered and increased at 48 hours (p<0.01). 
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4.8.2 Film Adhering Method (Quantitative analysis) 
The quantitative tests provided a more detailed measurement of the antibacterial activity in the 
studied samples. In the film adhering method, higher inhibitory rates suggest that the studied 
specimen possesses higher antibacterial activity.  
 
Film adhering method with Ag-HA 
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Figure 4. 36: Zone of inhibition of Zn-HA samples against S.epidermidis (top) and E.coli 
(bottom) 
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As Figure 4.37 shows, the Ag-HA samples had significant growth inhibition against both 
bacteria in comparison to the control sample in all three different ratios.  
The graph reveals that, even with the lowest Ag content (1 %), antibacterial properties can be 
obtained against both Gram positive and Gram negative bacteria. For the high Ag content (10 
%) sample, the colony formation units (CFU) reduction reached 80% after 143 hours. Similar 
to the ZI experiments, the Ag efficiency was shown to be dose-dependent and was more 
pronounced against Gram-negative bacteria (E.coli) than Gram-positive bacteria (S. 
epidermidis). 
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Film adhering method with Zn-HA 
The CFU reduction values for the Zn-HA samples (Figure 4.38) confirm that there is a 
significant growth inhibition in comparison with the NS-HA (control) samples. However, the 
CFU reduction was lower in comparison to the Ag-HA plates. 
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Figure 4. 37: CFU Reduction (%) of Ag-HA samples against E.coli  (top) and S.epidermidis (bottom). 
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The Zn-HA samples were not able to remove completely the colonies of E.coli and 
S.epidermidis in any studied concentration of Zn even after 143 hours. The Zn-HA also shows 
to be more effective against S.epidermidis and its antibacterial properties increases at higher 
ion concentrations. The lowest Zn concentration (1 %) still shows a CFU reduction with both 
bacteria cultures. The graph reveals that the highest growth reduction was reached after 72 
hours with both positive and negative bacteria and in different Zn concentrations.   
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Figure 4. 38: CFU Reduction (%) of Zn-HA samples against E.coli  (top) and S.epidermidis (bottom). 
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CHAPTER 5 
DISCUSSION 
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5 Discussion 
5.1 X-ray Diffraction 
XRD technique was used for phase identification, measuring the degree of crystallinity, 
crystallite size and also the calculation of lattice parameters. 
5.1.1 X-ray diffraction analysis of Non-Substituted Hydroxyapatite (NS-HA) 
Phase Identification of NS-HA 
As shown in Figure 4.1, the XRD pattern obtained for NS-HA showed the characteristic peaks 
for calcium phosphates, consistent with the International Centre for Diffraction Data (ICDD) 
files for the same material. The overall diffraction pattern of the sample was in agreement with 
the results of previous studies (62, 66, 178, 179). The NS-HA sample in this study was sintered 
at 1100°C.  As diffraction profiles show, a small amount of HA decomposed to β-TCP.  
Highly crystalline hydroxyapatite is expected to be synthesised when HA is sintered at 1100 °C 
(220, 221), while at higher temperatures (>1100 °C), β-TCP phase is synthesised from the 
partial spontaneous decomposition of HA (222). The calcination was set up for 2h, for 
prevention of further decomposition)The advantage of β-TCP, and in general all TCP phases, 
for biological applications is their relatively higher mechanical strength and better bioresorption 
rates when compared to HA (223).  
The decomposition of HA can be associated with the formation of oxyapatite intermediate 
phase (Ca10(PO4)6 O☐), where ☐ denotes a non-charged vacancy in the HA lattice. This phase 
begins to form with the gradual loss of radical OH- (dehydroxylation) in the matrix when HA 
is heated in air to above 1200°C (224). As a result, one of the lattice sites originally occupied 
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by two OH groups will be occupied by an oxygen while the other is left vacant (224). The 
formation of oxyapatite is believed to follow the reaction mechanism below: 
Ca10(PO4)6(OH)2  ⇒ Ca10(PO4)6 O.☐ + H2O                                                                  Eq. 5.1 
where ☐ denotes a non-charged vacancy in the HA lattice. Oxyapatite is stable although it can 
undergo further decomposition to form tricalcium phosphate (TCP) and tetracalcium phosphate 
(TTCP) at higher temperatures.  
There are several possible explanations why HA has decomposed in this study. A longer 
sintering time could lead to higher dehydration and decomposition rates of HA at lower 
temperatures (1100°C), as also suggested by Wang et al. (225). Furthermore, the presence of 
moisture in the sintering atmosphere can affect the rates of decomposition up to 1300°C. Wang 
et al.’s experiments were carried out at relative humidity of 80% (225), while experiments in 
this study, air humidity during the material processing steps was expected to be about 50% 
(based on the official seasonal average measurement obtained from the UK Meteorological 
Office website), which may have contributed to the minor instability in the HA phase in case 
of this study. Possible inaccuracy in the stoichiometry of reaction can also impact the 
composition of phases, since secondary phases start to form at Ca/P ratios of above 1.8 
(Ca/P=1.8 was used for all samples in this study) (226).   
The method used for the preparation of HA samples (wet precipitation) can also impact the 
stability of HA phases. Based on results from Ramesh et al. (226), HA synthesis by  
precipitation can decompose to TCP at about 800°C, while no follow-on decomposition phase 
(α-TCP) was present. 
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Special attention was given to the selection and purity of the reactants. This was to ensure the 
absence of intervening ions such as chloride (Cl-), potassium (K+), or sodium (Na+2), which can 
impact the quality of the final product. Chloride (Cl-) ions are shown to impact the morphology 
and crystallinity of the final HA by substituting hydroxyl groups (227).  Similarly, potassium 
(K+) ions can substitute calcium ions and negatively impact the bulk structure of the final 
sample (228). Hence, NH4OH was used as the source of hydroxyl groups (OH) rather than 
KOH. The presence of Na+2 ions was also avoided in the reaction medium since previous studies 
suggest that their presence will easily lead to their incorporation into the crystal lattice and 
formation of non-stoichiometric HA (66, 227). The XRD results in this study confirm that none 
of these elements were present in the final HA samples.  
In addition, the NO3 ion was also absent from the final HA as expected, due to its large size 
which limits its ability to substitute hydroxyl groups (229). NH4+ ions were not observed mainly 
because of several washing steps used following the synthesis step. CaO has been shown to 
have negative impact on the biological response and success of implants, due to its dissolution 
in the surrounding environment and pH increase resulting in the inhibition of bone growth 
(230), though no peak referring to CaO was observed in any of the prepared samples. The 
presence of CaO can be attributed to little or no carbonation of HA during the reaction synthesis 
(66, 231).  
Crystallinity and crystal size of NS-HA 
The degree of crystallinity of HA is one of the critical elements which correlates to its thermal 
stability and rate of dissolution in physiological environment (232).  
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Sintering of HA samples at 1100°C resulted in a considerable increase in degree of crystallinity. 
There was a substantial increase in the height and sharpness of peaks, corresponding to an 
increase in crystallinity levels. Non-sintered HA possessed a crystallinity of 61.75 ±3.2 %, 
while sintered HA attained levels of crystallinity of 88.8 ±5.7 %; an increase of about 27%. All 
the powders produced in this study, including NS-HA and Mg-HA, Zn-HA and Ag-HA for all 
ion ratios had a crystallinity degrees lower than 95%, the minimum requirement as set out by 
FDA (233). An explanation for this relatively low crystallinity could be the short time available 
for calcination (2 hours). It is expected that by increasing this time, the final product would 
attain a higher degree of crystallinity. 
Another explanation could be the non-optimised ripening time which was not used in this study, 
which is believed to have a strong contribution to the crystallinity of the final powder (234). 
During the ripening stage, which initiates in the reactions but continues until the crystals are 
physically separated from the solution, crystals undergo the nucleation and growth stages in a 
supersaturated solution. This is considered to impact the crystal size and its morphology. 
Producing highly crystalline HA was not the objective of this study and ripening time was not 
controlled during the experimental work. Reaction temperature, kinetics and unknown 
interactions between different ions in the solution are also expected to affect the crystallinity of 
the product as suggested in other studies (179, 234, 235), which were not studied in this study. 
To control the crystallinity as a quality attribute for a biomedical material, however, all these 
parameters are expected to be identified, controlled and optimised during the reaction. 
There are key parameters which can influence the final crystal size in the 002 plane. For 
example, using an inert atmosphere (e.g. a nitrogen purged medium) is shown to have a major 
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effect on the size of the crystals in this plane. As shown by Smiciklas et al. (179), an increase 
in crystallite size was observed when an inert atmosphere was used.  
Another factor is the two-way interaction between the reaction temperature and the ripening 
time, as highlighted previously. Both Pang et al. (234) and Smiciklas et al. (179) reported that 
crystal size increases by increasing the reaction temperature and ripening time in this plane.  
While the above-mentioned parameters are known to impact crystallinity and size of the 
crystals, again, it was not the purpose of this research to optimise these parameters. However, 
they were expected to remain constant in this study, and any change to crystal size and 
crystallinity was due to the change in the type and concentration of added metal cations.  
Lattice parameters and crystal size of NS-HA 
The reported values for lattice parameters are consistent with the available lattice data for HA 
and β-TCP phases reported in the mentioned references (and purchased standard HA) as starting 
values. The slight difference in lattice parameters in the prepared NS-HA may be due to some 
deviation from the reaction stoichiometry. Generally, an increase in the lattice parameter c with 
a reduction in lattice parameter of a indicates either (236): 
1. A change in the Ca/P ratio in the HA; 
2. A change in the Ca/OH ratio in the HA; or 
3. Substitution of OH groups by CO 2-3 groups.  
Cases (1) and (2) can be described as a change in the composition on account of precipitation 
of the impure phases (e.g. β-TCP) present in the HA, and are discussed in section 4.6 for XRF 
analysis. Case (3) suggests that HA may have reacted with carbonate ions present in the solution 
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originating from CO2 in the air, as opposed to the inert environment which may used during 
the preparation of reference HA.  
The HA crystal consists of two types of crystal planes, each with different charges: positive 
charge for the a-planes and negative charge for the c-planes (236). Controlled orientation may 
be obtained by changing the morphology of the HA crystals. As an example, by increasing the 
surface charge of the HA, hexagonal-shaped HA starts to grow along the c-axis so that the 
(a=b)-plane is wider than the c-plane.  
When the lattice parameter in the a-axis was compared to those for the stoichiometric HA 
sample (the reference and had Ca/P=1.67), the higher Ca2+ concentration of HA sample (as a 
higher Ca/P ratio (=1.8) was used in these experiments) resulted in a higher a value, the 
expected outcome which was also reported by Aizawa et al. (183). 
5.1.2 X-ray diffraction analysis of Silver-Substituted Hydroxyapatite (Ag-HA) 
Phase Identification of Ag-HA 
The XRD patterns of all samples were very similar to that of NS-HA. However, two sharp 
peaks at 2θ = 33.29° and 36.58°, and also a small peak at 27.16°, were present in the XRD 
pattern of Ag-HA 1% sample which belongs to Ag3PO4. When Ag concentration increased in 
Ag-HA 5%, an additional Ag3PO4 peak at 2θ= 20.82 ° became visible.  
A study by Ipekoglu et al. (237)  reported Ag3PO4 peaks for 5 and 10 wt.% Ag-HA samples. It 
was expected that the majority of silver at lower concentrations was incorporated directly as 
Ag+ ions into the HA structure, with less chance for it to react with the phosphate ions and form 
silver phosphate. However, as silver concentration increased in 5 and 10 wt.% samples, more 
silver was available leading to the formation of silver phosphate.  
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In addition, hexagonal crystal planes of metallic silver were observed in the XRD pattern of 
Ag-HA. Similar observations were reported in other studies where silver substituted 
hydroxyapatite was synthesised and studied (184, 185). However, the intensity of the small 
peaks associated with the presence of metallic silver was much lower than that found in JCPDS 
no. 04-0783, which may be explained by an increased degree of silver substitution and thus a 
lower concentration of residual metallic silver residue.  
Crystallinity and Crystal Size of Ag-HA 
As XRD patterns shows, by introducing silver to hydroxyapatite in concentrations of 1 to 10 
wt.%, HA peaks became only slightly sharper, suggesting that a marginal rise in crystallinity 
after silver incorporation. The XRD pattern also shows that the powders obtained by co-
precipitation exhibit an apatite structure with good crystal characteristics. Similar results were 
obtained by Ciobanu et al. (238), who prepared silver doped hydroxyapatite without forming a 
new phase. They reported an increase in lattice parameters but showed a minor reduction in 
crystallinity when silver concentration increased from 0.05 to 0.3 (238). Stanic et al. (138) used 
Ag2O as the source of silver and similarly showed an increase in lattice parameters but again a 
slight decrease in crystallinity of final Ag-HA in comparison to pure HA.  
In another study by Nirmala et al. (239), TEM was used to assess the incorporation of Ag 
particles and also to measure the crystal size. While a high crystalline sample was formed, they 
showed that Ag particles were mostly attached on the surface of HA crystals. Although they 
did not measure the crystallinity but reported no significant change in the peak sharpness in the 
sample’s XRD pattern after Ag was incorporated up to 5 wt. %. While there is a good agreement 
in terms of having a highly crystalline Ag-HA, results from this study show a different crystal 
size in the final product, which is expected to be due to different experimental methods. 
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Lattice parameters of Ag-HA 
When cations are substituted into the HA lattice, they tend to change the lattice parameters and 
cause the HA structure to be disordered. Depending on the size and charge of the cation, the 
unit cell can become bigger or smaller. This change can be observed even in the XRD pattern, 
as represented by broader or narrower peaks. 
Lattice parameters a and c increased with an increasing amount of silver ions in HA and β-TCP 
phase, which indicate that Ag ions are included in the HA lattice and may have replaced Ca+2 
sites in both phases.  
Similar expansion on the a and c axes was observed in a study by Ipekoglu et al. (237), where 
they prepared Ag substituted HA using a microwave technique. They claim that this led to Ag 
replacing Ca+2 sites, due to an increase in the unit cell parameter.  
The observed change in the cell parameters is a result of inclusion of Ag ions (size of 0.128 
nm) in the HA structure made of Ca cations (size 0.099 nm), resulting in a change of crystal 
structure. This theory is consistent with previous work by Rameshbabu et al. (240), which also 
assumed that silver had substituted calcium ions following a similar synthesis route and 
reported an increase in lattice parameters. Janackovic et al. (241) used a neutralization method 
for synthesis of monophase silver-doped HA nanoparticles and observed an increase in lattice 
parameters when silver was increased to maximum of 0.25 mol.%. Similar results were reported 
by Ciobanu et al. (238), who doped nanocrystalline HA with silver in different ratios (0.05, 0.2, 
and 0.3 wt.% ) and found a constant increase in the lattice parameters for HA phase only. 
However, they did not measure the lattice parameters in other calcium phosphate phases (238).  
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Deformation in crystal structure by increasing unit cell parameters can even be  observed with 
lower amounts of silver, as reported by Lim at al. (242). They only substituted 0.5 wt.% of Ag 
into the HA structure, lower than what was achieved as discussed in the XRF section, and still 
indicated an expansion in lattice cell parameters in Ag-HA. 
5.1.3 X-ray diffraction analysis of Magnesium-Substituted Hydroxyapatite (Mg-HA) 
Phase Identification of Mg-HA 
When Mg ions were added to HA, the XRD pattern shifted to lower 2θ values compared to NS-
HA, and the presence of β-TCP phase was more significant. However, the resulting peaks 
became slightly broader compared to NS-HA samples, which may imply that Mg ions were 
engaged in the HA structure leading to deformations of the crystal lattice.  By increasing the 
Mg content, all peaks became broader, suggesting lower crystallinity with less grain growth 
because of Mg ion substitution.  
The 2θ values derived from the XRD patterns of Mg-HA (5 and 10%) samples showed a 
considerable shift with respect to stoichiometric hydroxyapatite, becoming more similar to 
Whitlockite. In fact, one of the main characteristic planes present at 31.81° shifted to a lower 
degree representing the formation of Whitlockite. Previous studies have also indicated that Mg-
Whitlockite can form through precipitation reactions when relatively low temperatures (range 
37 - 95 °C) and acidic or neutral pH were used (13, 243, 244). As Mg-Whitlockite was also 
present in non-sintered hydroxyapatite, its formation cannot be attributed to the sintering 
process, though it is expected that the presence of Mg ions contributed most to the formation 
of Mg-Whitlockite. Fadeev et al. (123) also reported that increasing Mg content to more than 1 
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wt.% and calcination temperatures up to 1000°C can promote transformation of HA to 
Whitlockite.  
The results in Figure 4.6 are in  agreement with the existing literature and confirmed the 
formation of Magnesium substituted β-TCP with increasing  magnesium substitution (13). 
According to Ryu et al. (245), when Mg is introduced, it substitutes the Ca2+ cations resulting 
in lattice contraction and respective displacement of β-TCP reflections towards lower 2θ angles. 
The effect of the magnesium incorporation became more evident with increasing magnesium 
content (114, 245). This shift was representative of the reduction in lattice parameters of β-
TCP, which was caused by larger radii atoms (Ca2+) being replaced by smaller radii (Mg) atoms.  
Brucite (Mg(OH)2) has been reported to be present in Mg-HA products synthesised in other 
studies (114)(245). No Brucite was observed in the XRD pattern of this study, which can be 
due to the use of different reaction precursors (MgNO3 instead of Mg(OH)2 ). Another 
explanation could be that brucite peaks overlap with HA peaks and therefore it would be 
difficult to identify it using XRD. It is also suggested that the calcination of Brucite will 
generate MgO peaks, but this was also absent from the studied samples.  
There are different values for the maximum amount of magnesium that can replace and 
substitute calcium in the HA structure when synthesised using precipitation and hydrolysis 
methods. RZ et al.  (246) reported a maximum of 0.3 wt.% Mg, while other similar studies have 
quoted less than 1 wt.% (111, 247, 248). Mayer et al. (249) precipitated HA powders containing 
up to 1.5 wt.% of Mg without simultaneous carbonate substitution. Golden and Ming managed 
to synthesise Mg-HA powders with up to 2 wt.% of Mg from aqueous solutions (250). Okazaki 
et al. (251), substituted up to 5 wt.% of Mg in HA using a precipitation method but with a total 
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loss of crystallinity. It is worth mentioning that a total replacement of Ca2+ with Mg2+ in HA 
powders has also been reported using precipitation at high pH solutions (252, 253).  
However, an excess of Mg is shown to have a negative effect on the bioactivity of certain 
biomaterials (254). While there are some degrees of substitution for Mg+2 ions, surface 
adsorption in other secondary phases like Brucite and Magnesium Oxide is also present. 
The position of Mg in the HA lattice is not clearly known. Mg can occupy one of the two 
crystallographic calcium sites or both, referred to as Ca(I) and Ca(II), which are present in 
different reaction conditions (118). 
Crystallinity and Crystal Size of Mg-HA 
The experimental data within this study indicated that Mg affects the crystallinity and crystal 
size of HA Table 4.5, and this effect is more pronounced at higher Mg concentrations. While 
there was a crystallised biphasic structure (β-TCP + HA) in the NS-HA sample, the peaks of 
HA and β-TCP became wider and their intensity reduced after Mg ion was introduced, 
especially in the 2θ range between 28° and 32° and between 45° and 55° Figure 4.6. The same 
effect was reported after Mg addition in other studies, and similar XRD pattern and degree of 
crystallinity were obtained (255-257).  
The crystallinity degree was 88.8% for NS-HA while it decreased to 83.2%, 64.8% and 63.5% 
for Mg-HA 1%, Mg-HA 5%, and Mg-HA 10% respectively (all sintered samples). A similar 
trend was present in other studies where the degree of crystallinity decreased when Mg 
concentration was increased (13, 114, 258). However, Kim et al. (259) reported no change in 
HA phase profile when a mixture of Mg and Si was added with Mg ion concentration of up to 
1 wt.%. Bertoni et al. (248) used a wet precipitation technique with addition of 1, 5 and 10 
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mol.% of Mg ions and crystal size decreased even at lowest concentration (1 mol.%). Ren et al. 
(217) measured the crystallinity and phase behaviour of up to 20 mol.% Mg ions in HA, and 
reported similar results in terms of decreasing crystallinity as well as the presence of a 
Whitlockite phase at higher Mg concentrations. They also indicated that the total concentration 
of Mg in solid phase was no more than 7 mol.% when a 20 mol.% solution was prepared.  
Change in crystal size for Mg-HA 1% suggest that magnesium ions affect crystal size by 
inhibiting the growth of HA crystals, as also noted by LeGeros et al. (111). Caccioti et al. (260), 
also concluded that the presence of Mg ions within the HA lattice decreases the degree of 
crystallization.  
Lattice parameters of Mg-HA 
Both a and c-axis parameters in β-TCP and HA phase samples decreased after the introduction 
of Mg2+ to the reaction, suggesting contraction of cell volumes after Mg2+ addition. As this 
contraction is more pronounced in β-TCP phase, it can be concluded that  a higher ratio of Mg2+ 
ions were incorporated in this phase. Identical results were reported by Bigi et al. (13), who 
proposed that Mg2+ is more likely to enter into the β-TCP rather than the HA phase. In another 
study, Mg was introduced to hydroxyapatite using hydrothermal method, and a similar effect 
was obtained from the refinement of the Whitlockite cell parameters and the unit cell volume 
for 1.5% Mg-HA was approx. 3480 Å. As Mg content changes from 1.5 to 4%, unit cell volume 
dropped by about 52 Å (261). 
The main reason for contraction on both a and c axes is the substitution of Mg2+ (ionic radii of 
0.072 nm) for Ca2+ ions (ionic radii 0.099 nm). 
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As mentioned previously,  no Whitlockite phase was present at Mg 1%, and the majority of 
Mg2+ ions were accumulated in the HA phase. As Mg concentration increased to both 5 and 10 
%, the Whitlockite started to form, suggesting that Mg substitution has shifted towards the β-
TCP phase. However, it is impossible to establish the relative magnesium content in the 
amorphous phase or on the crystal surface. Posner et al. (262) suggested that magnesium 
prevents the transformation of amorphous calcium phosphate into HA by distorting the 
hydroxyapatite pre-nuclei structures, inhibiting further HA growth as a result of a structural 
mismatch. A similar mechanism may explain the inhibiting role of magnesium on the 
crystallisation or crystal growth of HA. Regardless of the location of Mg in the HA structure 
(either on the surface, being present as defects or formed within the amorphous phase), Mg can 
promote the formation of magnesium substituted hydroxyapatite (following a similar pattern as 
in Whitlockite).  
It was also shown that based on measurements of the lattice parameters for HA samples, 
systematic cell volume reduced when levels of substituted magnesium changed from 1 to  
10 wt. %.  
As described earlier, a and c-axis parameters decreased in HA phase in all Mg concentrations. 
In case of β-TCP phase, however, the a axis parameter decreased when 1 wt.% Mg was added 
and it did not change even with more addition of Mg. The value of c-axis dropped after addition 
of 1, 5 and 10% Mg. This changing in the profile of cell parameters may be due to the limited 
replacement capacity of Mg2+ ions within the β-TCP network. Hesaraki et al. (263) reported 
that the maximum capacity of β-TCP for Mg replacement is about 15 mol.%. However, in 
another study, maximum replacement of Mg2+ on Ca2+ sites was reported to be about 10 mol.%, 
and a steady contraction of c-axis was also observed (264).  
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The exact location and quantity of Mg substitution, whether replacing Ca2+ ions or being 
adsorbed on the surface, or even being incorporated as defects are still under debate. Neuman 
et al.(265) stated that a high percentage of Mg ions were adsorbed on the surface of apatite 
crystal when HA crystals were precipitated under physiological conditions. However, Riman 
et al. (114) suggested that Mg2+ ions were not detected on the surface of HA. LeGeros et al. 
(246), indicated that Mg substitution in an apatite lattice significantly affects the degree of 
crystallinity and solubility of HA.  
Experimental evidence from Ren et al. (217), suggests that magnesium does substitute the 
calcium in apatite. Also, their experimental data from ab initio simulations predicted that Mg 
ion occupancy on Ca (I) sites was energetically favored. In contrast to Ren at al.’s results, 
Laurencin et al. (118) claimed that the preferential incorporation of Mg is in the Ca(II) triangles 
along a single OH channel, which could have a direct impact on the properties and reactivity of 
Mg-HA. Their evidence from the computational data indicates that deformation of the HA 
lattice mainly occurs closer to the Mg sites, since the Mg/O bonds are much shorter than Ca/O 
ones. Also, their calculations confirmed that at higher Mg concentration, there is a preference 
for an ordered pattern of Mg ions in alternating positions in the Ca(II) triangles along a single 
OH channel. 
5.1.4 X-ray diffraction analysis of Zinc-Substituted Hydroxyapatite (Zn-HA) 
Phase Identification of Zn-HA 
The broad diffraction peaks in all Zn-HA samples, particularly in 5 and 10 wt.% samples may 
suggest smaller apatite crystals. For Zn-HA 1% sample, the phase pattern remained unchanged 
when compared to NS-HA. The same peaks of β-TCP and HA could still be detected and no 
other phase (such as calcium oxide or α-TCP) was detected. Absence of any secondary phase 
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in the diffraction pattern was also indicated by Thian et al. (266), as they introduced a maximum 
of 1.6 wt.% Zn using a precipitation technique. All HA and β-TCP peaks however were shifted 
to lower 2θ, indicating the deformation of crystal planes. 
A new phase was detected at Zn-HA of 5%, which was comparable to calcium zinc phosphate 
hydrate or Parascholzite. Parascholzite can be classified as a Zn-substituted TCP, and its 
intensity increased in Zn-HA 10 wt.% while the intensity of HA phase decreased. β-TCP phase 
became stronger when the Zn concentration increased to 5 and 10 wt.%, suggesting that the Zn-
HA had been transformed into Parascholzite, as also suggested by Li et al. (135).  
Crystallinity And Crystal Size of Zn-HA 
By introducing Zn ions to the hydroxyapatite, all the peaks became broader, suggesting 
decreased crystallinity and crystal size in comparison to the NS-HA sample. This reduction 
trend was more pronounced when the Zn concentration increased to 5 and 10 wt.%.   
An identical trend was observed after addition of Zn in previous studies (15, 127, 135). It is 
suggested that the presence of Zn in the solution strongly inhibits the crystallisation of HA, and 
the single crystalline HA phase was only achievable at a Zn concentration of up to 25 mol.%. 
Ren et al. (126) reported comparable results after using a similar precipitation technique to this 
study (126). LeGeros et al. (267) reported the same effect with the addition of Zn, suggesting 
that even lower concentrations of Zn (< 1 wt.%) may lead to the inability of the structure to 
host greater amounts of Zn.  
Concerning crystal growth inhibition, Ren et al. (126) proposed that this behaviour is likely to 
be caused by a mismatch between the ion sizes of calcium and zinc, which generates a distortion 
in crystal structure. They also reported that samples with higher Zn content were far harder to 
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compact, due to higher agglomeration rates when crystal size decreases and surface area 
increases. Their results were further confirmed by scanning electron microscopy, which 
indicated that “particle sizes” increases with the addition of zinc ions to the HA structure. 
Miyaji and co-workers also reported similar changes in the HA structure, crystallite size and 
crystallinity after increasing the Zn concentration (268). They synthesized Zn-substituted HA 
using precipitation method (at pH= 8.0, temperature= 90°C) and measured the lattice 
parameters using XRD and an internal standard. They showed that the maximum Zn 
concentration that can be substituted in HA is 15 mol.% and also measured the change in lattice 
parameters. In case of a, it decreased for Zn concentrations of up to 5 mol.% and increased at 
higher concentrations (10 mol.%). In case of lattice parameter c, it monotonically decreased as 
Zn concentration increased in the sample.  
Hayakawa et al. (269) prepared Zn-containing HA particles using an ion-exchange reaction 
process using zinc nitrate, involving HA particles with aqueous solutions containing various 
amounts of zinc nitrate, which showed a minor change in degree of crystallinity (without 
mentioning whether it  increased or decreased), particle size and specific surface area. The 
lattice parameters of HA decreased with an increase in Zn concentration for up to 3 mol.% in 
their research (269).  
Lattice parameters of Zn-HA 
Comparing lattice parameters of Zn-HA with pure HA, it was evident that both a and c-axis 
parameters decreased after the introduction of Zn2+ in both β-TCP and HA phases which 
suggest contraction in cell volume. This contraction in cell parameters is again due to the lower 
ionic radii of Zn (0.745 Å) when compared to Ca ions (57, 186, 187). 
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The decrease in the lattice parameters on both a and c axes, is consistent with observations by 
Li et al.(135). Ren et al. (126) also reported a reduction in cell parameters and indicated that 
both a and c axes decreased when Zn was added for up to 1 mol.%. However, they reported a 
slight increase in the lattice parameters when the Zn concentration exceeded 10 mol.%. Miyaji 
et al. (268) showed that the lattice parameter a decreased first when Zn content increased up to 
5 mol.%, but increased for Zn of more than 5 mol.% and became almost constant over 10 mol.% 
Zn. The lattice parameter c decreased constantly with increasing Zn concentration. The size of 
reduction in c decreased over 10 mol.% Zn (268).  
Results reported by David et al. (270) slightly differ from the findings in this study. They used 
either the nitrate route with (two different temperatures of 20°C ± 1 and 9°C ± 1) or the 
hydroxide route, after which they observed a reduction in the a lattice but an increase in the c 
lattice. These variations may be due to different reaction temperature to what was used in this 
study (90°C followed by sintering at 1100°C). Miyaji et al. (132) reported that lattice parameter 
a may increase, as H2O substitutes the OH sites in the zinc-doped hydroxyapatite. 
 
5.2 Fourier transform infrared spectroscopy (FT-IR) 
FT-IR was used as a complementary technique to X-ray diffraction analysis and confirmed the 
chemical changes in HA after the addition of ions. 
5.2.1 FT-IR study of NS-HA  
As Figure 4.14 shows, the presence of apatite phase in the final powder can be established by 
the presence of fundamental vibrational modes of PO43−
 
group. The bands at 630 and 3570 cm-
1 are representative of OH group in the apatite phase while the adsorbed water can be seen in 
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the region around 3300-3600 cm-1. The presence of carbonate CO32- groups at 1430 cm-1 can be 
due to the adsorption of soluble carbon dioxide originating mainly from air during the aqueous 
precipitation as the experiemnts were not carried out in an inert environment. 
As ammonium solution was used for pH adjustment during HA synthesis, it is believed that 
some residual trace of ammonia was left which was apparent as a small broad peak at  
1422.6 cm-1 and is the characteristics peak for NH4+ group. A similar peak and explanation was 
observed following HA synthesis in a study by Kang et al.  (189).  
The presence of nitrates (NO3) was clear from the peaks in the region around 1320-1480 cm-1 
as also was pointed out by Raynaud et al. who used a similar synthetic route for preparation 
and used FT-IR for chemical analysis (207).  
FT-IR analysis showed that partially carbonated hydroxyapatites has been formed, based on a 
strong carbonate-specific bands in the range of 1460–1410 cm-1 indicating that carbonate 
groups have substituted PO43− in the hydroxyapatite lattice. 
A small peak at 1635 cm-1 and a stretched band between 3000-3600 cm-1 is expected to be 
caused by “bound” water or hydration layer, which was present in all the FT-IR spectra and is 
associated with HA crystals. It is long been known that this hydration layer contains high 
concentration of calcium and phosphate ions (188). Neuman et al. (271) have shown that ions 
in the hydration layer are readily exchangeable in the bulk solution. The same peaks were 
identified in the results obtained by Pak et al. (272) and Avnimelech et al.  (273) for HA 
samples.  
5.2.2 FT-IR for Ag-HA 
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The characteristic PO4-3 group peaks appeared in all apatite samples. This is in good agreement 
with previous studies (200, 201) (195). The characteristic OH- peaks were also present and is 
in agreement with the literature (200, 202, 203). Although not much difference was observed 
between the HA spectrum with and without silver, the presence of Ag3PO4 band around 1070 
cm-1 was clear. Jelinek et al. (274), reported a small change in the slope of the band in the region 
of 4000-2000 cm-1 in the case of silver doped HA using KrF excimer laser deposition. 
Fowler et al. (193) also reported a linear downshift in the internal PO4-3 modes with FT-IR 
analysis of apatite samples with the decreasing cationic radii and also concluded that this 
phenomenon is caused by decreased anion-anion repulsion and higher anion-anion separation 
(193) . 
Nirmala et al. (239) reported the change in FT-IR spectrum when they synthesised bioresourced 
hydroxyapatite containing silver nanoparticles and detected the characteristic transmittance 
bands for phosphate ion at 845,1045, 1458, 568 and 601 cm-1. 
The absorption bands at 873 and 1400 cm-1 of the Ag-HA were attributed to the carbonate ion 
in HA. For hydroxyl groups, they are more apparent at 3569 cm-1 at 5 wt.% Ag while the broad 
hydration layer peak was reduced significantly. In another study by Lim et al. (242), similar 
results were obtained when Ag introduced to HA using wet precipitation method at 
concentration range of 0.3, 0.7, 1.6, 3.0, 4.5, and 10 wt. %. They also detected a stretching band 
between 3200 and 3700 cm-1 in the autoclaved Ag-HA which corresponds to bound water 
molecules. 
5.2.3 FT-IR for Mg-HA 
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After introducing 1 wt.% Mg to HA, all the FT-IR absorption bands were present at similar 
positions to the ones in NS-HA. This indicates that Mg substitution did not change the apatite 
structure in HA.  The same representative bands for PO43−
 
group (574, 609, 966 and 1020–1120 
cm-1) and OH groups (630 and 3570 cm-1) of apatite phase are still present in all the Mg-HA 
samples.  
FT-IR patterns tend to coincide with the XRD results as the intensity of OH and PO43−
 
bands 
was reduced after the introduction of Mg in the structure. Adsorbed water could also be detected 
in the same region (around 3300–3600 cm-1) as well as carbonates (CO32- ) around 1660 cm-1, 
which is more pronounced in 5 and 10 wt.% samples. Nitrates (NO3) were also present around 
1320–1480 cm-1 resulting from the residual species in the reaction (NO3 -1, NH4  +) and has 
already been reported elsewhere (207). A peak at 1424 cm-1 can be attributed to CO3 -2 group 
which is common for the powders synthesised under air atmosphere.  
According to LeGeros et al. (275), the PO4 -3 group (B-type substitution) and the OH- group (A-
type substitution) of HA can be substituted by CO3 -2 groups. B-type PO4 -3 substitution, which 
is believed to occur mainly during wet chemical synthesis of calcium phosphates has a 
characteristic vibration band at 1428 cm-1 (275).  
Increasing the Mg concentration to 5 wt.%, the FT-IR bands assigned to the four PO4-3 modes 
appear at similar wavenumbers as in HA. However, a reduction in the resolution at around 634 
cm-1 can be assigned to OH- librational mode (83, 200, 203), which may indicate the presence 
of Mg-Whitlockite. The formation of Whitlockite was previously discussed in XRD results in 
Section 4.1.3. In addition, the PO4 -3 peaks, which are present at around 1029 and 1059 cm-1 
assigned to (195, 200, 201), are merged into a peak at 1062 cm-1. This pattern show that the 
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phase transformation from Mg substituted apatite to Mg substituted β-TCP (Whitlockite) is 
more pronounced at higher Mg contents. 
FT-IR spectrum in 10w t.% Mg-HA resembles the pattern at 5 wt.% sample with lower 
separation between the peaks. In addition, the peak broadening is more significant when Mg 
concentration increases suggesting that the apatite structure is possibly distorted (114).  
As mentioned earlier, when magnesium content raised from 1 to 5 wt.%, there was a reduction 
in the intensity of hydroxyl peaks at 3570 and 633 cm
-1
which is consistent with the onset of 
Whitlockite formation. The FT-IR spectra for Mg-HA 10 wt.% revealed a phosphate peak 
(range 1550–1450 cm-1) that grows wider when MG concentration increases. This also matches 
with the crystallinity reduction in Mg-Whitlockite (as presented in Table 4.2).  
The results in this study were in good agreement with previous studies. Mg-HA has been 
reported to have lower intensity of OH− vibration modes at 630 and 3570 cm−1, as well as broad 
PO4 -3 bands when compared with pure HA (13, 114). While the impact of Mg addition was 
stronger at higher Mg content, these effects were mostly observed in samples prepared by wet 
chemical precipitation and can be explained by the increased lattice disorder due to PO4-3 
substitutions (111, 114, 256).  
The position of the CO3 -2 derived bands indicates that CO3 -2 for PO4 -3 substitution (B-type) 
was dominant in the Mg-HA powders while OH-2 groups are replaced by CO3 -2 when during 
wet precipitation route (276) (111). 
 
5.2.4 FT-IR for Zn-HA 
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Zn-HA samples at concentration of 1 wt.% showed a new broad peak in the region of 1517-
1306 cm-1 and two water bands at around 3155 and 3037 cm-1. Zn at this concentration did not 
show any other significant change to the FT-IR spectra. It has also been reported that the 
CO3-2 which is present in the region of 1570-1410 cm-1(205) might have overlapped with the 
band in the region of 1575-1279 cm-1 originating from residual nitrates (206, 207). CO3 -2 is 
most likely present in Zn-HA like other experiments, especially when the CO3 -2 at 871 cm-1 
was present in the FT-IR spectrum(205).  
By increasing Zn concentration to 5 wt.%, the PO4 -3 bending bands appeared at 562 and 600 
cm-1 whilst the PO4 -3 stretching bands were centred at 1037 and 1089 cm -1. The broad band 
between 3300 and 3700 cm-1 again is for hydration layer, which overlap and covers the 
hydroxyl band at 3571 cm-1.  
5.3 Raman spectroscopy  
5.3.1 Raman analysis for NS-HA 
As Figure 4.18 shows, an intense peak was detected at around 960 cm-1 which can be assigned 
to PO43-(v1) and is believed to be the characteristic peak of HA present in 963 and 961 cm-1 
(208, 209). This observation supports previous results from XRD and FT-IR analysis, which 
showed the presence of the apatite phase.  
The Raman spectra clearly indicates that the highest intensity belongs to O–H peak in HA 
phase. It has been reported by De Aza et al. (215) that the intensity of this peak is directly 
relative to the crystallinity of the sample. As sintered HA shows higher crystallinity when 
compared to non-sintered HA, the intensity of this PO43-(v1) is more pronounced. In addition, 
three other PO43- modes are present in the region of 447-430 cm-1 (PO43-, v2), 1076-1030-1048 
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and 1054 cm-1 (PO43-, v3), and 610-620-578 and 594 cm-1 (PO43-, v4), which are also shown in 
Figure 4.18 for HA samples. 
Penel et al. (209) pointed out that the Raman peak at 1070 cm-1 does not correspond to the PO43- 
(v3) mode solely, as the A-type and B-type CO32- (v3) modes were also present at a similar peak 
position at 1107 and 1070 cm-1, respectively. This may suggest that some Carbon Dioxide may 
have been included during synthesis. Additionally, the Raman peak at 1076 cm-1 can be caused 
by both PO43- (v3) mode (208, 209) and B-type CO32- (v1) mode (209) (Figure 4.19). 
5.3.2 Raman analysis for Ag-HA 
Similar to NS-HA sample, the symmetric stretching for P-O bonds (ν1) was detected at (960 
cm-1). The vibrational bands at 429 cm-1(ν2) and 450 cm-1(ν2) can be attributed to the O-P-O 
bending modes. Both peaks at 1046 cm-1 (ν3) and 1074 cm-1 (ν3) were assigned to asymmetric 
ν3 (P-O) stretching. The ν4 frequency (589 and 608 cm-1) can be addressed mainly to O-P-O 
bending character. As silver concentration increased to 5 %, the intensity of vibration peak 
reduced but in general, most phosphate bands became broader after addition of silver ions, 
responsible for increasing disorder in the structure. Again, these results compliment the findings 
from the XRD and FT-IR analysis. 
It worth noting that pure metallic Ag is neither IR nor Raman active and the formation of AgO 
and Ag2O are not thermodynamically feasible up to the maximum sintering temperature 
(1300°C) (216). Also the Ag–O bonding from either AgO or Ag2O phase could not be detected 
by FT-IR within its detection range of 400–4000 cm-1.  
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5.3.3 Raman analysis for Mg-HA 
Raman spectra peaks in Mg-HA 1 wt.% sample were almost identical to ones present in the 
NS-HA. Peaks at around 1075 and 1046 cm-1 in the spectrum are believed to correlate to 
asymmetric stretching (ν3) of the P–O bond in phosphate. However, the small shift can be due 
to the non-stoichiometric HA and also incorporation of Mg in HA. The peak around 970 cm-1 
is expected to have been caused by the symmetric stretching mode (ν1) of the P–O bond in the 
phosphate group. This peak, however, is normally expected to be present at 961 cm-1 in 
hydroxyapatite (209). The small shift observed can be caused by the incorporation of the 
magnesium ions in the HA lattice. Moreover, based on the unit cell lattice parameter results, 
which were obtained from the XRD data (Section 3.1.3), the unit cell volume decreased with 
higher magnesium content (because of larger calcium ion being replaced by the smaller 
magnesium ion).  
The resulting compressive stresses after the change in the unit cell volume can be responsible 
for the observed shift in the peak position (277). A similar peak broadening in Raman spectra 
was reported by Sprio et al. (278), after the addition of Mg to HA and was explained by the less 
ordered structure. This peak broadening effect can also be caused by the segregation of Mg ions 
outside the HA lattice (278) or the accumulation of CO3 2-  ions within the sample. Specifically, 
it has been reported that the phosphate peak became broader when CO32-concentration was 
increased (279). 
There are two factors which may influence the vibration behaviour of phosphate ions: 
1) P-O bonds may experience weaker intra-molecular interaction due to new inter-ionic Mg–O 
interactions and 2) the repulsion potential of the lattice, which is inversely proportional to the 
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unit-cell volume. These two factors are believed to contribute to the broadening of the 
phosphate peak in these samples, as also described in a study by Chaudhry et al.(280).  
Two peaks at 610 cm-1 and 587 cm-1 correspond to the (ν4), whereas the peaks at around 442cm-
1
 and 432 cm-1 correspond to the (ν2) bending of the O–P–O linkage in phosphate groups in HA. 
The small shift observed in (ν4) and (ν3) in the spectra of Mg-HA 5 wt. % and Mg-HA 10 wt.%, 
which can be caused by the incorporation of magnesium ions in the HA lattice and formation 
of TCP. Also Mg-HA 5 and 10 wt.% samples each revealed a peak at 555 cm-1 and 633 cm-1 
which corresponds to the bending modes of the O–P–O linkage in phosphate ions in Whitlockite 
(281). These results are also in agreement with the appearance of the Whitlockite phase in the 
XRD profile as shown in Figure 4.6 and Figure 4.7. 
5.3.4 Raman analysis for Zn-HA 
Similar to previous samples, the spectra for Zn-HA 1 wt.% are very similar to those observed 
for NS-HA. This indicating, that the HA structure can tolerate the presence of 1wt.% of Zn, and 
XRD results have already supported this conclusion.  
 The asymmetric stretching peaks (ν3) of the P–O bond in phosphate are again present at around 
1076, 1055 and 1029 cm-1. However, stretching peaks (ν3) of P-O band of phosphate in 1030 
cm-1 are more pronounced by adding Zn in HA. The peak around 961 cm-1 is lost likely caused 
by the phosphate group. As discussed earlier, this peak is generally expected to be present at 
around 963 cm-1 in pure HA (209). Similarly, the shift can be explained by the addition of Zn 
into the HA lattice and as unit cell measurement suggests (as described in section 4.1.4), a 
similar drop in unit cell volume was resulted with the increase in Zn content (because smaller 
Zn ion replaced the larger calcium ion). Peaks at around 610 cm-1 and 587 cm-1 correspond to 
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the (ν4). Peaks at 447 cm-1 and 433 cm-1 also correspond to the (ν2) bending of the O–P–O 
linkage in phosphate in HA. The small shift observed in (ν4) and (ν3) in the spectra of Zn-HA 
5 % and 10 wt.%, which can be caused by the incorporation of the zinc ions in the HA lattice 
and formation of TCP. Also, Zn-HA 10 wt.% samples each reveal a peak at 546 cm-1, which 
are caused by bending modes of the O–P–O linkage in phosphate. 
Gomez et al. have reported the new modes (ν1) at 940 cm-1 which is believed to be for a new 
component, (282). The new modes (ν1) indicate a loss of order (due to statistic disorder in the 
hexagonal channel) when Zn inserts the HA crystal structure. By increasing the Zn 
concentration, a new band appeared at 3410 cm-1, which is attributed to the Zn insertion in HA 
crystal unit. This confirms that Zn is directly responsible for the deterioration of HA 
crystallinity. However, these two new modes have not been detected in present study. 
Disorientation in HA crystal observed by Gomes et al. but has been reported to occur at lower 
concentration of Zn (1 wt.%) (283). Their results from Raman spectra of Zn substituted samples 
show the presence of a third [OH] stretching mode at 3584 cm-1.  
5.4 Thermal Stability Analysis  
5.4.1 Thermogravimetric analysis of NS-HA 
The TG analysis of the HA powder (NS-HA) was carried out between the room temperature 
and 1100°C (sintering temperature in this study) in order to understand the phase transformation 
within the sintered samples. There are three regions of interest corresponding to HA structure 
which are applicable to the temperature range studied in this research: 
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1. Up to 200°C, which corresponds to the removal of structure-adsorbed water. Adsorbed 
water is characterised by its removal between 25 to 200°C and weight loss with no 
impact on lattice parameters (284). 
2. Between 200°C and 400 °C, which corresponds to the lattice water. Within this 
temperature range, contraction of a-lattice dimensions occurs during heating (284).  
3. At higher temperatures (above 400 °C), the hydroxyapatite gradually dehydrates, which 
leads to the release of OH- ions and the subsequent transformation to 
oxyhyrdroxyapatite (OHA). The HA dehydration does not occur instantly but over a 
wide temperature range, which is suggested to be dominantly dependent of the partial 
H2O pressure during the heating step. If performed under vacuum, HA loses its OH at 
a lower temperature, about 850°C. If HA is heated in H2O stream, the structure of HA 
is then preserved up to 1100°C (285).  
For NS-H samples, the weight loss at the beginning of the TG plot between 25°C and 200°C 
corresponds to the removal of adsorbed water (about 0.9 % ± 0.021 weight loss). At higher 
temperatures (between 200 °C to 500 °C), the weight of NS-HA sample gradually decreased 
which corresponds to the removal of lattice water (about 0.77% ± 0.027% weight loss). Rootare 
et al. (286) carried out detailed studies of vapour phase adsorption of water on HA and 
concluded that the water monolayer that is in contact with the HA surface (lattice water) was 
more strongly bound than the additional water. 
The weight loss trend continues (at a slower rates) from 500°C to 800°C which corresponds to 
the transfer of HA to OHA (about 0.59% ± 0.13%). Consequently, partial decomposition of HA 
to TCP happen as described above. The total weight loss was about 2.5 wt.% for NS-H sample. 
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5.4.2 Thermogravimetric analysis of Ag-HA 
The temperature where the weight loss peak (or slope change) appears between 700-850 °C is 
a representation of how much the HA phase is stable. Based on the results from XRD analysis 
(see section 4.1.2), the stability of the HA phases increases by addition of more silver ions. 
Hence, it is expected that the weight loss peak appears at higher temperatures when the ion 
concentration increases in the HA samples 
In case of Ag-HA sample, a sharp peak was present in region of up to 200 °C. The main stage 
which corresponds to the stability of the sample is the region between 600 and 1000°C. This is 
when the further removal of hydroxyl groups occurs and the early decomposition of 
hydroxyapatite lattice onsets.  However, it is expected that the decomposition temperature was 
higher than NS-HA when Ag concentration increased. This result is consistent with the findings 
in XRD analysis (Section 3.1.2), confirming the increased stability of HA phase by addition of 
silver. The total weight loss for the Ag substituted HA in the range of 25–1100°C was maximum 
about 1.2 wt. %. Also the residual weight increased slightly as Ag was added in the HA sample, 
as Figure 4.22 shows. 
5.4.3 Thermogravimetric analysis of Mg-HA 
As it is expected, a series of weight losses were observed in the TGA curves for Mg-HA 
samples. The weight loss in all different Mg-HA samples are very similar to NS-HA in 25°C 
to 400°C region. 
The weight loss within 690–800 °C region is probably due to the loss of OH during 
decomposition of HA to β-TCP. TG curves suggest that the decomposition temperature 
decreases with increasing Mg content. As XRD data confirmed (Section 4.1.3), by introducing 
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more Mg to HA structure, Whitlockite phase was formed which causes more Mg destabilization 
in the apatite structure. The TG curves presented in Figure 4.23 supports the presence of Mg 
within apatite structure, as the surface adsorption of Mg cannot influence the decomposition 
temperature of HA structure. 
The total weight loss increased with increasing Mg concentration as opposed to Ag samples. 
Mg-HA 10 wt.% showed the highest weight loss of about 8 wt.%. The thermal decomposition 
of apatite to (β-TCP) can be seen by the slope change in the TGA graph because of the OH loss 
associated with apatite phase change. Above 600–700 °C, nonstoichiometric Mg-HA 
decomposes usually with the formation of whitlockite and water (111, 287). However, at higher 
Mg concentrations, formation of Ca4Mg5(PO4)6 or β-Ca2P2O7 has also been reported (287).  
As Figure 4.23 shows, TGA curves for Mg-HA also shows three different thermal profiles. The 
Mg-HA with 5 wt.% showed a sudden weight loss between 735°C to 798°C which is believed 
to indicate the decomposition into whitlockite (total weight loss about 10.52%). On the other 
hand, the Mg-HA sample with 10 % showed a weight loss at 720°C which could be due to the 
presence of larger quantities of Mg2+ and lower crystallinity (114, 287), which was also 
confirmed by XRD results (Section 4.1.3). As a conclusion, the thermal stability of Mg-
substituted hydroxyapatite decreases by increasing the content of Mg into hydroxyapatite 
products and also Mg-HA partially transforms to Mg-substituted β-TCP or Whitlockite when 
more Mg was added. 
5.4.4 Thermogravimetric analysis of Zn-HA 
As Figure 4.24 showed, the weight loss is more significant in samples with higher Zn 
concentrations (total weigh loss about 10.52%). The amounts of both the adsorbed and lattice 
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water increase with increasing Zn substitution. Miyaji et al. reported that the lattice parameter 
a decreases with increasing the amount of lattice water (132). The value for lattice parameter a 
decreased by the increase of Zn concentration (Section 4.1.4), which can be explained by the 
combined effects of the ionic radius of Zn and the lattice water. For the samples with higher Zn 
concentrations, the effect of increasing lattice water might overcome that of the substitution by 
Zn with smaller ionic radius (132). 
Similar to previous samples, there is a continuous weight loss in the samples as temperature 
rises. The significance of the weight loss during the last stage increased as the amount of zinc 
in the samples increased, which might be linked to the formation of other phases or removal of 
a volatile species of zinc.  
As expected, the TCP formation for the lowest Zn content (1 %) sample occurs at a higher 
temperature suggesting its higher thermal stability. The temperature when the destabilisation 
begins is about 790°C, which is very similar to NS-HA.  By increasing the Zn concentration, 
the decomposition temperature drops to about 740 °C suggesting its lower thermal stability. 
Results from the XRD analysis (Section 4.1.4) also confirmed that the parascholzite formation 
was very similar in samples with 5 and 10 % concentrations. 
5.5 Measuring the substituted ions in solid samples  
Ion substitution using the wet precipitation technique consists of a reaction between mixing 
soluble precursors and the formation and precipitation of a generated calcium phosphate phase. 
The soluble ion reactants in the reaction medium also drive the substitution of Ca cations in the 
HA structure. The concentration of the substituted ions may be assumed to be the same as the 
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initial concentration of ions in the reaction solution. However, this may fail to be the case with 
the used technique in this research because: 
1) The total uptake of ions in the solid can be affected by the reaction conditions and possible 
structural considerations, which may limit the number of ions impregnated in the HA crystal. 
2) The final powder is washed several times with distilled water to remove any non-reacted 
reaction residues that may have left on the powders. This was of particular importance in this 
study, as these samples were to be used in biological and microbiological studies where any the 
intention was to minimise any interference from chemicals other than the solid phase 
hydroxyapatite. 
A review of existing published research where similar biomaterials were used to measure the 
biological response indicated that most of the studies assumed a “nominal” concentration of the 
ion in the solid phase of hybrid hydroxyapatite formulation. 
Measurement of the ions substituted in the solid phase was of special importance for this 
research, in order to explain the correlation between the biological response and the ion 
concentration in the final biomaterial. The existing values for ion toxicity levels and any impact 
on cellular activity (such as proliferation, differentiation and mineralisation) are assumed to be 
mainly due to the additional ions. In addition, the release profile data will be more meaningful 
if the concentration of ions in the solids are known. 
It worth to note that because of the non-selective nature of wet precipitation technique and the 
poor control of synthetic reaction, there is always the possibility of secondary phases formation 
or surface adsorption of ions. Analytical techniques such as XRD and FT-IR can only be used 
to obtain qualitative measurements and to confirm the inclusion of the ions in the solid apatite 
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structure. These techniques cannot accurately measure the concentration of the substituted ions. 
Hence, Inductively Coupled Plasma-Mass Spectroscopy (ICP-MS) and X-Ray Fluorescence 
(XRF) methods were selected as two techniques to measure more accurate levels of ion 
substitution in the prepared powders. 
XRF is the selected method for quantification of different elements using their characteristic 
secondary X-ray patterns within the solid structure. XRF is a gold standard technique in 
studying ion-substitution in hydroxyapatite ceramics which enables the determination of total 
ion incorporation in the HA structure. Knowing the content of the substituted ions, it is possible 
to elucidate the chemical composition and Ca/P ratios within the HA structure, and investigate 
how much of the selected ion was substituted.  
To minimise any possible matrix or surface effects during XRF measurement, quantification of 
ion substitution was accompanied by ICP-MS technique. While XRF can be used for solid 
specimens, ICP is predominantly for liquid samples. However, as explained in Section 4.5.1, 
mass balance calculation was used to measure the total ions remaining in the solid phase. 
Results from these two techniques reported almost identical values for the amount of ion 
incorporation in each sample.  
5.5.1 Measuring of degree of ion substitution by XRF 
For all samples, XRF measurement confirmed the presence of metal cations in the HA powder. 
While washing of the solid powder should have removed most of the non-substituted ions 
trapped in the loose structure or surface-adsorbed cations, the detected metals were assumed to 
refer to ones incorporated in the HA structure.  
The XRD pattern indicated that lattice parameters have changed, confirming the substitution of 
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selected cations in the lattice structure of the HA. XRF measurements, as shown in Tables 4.17, 
4.18 and 4.19, also confirm that the Ca/P ratio of the resulting HA has changed from that of the 
starting material, suggesting a change in the reaction stoichiometry. 
In case of Ag-HA, XRF measurement in Table 4.17 confirmed that silver was incorporated in 
HA and that its concentration increased as more silver ions were available in the reaction 
medium. 
The higher ratio of cations to phosphorus can be due to the change in the stoichiometry of the 
HA structure, or to the depletion of phosphate ions in the HA structure due to the presence of 
carbonate ions. It is also possible that some of the Ag ions were only adsorbed on the surface 
of HA or being incorporated as defects, suggesting that the actual Ag in the structure is less 
than what was measured. The substitution of Ag ions was confirmed earlier by changes in the 
lattice parameters, though the extent of the substitution may not be as high as levels measured 
by the XRF. XRF cannot distinguish between ions adsorbed on the surface and those which are 
just incorporated as defects or ones which are substituted in the structure. 
The amount of Ag substitution in the solid was almost half of what was expected; a maximum 
of 4.23 wt. % of Ag was substituted. While the ratio of cations (Ag/Ag+Ca) during reaction 
was adjusted to 1, 5 and 10 mol.% in the reaction medium, the actual amounts of Ag/Ag+Ca 
were 0.48, 2.53 and 3.68 mol.% in the respective samples. Ca/P and Ca+Ag/P molar ratio 
increased to about 2 as Ag was introduced into the structure, which suggests a change in the 
stoichiometry of the reaction. Also, some of the phosphate may have been replaced by other 
anions (such as carbonate ions) resulting in fewer phosphorus ions being available in the solid. 
Other studies have also indicated lower levels of Ag in the solid phase than expected. Lim et 
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al. added 0.3, 0.7, 1.6, 3.0, 4.5, and 10.0 wt.% of Ag to the reaction medium, but the resulting 
solids showed 0.2, 0.3, 0.5, 0.9, 1.0 and 1.1 wt.% respectively, suggesting a maximum of about 
1 wt.% Ag substitution (242).Oh et al. (288) also used the wet precipitation route for preparation 
of Ag-HA, but could not incorporate more than 32% of the starting material into the final solid 
structure. 
 Loss of Ag ions during the powder washing steps, which aimed to remove impurities and 
reaction residues, might also contribute to a lower concentration of Ag in the final sample. Ag 
ions also have a larger ionic radius than Ca, which is expected to obstruct the Ag being fully 
incorporated during HA synthesis, resulting in lower levels of Ag incorporation in the solid 
(242).  
With regards Mg-HA samples, both XRF and XRD assays confirmed the incorporation of Mg 
in the HA structure. The XRD pattern in particular confirmed that Mg was substituted in the 
HA lattice, as the lattice parameters changed after Mg was introduced into the medium. As 
Table 4.18 shows, the expected values for Mg incorporation for both molar ratio and wt.% ratio 
were very similar to what was expected in the final powder. Mg concentration (wt.%) in the 
HA reached a maximum of 2.43 wt.% in Mg-HA 10% (vs. 2.55 wt.% expected), which was 
9.07% in terms of molar concentration (Mg/Mg+Ca). 
The content of Mg in Mg-HA ceramic and the level of its incorporation has been the subject of 
many discussions within the research community, and different levels of Mg incorporation have 
been reported. LeGeros et al. (111) indicated that incorporation of Mg in synthetic HA is limited 
to 0.4 wt.%, while Yasukawa et al. (124) reported that 31 mol.% of Mg (or the ratio of 
Mg/Mg+Ca) is the maximum of Mg in HA phase through wet precipitation before an 
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amorphous phase being formed. The maximum amount for Mg incorporation was not more 
than 10 atom.% in the study conducted by Bigi et al. (13). 
It has also been suggested that Mg has a tendency to stay on the surface of HA crystals during 
wet precipitation (surface adsorption) rather than being fully substituted in the HA structure 
(13). XRF analysis alone cannot determine the location of ion accumulation, whether on the 
surface, being present as defectsor at different regions of the crystal. Other techniques such as 
XPS are capable of determining the ion concentration at various depths of crystals (29), but 
were not used in this study because of limited technical resources. It is not possible for us to 
determine what ratio of Mg was being surface adsorbed or substituted within the structure, but 
it is expected to be a combination of these two cases. 
Similar to Ag-HA preparation, the ratio of cations to phosphorus ions (Ca+Mg/P) was adjusted 
to 1.8, but this ratio increased to 1.91, 2.02 and 2.07 for Mg-HA of 1, 5 and 10 mol.% samples.  
Most studies, however, confirm that increasing the Mg content will decrease crystallinity and 
lead to amorphous phases, such as Whitlockite (29) (217), similar to the results as discussed in 
Section 4.1.3 for XRD analysis of Mg-HA. The presence of Whitlockite phase in Mg-HA 5 and 
10 mol.% samples were also observed, as discussed earlier. 
For Zn-HA samples, the values for Zn substitution are summarised in Table 4.19 and they 
confirm that Zn was incorporated in the HA structure, but not at levels observed with Mg ions. 
Zn concentration in Zn-HA 1% was 0.56 wt.% (vs. 0.65 expected), for Zn-HA 5 wt.% it was 
2.8 wt.% (vs. 3.2 wt.% expected), and for Zn-HA 10% it was 4.23 wt.% (vs 6.32 wt.% 
expected). These values, however, were consistent with the values obtained from ICP-MS 
analysis for Zn incorporation in Zn-HA (Section 4.5.1). 
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Different levels of Zn incorporation in HA have been reported in different studies. Ren et al. 
reported up to 20 mol.% (Zn/Zn+Ca) of incorporation using the wet precipitation technique, by 
setting the Zn concentration to 20 mol.% in the solution. However, they reported that an 
amorphous phase was formed at this high concentration of Zn (126). However, could not detect 
more than 0.7 wt.% of Zn while they expected to have a maximum of 5 wt.% (289). Li et al. 
(21) suggested that at Zn concentrations of more 0.13 wt.%, a new phase of Zn-TCP was 
formed, which was in agreement with the results of observing a TCP phase at 5 and 10 mol.% 
(the equivalent of 2.8 and 4.23 wt.%). 
The Ca+Zn/P ratio for Zn-HA 1, 5 and 10 % was higher than what was set in the reaction (1.8), 
similar to Ag-HA and Mg-HA. The higher ratio of cations to phosphorus can be explained by 
either less phosphate ions in the HA structure (for example, because of carbonate substitution 
instead of phosphate) or by the surface adsorption of Zn instead of substitution in the HA lattice. 
Again, it was not possible to fully quantify how much Zn was substituted in the lattice, but the 
change in lattice parameters and the provided XRD profile confirm that Zn substitution in the 
HA phase has occurred. 
 
5.5.2 Measuring ion substitution with ICP-MS 
The discrepancy between the molar and weight ratio is directly related to the molecular weight 
of each ion. It is expected that when Ag with a MW=107 is substituted in the HA structure in 
similar molar ratios, it results in a higher weight ratio in comparison to Zn.   
The overall results suggest that no matter how high the concentration of ion alters in the 
solution, there is a limit to how many ions can be substituted in the hydroxyapatite structure. 
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This limit based on the results was calculated to be 3.5 wt.% for Ag, 2.2 wt.% for Mg and 5.3 
wt.% for Zn. The hydroxyapatite structure did not take up relatively more Ag (only increased 
by 10%) when the concentration of Ag was doubled from 5 to 10 wt.% in the solution. In 
absence of advanced analytical assays, one explanation for this limitation may be the larger size 
of Ag ions in the lattice compared to Ca, Mg or Zn and difficulty to fit in HA lattice. 
With regard to Mg-HA, the lower MW of Mg ions explains the lower values for Mg weight 
ratio, as explained earlier. When the molar ratio of Mg in the solution increased, the wt.% ratio 
of the Mg in the HA lattice increased at almost the same order. When the concentration of Mg 
was increased 5-fold (5%) and 10-fold (10%) in the solution from the 1% sample, the wt.% of 
substituted Mg also increased by factors of 5.9 and 7.8 respectively. 
In case of Zn-HA samples, increasing the concentration of Zn by factors of 5 and 10 resulted 
in 2 and 3.1 times increase in the Zn wt.% incorporated in the HA lattice. 
5.5.3 Release profiles for Ion-substituted HA 
The maximum concentration of ions in the medium plateaued in the range of 0.04, 10 and 0.01 
ppm for Ag, Mg and Zn samples respectively. In terms of total number of ions released, these 
concentrations are only a minor fraction of the ions substituted in the solids, except for Mg (see 
Figures 4.25, 4.26 and 4.27). 
The release profiles for the three different samples follow a similar pattern and confirm that: 
a) For all samples, a direct relationship exists between the concentration of ions in the solid 
sample and the amount of ions released. 
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b) Most of the ion contents are released during an initial burst from the solid sample. This was 
less evident for Mg-HA, which showed a more sustained release. This burst release may also 
suggest that there is a considerable levels of surface adsorption of ions to solids in all the 
samples. d 
The ion release data can be used to estimate the relationship between final ion concentration in 
the liquid phase and the solid phase. Using these data, it is possible to synthesize an HA sample 
with the right amount of substituted ions in the solid for the expected concentration in the liquid 
phase, which can give the optimum biological response (for example, in terms of antibacterial 
activity). After 21 days, there was only a slight sign of visible disintegration of the solid. The 
surface area will directly affect the final concentration of the ions in liquid; however, this 
parameter was not investigated in this study, and all samples were prepared in identical disk 
shape.  
Assuming that solid structure and morphological parameters remain the same in all the samples, 
it is expected that ion solubilisation was controlled by the following mechanisms (Figure 5.1): 
1) Diffusion, from the solid surface to the liquid and then to the bulk of the liquid; 
2) Dissolution, during which the solid is solubilised in the liquid and ions are released while 
diffusion occurs at the same time. 
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Figure 5. 1: Proposed mechanisms for the release of metal ions from solid disks. Diffusion (left) and 
Dissolution and diffusion (right) 
 
Mass transfer and diffusion within the solid structure towards the surface is believed to be 
limited, hence ion diffusion mostly occurs from the outer surface of the disks to the immediate 
layer of liquid surrounding the solid. By depletion of the ions in the surface, the concentration 
of the ions in the liquid phase will reach a plateau, which normally is a small fraction of the 
total ions available in the whole disk of solid. 
The dissolution mechanism, on the other hand, is expected to result in a higher quantity of ions 
being released. The resulting higher number of solid particles will increase the total surface 
area, resulting in higher rates of diffusion in the liquid phase. The dissolution mechanism is 
expected to be present in the solid samples which are readily soluble in the liquid phase. As an 
example, TCP phase in calcium phosphates is believed to have much higher solubility when 
compared to HA phase. As a result, when TCP phase is present in the solid structure, higher 
solubility and higher concentration of ions are expected to occur in that sample. 
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As explained earlier, other parameters may influence the rate of solubilisation such as 
morphology, crystal size, crystallinity, density and Ca/P ratio but were not studied in this 
research (138).  
The measured release profile is strongly affected by the surface area of the solid, and the surface 
of the disk is much smaller than the powder coating which is disturbed on the surface of the 
implant. The size of the crystals then becomes important factor, as finer particles will have more 
surface area and a higher release of metal ions will occur. These parameters were expected not 
vary significantly within the range of samples prepared in this study. Sample disks were 
compacted with high force to ensure that they sustain their solid structure when submerged in 
the experiments, and thus the effects of particle size on mass transfer is expected to be 
minimum. However, it is expected that the proposed model for mass transfer to have limitation 
to fully simulate the mass release profile from powder coatings in real samples. 
As a general observation, Ag-HA and Zn-HA samples showed a burst release during which 
almost all the ions were released in the first 48 hours. For Mg-HA, the burst release was less 
pronounced and Mg tended to show a more sustained release.  
A burst release in the prepared solid structures may be due to the following reasons: 
a) During sample preparation, some of the ions were accumulated on the surface of the powder 
or may have been adsorbed by weak physical bonds or as defects, which are released only when 
submerged for extended times. This fraction of ions may have remained on the solid surface 
even after being washed several times during sample preparation steps. 
b) A burst release can also be attributed to the release of ions from crystals on the surface which 
ions substituted in their lattice. While most ions on the surfaces or defect fractions are 
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solubilised, the concentration remains constant and no more ions are solubilised from the 
surface (as a result of the diffusion mechanism described earlier). 
In case of Ag, the maximum concentration of silver ions was reached at 0.4 ppm from 10% Ag-
HA sample after an initial burst release. 0.4 ppm of silver in the liquid was equivalent to less 
than 0.2% of total Ag in the solid specimen. 
Mg-HA, however, followed s slightly different pattern when compared to Ag-HA and Zn-HA 
(Figure 4.26). Firstly, the concentration of Mg in the liquid was much higher when compared 
to Ag and Zn (almost 100 times), and secondly, Mg release followed a more extended release 
profile, as it reached its maximum concentration after more than 100 hours compared to 24 to 
48 hours in Ag-HA and Zn-HA. 
The main factor which may explain the high concentration of Mg in liquid are either the 
1) higher surface adsorption of Mg ion on the surface of HA, or 2) higher solubility of Mg-HA 
in liquid because of higher dissolution of solid in the liquid phase. Based on the solubilisation 
mechanisms explained earlier, it is expected that Mg-HA solubilisation is mainly governed by 
the second mechanism since: 
a) The mass balance calculation (discussed in Section 4.5) indicated that the concentration of 
substituted Mg varies between 0.3, 1.7 and 2.2 wt.% in 1, 5 and 10 % Mg-HA respectively. 
When compared with Ag-HA and Zn-HA, there is a similar range of ion concentration in the 
solid. Hence, if the diffusion was the main mechanism (a function of ion concentration on the 
surface of the solid), there should have been a similar range of ion concentration in the liquid 
for Mg-HA as well.  
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b) Morphology, physical conditions and fluid dynamics, which may change the diffusion 
mechanism, were identical in all experiments.  
c) XRD results in Section 4.1 confirmed the presence of TCP phase in Mg-HA samples. TCP 
phase is known to have higher solubility and less stability compared to HA phase (discussed in 
the literature survey in Section 2.3: Calcium phosphates), suggesting that the dissolution 
mechanism will predominate over diffusion in this sample. As TCP phase solubilises in 
solution, any Mg-ion contained within that phase will be released, which may explain the high 
concentration of Mg ions in the liquid phase.  
The higher ratio of Mg ion release may also be due to a higher amount of Mg adsorption on the 
surface of the solid Mg-HA samples or incorporated as defects, but no specific surface 
measurement techniques (such as XPS) were available to confirm this hypothesis.  
In respect of Zn-HA, it showed lower rates of ion release (similar to Ag-HA) accompanied by 
a burst release within the first 24 hours. The maximum concentration of Zn in liquid was 0.06 
ppm, predominantly from the surface of the solid. Lower rates of Zn release can support the 
idea that the majority of the ions are substituted within the HA structure and there was no strong 
surface adsorption. These results were also in agreement with XRD confirming Zn substitution 
in the HA structure.  
The small fraction of β-TCP phase was observed in the XRD profile of Zn-HA of 5 and 10% 
samples (Figure 4.10). This, however, did not seem to have much effect on the solubility of Zn-
HA samples.  
5.6 Cell Biology 
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5.6.1 Cell Proliferation  
Metallic compounds are known to initiate adverse responses in humans or experimental animals 
in an excessive amount that may represent their toxicity level (219, 290). However, even a 
chemical generally regarded as toxic (such as Ag) shows no toxic effect in a small 
concentration, while a vital substance (such as Mg or Zn) may trigger adverse responses at high 
concentrations.  In case of the metal ions selected in the current research, there are no inclusive 
studies to measure and compare the relationship between the concentration of these ions and 
the resultant toxicity and biological responses. Furthermore, the level of released ions from the 
implanted devices cannot easily be determined in vivo. Therefore, in vitro experiments were 
developed with the objective of measuring the relationship between the concentration of 
metallic compounds and biological responses of cells. Generally, it is expected that an ideal 
bioactive implant will offer active interaction with cells and stimulate cell growth (291).  
As indicated in Figure 4.28, there was a steady increase in 2T3 proliferation from 2 days to 6 
days in the presence of NS-HA discs. These preliminary results, which represent a favourable 
response from the studied cells, confirm the biocompatibility of hydroxyapatite in terms of 
cellular response 
 The same behaviour in osteoblast cell lines has been reported by Qu et al. (292) but only after 
3 days incubation. They demonstrated that cells cultured with ceramics with higher crystallinity 
initiate a higher proliferation until they reach the highest proliferation rate within 3 days. 
Regardless of any contribution from the incorporated metal ions, there are three main factors 
that can lead to different cellular responses in the studied experiments: 
1) Physical properties, such as the morphology of the specimen, agglomeration of the 
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particles and  crystal size (including  degree of crystallinity), can change the response 
of the studied cells. As explained by Evans et al., cell interaction and, ultimately, any 
positive and negative impacts are directly related to the cell-particle interaction, which 
can be affected by physical attributes of the solid sample independent of the chemical 
nature of the particles (293).  
2) Chemical properties, such as the material’s composition and variation in its chemistry, 
which can change the chemical ingredients in the culture media in favour of or against 
cellular activity. In case of HA samples, the rate of calcium phosphate dissolution is 
correlated with the ratio of Ca/P ions and, consequently, the pH of the surrounding 
environment (293). The dissolution rate (both in body fluids or in vitro) is more critical 
when the crystallinity degree is lower, as it results in higher ratios of dissolution. The 
resulting alkaline pH would lead to a cytotoxic effect inhibiting DNA, and protein 
synthesis and cell proliferation in cell cultures.  
3) Biological properties, the osteoblast cells used in this study had different origins, which 
may result in the varied responses observed compared to Qu et al. Lang et al. (294) 
reported that the human osteoblast-like cells reacted slightly more sensitive to toxic 
substances on tested materials compared to rat osteoblast-like cells.  
 
Based on the results from Ag-HA samples, it can be concluded that silver can promote cell 
proliferation but can have negative effects at  higher concentrations of the study (10 wt.%), in 
vitro. Although Ag has been shown to have a broad antibacterial effect; high concentrations of 
Ag have been reported to be cytotoxic against human cells. The results showed that 10% Ag-
HA samples expressed adverse effects against osteoblast cells by dropping their proliferation 
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rate at all time intervals. In addition, by increasing silver to 10%, the degree of the crystallinity 
of final samples decreased, and consequently, the solubility of HA should have increased. 
Because no unfavourable effect was observed in the NS-HA sample, it can be concluded that 
Ag ions can be the main factor in the reduction of cell proliferation. This conclusion, however, 
assumes that any change to HA structure because of Ag incorporation had a minimum impact 
on the biological response. As discussed earlier in Section 2.4.4, silver’s toxic mechanism can 
be explained by electrostatic interactions with the cell membrane followed by their entry into 
the cytoplasm and subsequent interactions with DNA and proteins (295).  
Based on the data presented in Table 4.20 and the results from the cell proliferation assessment, 
when the concentration of the Ag ion increases to 0.3 ppm (which is expected to be achieved 
by the 5 wt.% Ag-HA sample in the cell culture medium), cell proliferation is negatively 
affected. Yamamoto et al. (296), compared the cytotoxicity of silver in HA samples to MC3T3-
E1 osteoblast cells. It was shown, that 0.298ppm of Ag+ reduces the proliferation of osteoblast 
cells by 50%. At a concentration of 1.07 ppm Ag+, only a small percentage of osteoblast cells 
could proliferate, and when the concentration of Ag increased to 2.14 ppm and higher, zero 
osteoblast cells survived (296). However, the results obtained from the present study indicate 
that a maximum silver concentration of 0.3 ppm (with the Ag-HA 5% sample) can increase the 
rate of 2T3 cell lines up to 19% before reaching a plateau. Moreover, a silver concentration of 
0.4 ppm (as was expected to be released from the Ag-HA 10% sample) can reduce the 
proliferation of the studied cell line by 35% after 6 days incubation. 
However, the effect of silver in HA in the attachment rate of mouse osteoplastic (MC3T3-E1) 
cell lines (an initial step to cellular response) has been examined in another study by Sandukas 
et al. (297), who suggested that the optimum concentration of Ag is between 1%wt. to 3% wt., 
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the equivalent of 0.78 ppm to 1.7 ppm in the medium. Sandukas et al. (297), however, suggested 
that higher concentrations of silver (0.7 ppm) do not show any negative effect (compared to 
0.3ppm in this study). They did not measure the proliferation rate of their cells, instead 
concentrating on the adhesion and spreading of cells on the surface of Ag doped HA. The 
surrounding liquid for measuring the Ag concentration was different, which may affect Ag 
release quantities, but they reported a similar burst release from hydroxyapatite after 172 h 
(297). 
In another study, the viability of the human mesenchyme stem cell (hMSCs) line on Ag-HA 
was studied, and positive results were reported in terms of the biocompatibility and antibacterial 
activity of hydroxyapatite with 0.5 wt. % of Ag which was equivalent to a maximum 0.5 ppm 
release(242). In the same study, it was also reported that actual silver’s incorporation into 
hydroxyapatite was lower than expected, which the XRF and ICP results also confirmed 
(Section 4.5 and 4.6). In addition, they showed the proliferation of the candidate cell line on 
0.05ppm silver to be similar to hydroxyapatite after seven days. These finding, however, 
suggests a sharp release profile of silver in 3 days followed by a minor release in the following 
days.  
Lim et al. (242), showed that the slow release of Ag in 7 days (0.5ppm) is favourable in terms 
of antibacterial properties, while the results suggest that 0.3 ppm silver in 3 days is effective 
regarding higher cell proliferation. Conversely, plateau release of silver after 3 days helps in 
retaining the antibacterial properties of samples.  
 Similarly, Chen et al. (108), reported that the HA coating with a silver concentration of <5% 
is not toxic to the murine fibroblast L929 cell line, but the antimicrobial activity is >90%. 
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However, they did not report any measurement of actual concentrations of silver in the medium 
and how it can be related to the activity of the murine fibroblast L929 cell line. 
The results, supported by the detailed results from the material characterisation and release 
profile measurement, directly relate to the characteristics of a solid sample. In addition, the 
concentration of released ions from the samples to the observed cellular activity. The results 
suggest that silver hydroxyapatite substitution in 1% and 5% (equal to a maximum 0.3 ppm of 
Ag release) can promote osteoblast cell proliferation by up to 18%, while introducing more than 
5 wt.% (equal to 0.4 ppm) can adversely affect cell proliferation. Hence, it should be prohibited 
from use in implantable devices. Notably, cell line, culture time period and proliferation assay 
can affect conclusions regarding the maximum safe concentrations of silver in hydroxyapatite. 
The data from an AlamarBlue assay with Mg-HA samples showed that 2T3 cells could 
proliferate on Mg-HA, as also demonstrated by the proliferation assay and confirming positive 
cellular responses to this material at concentrations of 1%, which was expected to be equivalent 
to 8.00 ppm of Mg ion in the medium. This suggests that the Mg ion could promote cellular 
proliferation more effectively than NS-HA. It can also be concluded that Mg-HA at a maximum 
of 1% concentration is biocompatible, and no obvious adverse effects were noted in the 
nominated concentrations and against the studied cells.  
Previous studies have reported that ion-dissolution products containing Ca and Mg from 
bioactive glasses and ceramics could stimulate cell proliferation (298, 299). It is also reported 
that the release of Mg ions from Mg alloys should not cause toxicity and may have beneficial 
effects on cell responses in the local tissue (300). As expected, there is a limit to the amount of 
Mg amount that can be incorporated into biomaterials, as reported by Serre et al. (15). In these 
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studies, collagen sponges and magnesium-enriched apatite were used, and the authors reported 
cytotoxic effects of samples contained 20 wt.% magnesium and 80 wt.% calcium on human 
osteoblast-like cells in vitro (254). In this study, Mg and Ca ions were released from the Mg-
HA into the medium solution as discussed in ICP and XRF Section 4.5. and 4.6. The higher 
level of ion release was highlighted as measured by ICP in Section 4.5 and is expected to be 
due to the lower degree of crystallinity of Mg-HA samples. Hence, the chemical composition 
of the medium (which contains a mixture of Mg and Ca ions) may have contributed to the 
improved cellular responses to Mg-HA disks.  
Sader et al.(299), cultivated human osteoblast cells over a sintered tablet of 2% mol Mg 
substituted β-TCP for maximum of 7 days. The result was improved cell proliferation.  
However, the findings from this study indicated a maximum of 1% mol of Mg incorporation in 
HA (which was expected to be equal to 6.22 ppm Mg in the medium) can increase proliferation. 
Another study by Tavares et al. (301), indicated that less than 1ppm Mg in β-TCP can be cyto-
compatible. Landi et al. (125), implanted HA granules containing 5.7 wt.% of Mg in rabbit 
femoral bone defects. They indicated that the osteoconductivity and resorption of the material 
was higher compared with commercial HA. Another study indicated that the presence of even 
6.8% mol of Mg in tricalcium phosphate discs had no effect on osteoclast apoptosis(302), while 
others have suggested that the presence of Mg in the TCP structure stabilised the cell-material 
interface and consequently, enhanced cell attachment and growth(303). 
Cell proliferation and protein adhesion to the surface of biomaterial can be affected by surface 
modifications and their chemistry. Osteoblast cells interact with biomaterial and bind directly 
through a process mediated by receptors from the integrin group (304). The presence of Mg2+ 
in the biomaterial structure can enhance the stabilisation of the osteogenic phenotype by 
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improving the integrin receptors intracellular signalling. Mg has been suggested to enhance 
cellular activity, as it is mitogenic for osteoblast cells and, when diminished, can inhibit cellular 
growth in vitro (24). Ryan et al. (305), have shown that  magnesium can have a positive impact 
on cell proliferation and collagen formation. Landi et al. (28), showed that osteoconductivity 
increases with Mg-doped hydroxyapatite (Mg-HA) when compared with pure HA and can lead 
to more favourable conditions for bone growth due to surface characteristics such as 
composition and nano-dimensions. Zreiqat et al. (306), reported that bone cell adhesion on 
magnesium-enriched alumina was increased in comparison to Mg-free alumina. The 
concentrations of both the integrin receptor and collagen I extracellular matrix protein were 
increased when cells were grown on Mg-containing alumina indicating that Mg can impact the 
cell attachment process (306). Bone cell attachment and cell growth on magnesium-enriched 
apatite and collagen have been studied, and reported positive results in both cases (307, 308).  
The data obtained from the AlamarBlue assay regarding the Zn-HA study showed that 2T3 
cells could proliferate on the Zn-HA. The results from this study clearly suggest that the 
addition of Zn ions to hydroxyapatite promotes cell proliferation in certain concentrations and 
at certain time points. However, the possible cytotoxicity of Zn is still under review in 
biomaterial research trying to minimise tissue cytotoxicity while maintaining a good inhibitory 
effect against bacteria. Zinc has been shown to induce cellular toxicity via the production of 
ROS and disruption of the energy metabolism at high concentrations (309). 
In this study, with the dissolution of Zn-HA, zinc can be gradually released into the surrounding 
medium (to a maximum of 0.06 ppm concentration) at a level that is well below the established 
toxic concentrations of zinc (12 ppm) (296). Other studies have reported that the incorporation 
of Zn into hydroxyapatite in low concentrations (1.6 wt.%) can enhance cell growth and 
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differentiation (310, 311). However, these studies did not report the concentrations of the Zn 
ion that were released from the prepared implant. 
Some studies have reported the presence of zinc oxide in the final sample and suggested that it 
has a higher solubility rate than the Zn-TCP and HA phases and can contribute to biological 
activity (296). The dissolution of zinc oxide will contribute to a higher concentration of zinc in 
the medium. This zinc concentration was more than twice of the level required to inhibit the 
MC3T3-E1 cells culture by 50% (296). Therefore, the reported cytotoxicity was mainly due to 
the presence of zinc oxide. No zinc oxide was observed in Zn-HA samples in the XRD pattern 
(see Section 4.1) and did not contribute to any of the observed responses to this compound. In 
a similar study by Ito et al. (312), they suggested that the zinc content must be  less than 1.20 
wt. % (3.53 ppm) to prevent any negative effect, when the Zn-TCP/HAP composite ceramics 
were applied to the MC3T3-E1 cell culture. They also suggested that adding Zn to TCP can 
change its phase to HA, which can affect the solubility and ionic composition of culture media 
(312).  
5.6.2 Alkaline Phosphatase (ALP) activity quantification 
Osteoblast cells undergo a temporal sequence of gene expression during the development of a 
fully differentiated osteoblastic phenotype. The sequence includes: proliferation, differentiation 
and mineralisation periods (313). The proliferation phase is characterised by an increase in cell 
number and by the synthesis of the extracellular matrix. This is followed by the expression of 
high levels of ALP (differentiation phase). Measure the ALP activity then indicates the level 
differentiation to cells which deposit calcium minerals.  
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A number of different parameters have been selected to monitor the behaviour of osteoblast 
cells in the early stages of colonisation. Besides proliferation, the ability of the cells to 
differentiate on the biomaterials also indicates cell viability and indirectly shows whether the 
materials are biocompatible (314). ALP activity has been used as an early marker of the 
functionality and differentiation of osteoblasts during in vitro experiments (315). The number 
of attached cells was measured at different periods to evaluate if the surface can support the 
attachment and proliferation of osteoblast cells. The level of ALP was assumed to be a reliable 
marker of cellular differentiation since it is a product of osteoblast cells.  
Cells from a single culture were used to reduce any effects arising from the cell origin or 
because of the maturation period. ALP is a non-collagenous protein regulating cellular 
metabolism through the hydrolysation of phosphate esters and indicates evidence of new bone 
formation, the onset of mineralisation and ECM matrix remodelling (316). 
The data obtained from ALP activity on the Ag-HA study showed that 2T3 cells could 
differentiate on the Ag-HA in limited concentrations of silver. Accordingly, bone 
differentiation of 2T3 cultured on 1% and 5 % Ag-HA samples was superior (by 27% and 31% 
respectively) compared to NS-HA, indicating the biological benefits of substituting silver in 
apatite. In another study, which was done by Liu et al.(317), silver nanoparticles were used, 
and the cytotoxicity and genotoxicity of silver nanoparticles were determined. In the 
aforementioned study, the uptake of silver nanoparticles and its effect on the osteogenic 
differentiation of human mensenchymal stem cells were investigated in vitro. The results 
indicated that silver nanoparticles cause cytotoxicity in hMSCs. Furthermore, it demonstrated 
that the uptake of silver nanoparticles did not affect alkaline phosphatase activity (317). 
However, the observed results suggest that Ag-HA 10% (with a silver concentration of between 
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3.00 and 4.00 ppm in the medium) can decrease ALP activity by 5% when compared to NS-
HA. 
Mahmood et al. (318), evaluated the concentration of 20 µg/ml Ag nanoparticles on cell 
calcification and bone matrix formation in MC3T3-E1 bone cells after 6 days of incubation. 
They reported more mineralisation and ALP expression in the MC3T3-E1 cells incubated with 
Ag particles than the cells treated in the Ag-free medium. The exposure of cells to the Ag 
nanoparticle was suggested to affect the genes responsible for osteogenic differentiation (318). 
Their results support the findings in this study with regards the increased ALP expression in 
the presence of Ag. Albers et al. (319), found that ionic silver had a strong impact on ` murine 
osteoblast differentiation and viability. They noted that silver ions can alter cell differentiation 
and viability on a scale that depends on the size of the Ag particles.  
The advantage of using magnesium in bone implant biomaterials is its enhanced 
biodegradability and enhanced mechanical properties (300, 320, 321). In addition, Mg 
deficiency is known to be a risk factor for osteoporosis (24, 300). However, the contribution of 
magnesium to the levels of cell differentiation is not clearly defined yet. Some studies indicated 
that low extracellular magnesium promotes cell differentiation (322), while others have reached 
opposite conclusions (323). 
These results showed that the ALP activity of the cells on the Mg-HA exhibited higher levels 
of expression by 15% than those on the NS-HA at 7 days, indicating that the Mg facilitated cell 
differentiation. It must be noted that the effect of Mg on the differentiation of osteoblast cells 
is dose-dependent. As these results also confirmed, ALP activity decreased at higher Mg 
concentrations for 5% and 10% Mg-HA samples. Lee et al. (324), evaluated the effects of Mg 
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ions on osteoblastic differentiation in hBMSC. They examined the differences between 
magnesium chloride, calcium chloride and strontium chloride to measure hBMSC proliferation 
and ALP activity. Their results showed that the treatment of human BMSC with Mg for 14 days 
enhances ALP activities. In addition, both ALP levels and proliferation were increased after 
Mg treatment. 
Several studies involving human cells, however, indicate that both high and low concentrations 
of magnesium could have harmful effects on bone metabolism and homeostasis (325). Leidi et 
al. (322), tried to focus on the effect of low (0.1mM) and high (5.0 mM) concentrations of the 
Mg ion on osteoblast-like SaOS-2 cells and the differentiation of normal human osteoblast cells. 
These results were consistent with this study, suggesting that a high concentration of 
magnesium decreases both the mineralisation and the activity of ALP. 
In another study by Cai et al. (323), that is consistent with our finding, magnesium was 
incorporated into a fluorinated HA coating. It was shown that a 1.5% concentration of Mg ions 
increases MG63 cells attachment, has a significant stimulating effect on osteoblastic cell 
responses and results in higher cell proliferation and faster cell differentiation. It waso showed 
that a maximum concentration of 1% Mg in HA (expected to be equivalent to 8 ppm of Mg in 
the medium) has positive effects on osteoblast cell differentiation. 
In a recent study, MC3T3-E1 cell differentiation was investigated with a magnesium coated 
titanium implant prepared by a plasma spray technique (326). Authors reported that Mg has a 
favourable effect on osteoblastic and osteoclastic cell differentiation and that Mg may 
accelerate the bone remodelling process and substantially activate osteoclast differentiation 
(326). However, they did not mention the effective concentration of Mg in their medium. 
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In a similar study, the Alkaline phosphatase activity of MC3T3-E1 was analysed after 7 days 
on magnesium-hydroxyapatite coated titanium prepared by radio frequency (RF) and direct 
current (DC) magnetron sputtering (327). The authors suggest that the presence of Mg and Mg-
HA coatings can stimulate the differentiation of the target cells into osteoblastic MC3T3-E1 
cells with potentially higher rates of osseointegration (327).  
Results from this study indicated that the ALP activity of the cells on the Zn-HA exhibited 
significantly higher levels of expression than those on NS-HA at 7 days, suggesting that Zn 
accelerated cell differentiation. As our results have shown 1, 5 and 10% of Zn can increase cell 
differentiation by increasing 25%, 33% and 32% respectively, as demonstrated by the ALP 
activity of 2T3 cells.  
The literature suggests that Zn incorporation into implants promotes bone formation around the 
implant and decreases the inflammatory response (328). Its stimulatory effect on bone 
formation and mineralisation has been reported with both in vivo and in vitro studies (328, 329). 
It was shown that the Zn2+ ion results in osteoclastic inhibition (128). However, it worth noting 
that high amounts of Zn2+ doping (up to 15–20% mol) can inhibit HA phase formation (126). 
It was noted that a concentration of 0.06 ppm observed for Zn-HA 10% can increase the 
differentiation of the 2T3 cell after 7 days. Badr et al. (330), reported higher levels of alkaline 
phosphatase in a rat calvarium-derived osteoblastic cell cultured on 5 wt.% zinc-containing 
glass powder combined with calcium. They reported that biphasic calcium phosphate shows 
enhanced mechanical and biological properties by incorporating small quantities (0.5-5 wt.%) 
of zinc-containing bioactive glass particles (330). No measurement was carried out for the 
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amount of zinc released form their powder formulation, while differentiation improved up to 
10% Zn-HA sample, which was the equivalent of 0.06 ppm of the zinc released ion. 
Seo et al. (331), evaluated the ALP activity of MC3T3-E1 cells against different concentrations 
of Zn at different culture times.  They concluded that 15 µM and 25 µM zinc (equivalent to 0.7 
and 1.2 ppm) showed the highest effects in increasing the ALP activity at the end of the 
proliferation phase and the start of the mineralisation stage. However, their data are consistent 
with findings in this study, as it was showed that their lowest studied zinc concentration (1µM 
or 0.06 ppm) increases ALP activity. A similar result with identical concentrations (0.06 ppm) 
in a 10% Zn-HA sample was also observed. 
In another study, the effect of zinc on SaOS-2 human osteoblastic cells on ALP synthesis was 
investigated. It was concluded that Zn can increase ALP activity in the range of 1 µM to 10 µM 
and decrease in 50 µM (332). A similar pattern was observed by Yang et al. (333),  who reported 
that a Zn-HA coating with a Zn/(Ca+Zn) molar ratio of 1.04%  significantly enhances the 
differentiation of MC3T3-E1 on day 7, with the potential benefit of enhancing implant 
osseointegration. Uysal et al. (334), reported that 2%mol Zn ions incorporated into the HA 
crystal resulted in an increase in the ALP activity of the Saos-2 cell line after 7 days  when 
compared to the pure HA. Moreover, they claimed that the incorporation of zinc can change 
the physical properties of final the HA, as its grain size has potential impact on the 
differentiation levels.  
5.6.3 Concluding statements  
The results from the cell biological studies confirmed that ions (Ag, Mg and Zn) substituted 
hydroxyapatite promote greater osteoblast cell proliferation and differentiation in comparison 
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with NS-HA samples. However, the biological response was limited by the concentrations of 
Ag, Mg and Zn ions.  
It can be claimed that silver substituted in hydroxyapatite can promote the proliferation and 
differentiation of mouse osteoblast cell lines (2T3) by 19% and 27% respectively, which 
corresponds to the Ag-HA 1% sample (0.3 ppm in the medium). Between 0.3 ppm and 0.4 ppm 
of silver shows no desirable effect on proliferation and differentiation. Zn-HA 10 wt.% with a 
maximum release of 0.06 ppm Zn resulted in a 41% increase rate of proliferation and 33% 
differentiation at the same time of incubation. However, Mg-HA 1 wt.% with 6.22 ppm can 
increase the rate of proliferation with up to 10% and differentiation by 13%. 
Adding any cation to the hydroxyapatite structure can change the physical and chemical 
characteristics of the crystals, and  each can individually affect the final biological response of 
HA.  
There was a decreasing degree of crystallinity after ion substitution (at different levels for each 
ion and concentration) for all the studied ions, which is believed to result in a higher degree of 
solubility in the liquid and potential impact on the chemistry and pH of the medium compared 
to the NS-HA sample. It was showed that substitution could influence the calcium phosphate 
stoichiometric as well as the chemical phases present in the final crystal structure. In the case 
of Mg and Zn substitution, in addition to the HA phase, it was reported that with TCP phase, 
the solubility of crystal and subsequently the pH and composition of the medium will be 
affected. Moreover, the rate of calcium phosphate dissolution is correlated to the ratio of Ca/P 
ions and again the pH of the surrounding environment (293). It is expected that the pH will 
become more alkaline by dissolving the HA material, which can have a cytotoxic effect on cell 
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proliferation in cell cultures. The dissolution rate (both in body fluids or in vitro) is more critical 
when the crystallinity degree is lower, as it results in higher ratios of dissolution.   
The method of introducing metal cations to HA can affect its microstructure in terms of particle 
charge, grain size, crystal size and roughness. All these parameters are expected to impact 
surface characteristics (such as wettability) and as a result the cell attachment on the surface. 
However, the main focus of this work was on the effect of ion addition and its presence in the 
medium against the cellular activity.   
The substitution of cations can occur on the Ca (I) or Ca (II) position (or between them) or even 
on the surface of HA with different cellular responses. Regardless of the mechanism of ion 
incorporation, the outcome of biological assessments to the total ions released and present in 
the medium can be correlated.  
 
5.7 Microbiological assays 
With increasing rate of microbial organisms becoming resistant to the existing antibiotics, many 
studies have tried to develop new and effective antimicrobial reagents free of resistance and 
with less cost. Such problems have led to the resurgence in the use of metal based antiseptics 
which are applicable to broader spectrum of bacteria with far lower susceptibility to induce 
resistance than common antibiotics(335). 
As discussed in Section 2.4.4, both silver and zinc have long been known for their antibacterial 
properties (96) against an exceptionally broad spectrum of bacteria, including gram-positive 
and gram-negative, as well as viruses and fungi (97, 98). Within metals with antibacterial 
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activity, silver has the highest efficiency even at a very diluted concentration (as low as 35 ppb 
range) within which there is no known toxic effect for mammalian cells (99, 100). In addition, 
microorganisms have a relatively poor ability to develop immunity to silver. Therefore, it has 
been widely used in many forms as an antibacterial agent, both in medicine (e.g., for the 
treatment of flash burns, catheters, the coverage of implant materials, urinary tract infections, 
dentistry(92) (101) and in other fields like clothing, home appliances and water treatment (336) 
(337). 
The main purpose of microbiological assay was to measure how the prepared samples 
“perform” in vitro in terms of antibacterial action against two strains of bacteria. The efficacy 
of the ion-substituted samples was measured and reported considering results from following 
three main assays which were carried out in this thesis: 
1) The exact measurement of ion content in solid samples from ICP-MS and XRF studies, 
which can be used to correlate to the observed antibacterial effect.  
2) The concentration of ions and their rate of change in the medium (release profile). Having 
the release profile results, it was possible to correlate the antibacterial activity to the 
concentration of ions known to be present for each sample. 
3) Placing the disks in bacterial culture to understand growth inhibition of cells and measure 
the antibacterial activity. 
While it is possible to outline the antibacterial strength of the samples with either of the 
mentioned experiments (zone of inhibition or film adhering technique) as in most previous 
studies (108, 338), each technique come with inherent limitations. For example, zone of 
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Inhibition technique is based on the release of ions in a semi-solid gel-like medium where the 
mass transfer is somehow more limited to the surrounding medium when compared with in-
vivo conditions. Likely, the mass transfer and inhibition of bacterial growth is largely dependent 
on the thickness of agar layer and dimensions of the disk, which is placed on the agar surface. 
To overcome these limitations, the spread plate/film adhering methods were developed to 
accompany the zone of inhibition study, to understand how the release will be like in the liquid 
medium and how the activity will change.  
In general, the substantial data from these experiments conclude that each of Silver or Zinc can 
inhibit the growth of selected microorganisms with varying degrees based on type and 
concentration of the metal in solid and also the type of bacteria studied.  
Further discussions to review the three main studies, i.e. zone of inhibition, spread plate method 
and adhering film are provided below.  
 
5.7.1 Measuring antibacterial activity 
The antibacterial action during the mentioned assays occurs in two main steps; 
1) Ion transfer from the disk to the surface of the bacteria 
2) Ion interaction with the cell, either through attraction or reaction with the cell or through 
diffusion into the cell. 
The ions are expected to reacts in a similar way regardless of which mechanism the ions used 
to reach to the cells. However, in each of the mentioned technique, it was believed that different 
mechanisms may have been followed during the ion transfer phase. It was expected that ion 
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transfer from the solid to the outer medium (agar or liquid phase) should have a significant 
impact on the observed results in this section of work. Hence, it is critical to explain and 
compare these mechanisms to make the right conclusion.   
Two main mechanisms can be considered on how metal ions in solid specimen can interact with 
the bacterial cells. The first mechanism is based on the attraction of microorganisms to the 
surface of the disk by electrostatic forces, where there is a direct interaction between the 
bacterial cell membrane and the metal ions (102, 103). This mechanism is expected to occur 
mainly in the film adhering method. However, in the second mechanism, Ag ions are first 
released from the surface of the solid and diffuse through the surrounding medium until they 
reach and react with the cells(84). Second mechanism is like diffusion and similar to general 
ion release profile, and is believed to be more dominant in the ZI study. 
On the other hand, molecular movement was expected to control the ion transfer in the ZI 
techniques. Ion diffusion within the agar gel controls the rate of the antibacterial activity until 
the ions reach the surface of the bacteria.  
In the film adhering technique, solid samples were shaken in the bacterial suspension (forced 
convection). Hence, two stages can be proposed during which ion interaction happens in the 
film adhering method: 
1) First, ions are released from the solid disk into the liquid solution. A similar release profile 
to what was occurred in ICP measurement assays (section 4.7) should be present in this method. 
However, as samples were shaken during the film adhering experiments, it is expected that the 
ion transfer from solid to liquid phase to be larger because of the disturbed liquid medium. The 
solid disks remained intact at the end of film adhering experiment, suggesting that diffusion 
regime should be dominant throughout this stage.  
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2) Ion interaction with the suspended cells in the liquid was at a different rate than what occurs 
during agar-based experiments. As there is an agitated medium, it was expected that a higher 
number of cells being affected with ions. Consequently, higher values for antibacterial activity 
may be observed in this test but while all samples are compared together, a better comparison 
can be provided. 
Measuring antibacterial activity of Ag-HA samples 
Strong inhibition in bacteria growth was observed in the Ag-HA samples in the studied culture 
plates. While the negative control (NS-HA) showed minor antibacterial activity which 
diminished after 24 hours, Ag ions indicated noticeable antibacterial activity in both ZI 
measurement and film adhering assays. Minor antibacterial activity of NS-HA can be due to 
the release of calcium and/or phosphate ions or other reaction residues with a potential of 
unbalancing the pH of the medium. A similar effect was exoected in all ion-substituted samples. 
Based on the results from the Ag release profile measurement (Section 4.5.2), the concentration 
of Ag in the liquid medium was expected to be about 0.25 ppm, 0.3 ppm and 0.4 ppm for Ag-
HA of 1, 5 and 10 %, respectively. The ZI experiments showed that these concentrations have 
been effective to some extent in the inhibition of bacterial growth for both Gram- negative and 
Gram-positive bacteria.  
Antibacterial activity was measured for up to 48 hours. Considering the release profile of Ag 
(Section 4.5.2), a burst release of Ag ions was expected during the first 24 hours, suggesting 
that most of the Ag should have been released. The release profile experiments were carried 
out in a liquid medium, in contrast to the semi-solid agar structure in the antibacterial assays. 
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However, the diffusion was assumed to be in a similar range in the liquid and semi-solid agar 
medium. For ZI tests in an agar medium, the Ag ions were able to diffuse from the solid surface 
and penetrate into the agar. Similarly, for the film adhering method, the ions were transferred 
from the surface of the disks to the attached layer of the bacterial cells. 
The type of experimental method to measure the antibacterial activity will affect the final 
results, although the results in this study were in general agreement with previous works from 
other research groups (339, 340). The Ag-HA samples in all the different ratios showed 
antimicrobial activity in a similar pattern to what was reported by Sondi et al. (341).  
Ag has been shown to be effective against bacteria at a concentration of 12 ppm (85), and it has 
been shown to be more effective than Cu+2 and Zn+2  when it was substituted in hydroxyapatite 
(342). In fact, Fenga et al. (85), reported that the minimum inhibitory concentration against 
bacteria (defined as the removal of 90% of the bacteria) for Ag was about 0.8 ppm (1.3 ppm 
for AgNO3), which is slightly higher than what was observed for the concentration of Ag being 
released from the sample. The results showed that even at a lower concentration of Ag, a high 
ratio of bacterial removal (based on the film adhering method) is achievable. 
The diameter of the ZI increased as the concentration of Ag increased in the solid structure, but 
the effect of Ag was more pronounced in the E.coli culture compared to the one for  S. 
epidermidis. Previous studies reviewing the mechanism of action of Ag ions referred to the 
thicker peptidoglycan layer of Gram-positive bacteria compared to Gram-negative ones (20-80 
nm in Gram-positive bacteria compared to 2-3 nm outer membrane and 8-10 nm in Gram-
negative bacteria (343)). This can protect the cell from the influx of Ag ions, resulting in a 
higher resistance against the Ag inhibitory effect (344, 345). The peptidoglycan layer is a 
238 
 
specific membrane feature of bacterial species and is not present in mammalian cells. In one 
previous study by Jun et. Al., however, a slightly different response in E.coli was observed 
when compared to S.epidermidis against Ag ions (346). In their results, the inhibitory effect of 
Ag was lower in S.epidermidis when compared to E.coli microorganisms. 
The mechanism of the antibacterial action of Ag ions is not fully understood yet (all 
explanations are reviewed in Chapter 1), while the interaction of the Ag ions and the cell 
membrane is predominantly the major factor in most hypotheses. Some studies suggested that 
the positive charge of the ion is critical for its action against the negatively charged particles on 
the bacterial cell membrane (347-349). In contrast, Sondi et al. (341), reported that “negatively” 
charged Ag particles also show antimicrobial activity on Gram-negative bacteria and its 
efficacy is solely determined by its concentration, which it was confirmed in the results. The 
charge of the Ag ions in this study was not measured but was expected to be positive based on 
the formulation and the neutral pH of the environment.  
Increasing the inhibitory effect by increasing the Ag concentration has been shown to be 
associated with the formation of “pits” in the cell wall of the bacteria (341). The Ag particles 
were shown to accumulate in the bacterial membrane and increase the cell permeability, 
resulting in cell lysis. Amro et al. (349), suggested that metal depletion may cause the formation 
of irregularly shaped pits in the outer membrane and may change the membrane permeability, 
which is caused by the progressive release of lipopolysaccharide molecules and membrane 
proteins (349) Sondi et al. (341),  speculated that a similar mechanism may cause the 
degradation of the membrane structure of E. coli during treatment with Ag particles.. 
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Measuring antibacterial activity of Zn-HA samples 
The advantages of using inorganic particles (e.g. Zn) as antimicrobial agents are their greater 
effectiveness on resistant strains of microbial pathogens, less toxicity and heat resistance (350). 
While it has been suggested that Zn ions act as a bacteriostatic agent rather than a bactericide 
(351), the inhibitory effect of zinc loaded hydroxyapatites against bacteria, including E. coli, 
Staphylococcus aureus(S. aureus), Candida albicans (C. albicans), and Streptococcus mutan 
have been previously confirmed (352). Zn is also a crucial molecule for human cells, 
particularly bone cells, and can exhibit strong activity at very low concentrations (353, 354). 
Zn is known to be in the active centre of more than 300 enzymes involved in bone metabolism 
(355). 
The antibacterial activity of Zn-HA formulation (as in 1, 5 and 10% samples) were tested 
following two different methods. Its antibacterial activity was evident in all the employed 
techniques when compared with the NS-HA control. 
Similar to the Ag-HA samples, the antibacterial property of Zn increased with a higher 
concentration in the solid sample. The presence of a ZI clearly indicates that Zn ions are 
released from the solid specimen into the agar and have an antibacterial effect against both 
strains. Similar to what Rizwan et al. (356), reported, increasing the concentration of Zn in 
hydroxyapatite leads to higher rates of growth inhibition. However, when compared to the Ag-
HA, the ZI was slightly smaller, particularly in the S.epidermidis culture plates. One 
explanation for the lower antibacterial activity could be due to the lower rates of Zn released 
from the Zn-HA samples. As results of Zn-HA release profile suggest, the maximum 
concentration of Zn in the medium reaches only 60 ppb for 10% Zn-HA after 48 hours. Even 
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at such low Zn concentrations, the bacterial growth was inhibited as indicated in both ZI study 
and film adhering method. Previous works have confirmed effective bioactivity and 
antibacterial properties with the hydroxyapatites sample doped with small amounts of Zn ions 
(less than 1%) (140, 141, 357). At a slightly higher concentration (1.3%), Zn ions shown to 
increase the level of osteoblast responses (311). Studies on a hydroxyapatite doped with Zn 
were synthesized using the wet method and a hexahydrate Zn nitrate of Zn (NO3)2⋅6H2O 
(wherein the Zn ion content was 1.6%), have shown its real impact on the reduction of S.aureus 
bacteria (310). It is critical to remember that for the optimum formulation, one needs to consider 
Zn cytotoxicity levels against human cells. Cytotoxicity effect has been reported to initiate for 
hydroxyapatites containing Zn ions when Zn concentrations is more than 1.2% wt. in the solid 
(310, 312) . 
The minimum inhibitory concentration (MIC) for zinc nitrate (ZnNO3) is not fully determined 
against E.coli or S.epidermidis, in contrast for zinc oxide (ZnO), which is a very common 
additive in cosmetic and topical formulations. ZnO is expected to be partially dissolved and 
generate Zn+2 ions, which are reported to partly contribute to its antibacterial activity(358). For 
ZnO, the MIC against E.coli varies in different studies, from as low as 0.1 ppm (359) to 400 
ppm (350). ZnNO3 is fully dissolved in water, and is expected that the released Zn+2 ions are 
responsible for any antibacterial activity (358). 
The size of the ZI was different according to the type of bacteria and the concentrations of Zn. 
The results also confirm that the effect of Zn ions is more pronounced against S.epidermidis 
bacteria, which is different from what was observed for Ag-HA samples. Results from previous 
studies also do not provide a conclusive explanation if Zn ion is more effective against Gram-
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negative or Gram-positive bacteria. While some studies reported a higher antibacterial property 
for Zn against Gram-negative bacteria (343), in another case a different pattern was reported 
(360). Several factors have been attributed to the different response of Gram-positive and 
Gram-negative bacteria against Zn ions. These factors are different cell wall structure, 
membrane or the outer layer in each bacteria strain and different resistances to oxidant 
compounds and defence mechanisms to tackle oxidative stresses (351, 361, 362). 
The mechanism of action of Zn as an antibacterial agent is described to be similar to Ag ions. 
When Zn reaches the microbial cell membrane, it will be strongly adsorbed and penetrate into 
the bacterial cell wall. The bacteria lose their proliferation capacity due to protein denaturation 
and the destruction that ultimately occurs (343). Zn also has been reported to bind to the 
membranes of the microorganisms, consequently prolonging the lag phase of the growth cycle 
and increasing the generation time of the organisms, so that it takes each organism more time 
to complete the cell division (362). Zn is also found to block the secretory effect of the cholera 
toxin and the E.coli heat-labile enterotoxin, which acts by cyclic adenosine monophosphate 
(363). 
Hybrid formulation of hydroxyapatite, which consists of mixing a common antibiotic with Zn 
ions, has been used to resolve the problem of local availability of the antibacterial agent and to 
provide a higher concentration of the antibiotic in the bone tissue (364). In the mentioned work, 
hydroxyapatite was doped with Zn ions as carriers for the controlled release of ciprofloxacin, 
which exhibits antibacterial activity against S.aureus and Pseudomonas aeruginosa. It was 
shown that both the ciprofloxacin and Zn ions co-release. The Zn not only increases the total 
antibacterial activity, but also it resulted in a higher amount of ciprofloxacin release from the 
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hybrid material as it reduces the crystallinity and increase the surface area of the nano grains. 
Using a similar formulation can result in higher efficiency of the therapy with lower doses of 
ciprofloxacin and a reduction in the formation of resistant strains.  
5.7.2 Concluding statement 
The results from the microbiology studies confirmed that Ag and Zn hydroxyapatite present 
antibacterial activity against two candidate bacterial strains. However, the antibacterial activity 
has been controlled by the concentration of the ion and type of bacteria. 
Ag-HA samples had significant growth inhibition against both bacteria in comparison to the 
control sample in all three different ratios. The Ag antibacterial activity was shown to be dose-
dependent and was more pronounced against Gram-negative bacteria (E.coli) than Gram-
positive bacteria (S. epidermidis). 
Zn-HA also showed clear growth inhibition in comparison with the NS-HA (control) samples 
and the level of reduction in bacteria growth was lower when compared to Ag-HA samples. 
Zn-HA also shows to be more effective against S.epidermidis and similar to Ag-HA, its 
antibacterial properties increases at higher ion concentrations.  
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CHAPTER  6 
CONCLUSION 
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6 Conclusion 
For decades, calcium phosphate has been used to mimic bone structure or enhance 
biocompatibility of implants in various formulations. Selected cations of Silver, Magnesium 
and Zinc were incorporated in HA to add their beneficial antibacterial activity and bio- 
functionality and reviewed their key characteristics through a multidisciplinary approach.  
The results proved that antibacterial activity is a positive attribute observed after addition of 
these cations but the type and concentration of these ions can impact other critical properties of 
the HA with potential impact on the final structure. The aim of this study, however, was to 
define how the most critical attributes were affected and conclude a meaningful review and fill 
the knowledge gap between material characteristics, biological response and antimicrobial 
activity of this type of material.  
Following section highlights the conclusion of the present study. 
6.1 The extent of ion substitution  
The selected cations were substituted in the HA structure but not necessarily in the ratios similar 
to the stoichiometric concentrations present in the starting reaction pool. Two different methods 
were used to measure and validate this hypothesis, as it is essential to know the exact amount 
of the present ion in the final formulation. The concentration of the incorporated cations in the 
powder (molar and wt%) were calculated and compared.  
In case of Ag-HA, it contained almost half of the expected silver while for other two cations, 
in particular for Mg-HA, the final values for ion incorporation were closer to the initial ratios. 
While XRD analysis confirmed that these cations have been substituted in the HA structure to 
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some degree, no definitive conclusion can be made to confirm how much of these cations are 
actually substituted in the HA structure and how much being either adsorbed on the surface, 
being incorporated as defects or formed a second phase.  
6.2 Changes in crystal properties   
We reported the changes in structural phase analysis and mapped clearly how the addition of 
cations impact the crystal phases, which ultimately can affect the micro- and macro-properties 
of the powder. Higher Ag concentration increased the crystallinity and crystal size slightly 
while for Mg and Zn, both crystallinity and crystal size decreased suggesting a contraction in 
the cell unit volume and inhibition in crystal growth. The change in crystallinity and crystal 
size can affect the nano grain size and ultimately the surface area and higher rates of release of 
drugs from the particles.  
6.3 Chemical structure  
Phase analysis of the final powders confirmed the formation of a strong β-TCP phase at higher 
Mg concentrations and most of the Mg was present in this phase resulting in the formation of 
Whitlockite. The presence of β-TCP phase was shown to affect the macro-properties of the 
powder (solubility and thermal stability as the only ones studied in this research) which can 
impact the overall stability of the powder. FT-IR and Raman Spectroscopy confirmed the 
formation of the HA and TCP phases and also indicated the presence of carbonate ions which 
suggest the importance of the reaction environment and CO2 in the atmosphere throughout the 
reaction.  
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6.4 Solubility and release properties  
We showed that there is a direct correlation between the amount of cation incorporated in the 
powder and the amount of ions released in the liquid phase. There is an initial burst release step 
for all the samples, which lasts average about 24 hours followed by a more sustained lower rate 
release. Maximum release of Ag and Zn was reached after 72 hours suggesting the poor 
solubility of the powder and mass transfer in these two formulations.  
As expected, the morphology and surface area of the final material will change the release 
profile. However, it was expected that the mass transfer from the solid HA phase to the surface 
should be very poor and most of the solubilised ions are ones which are released from the 
surface of the powder. In addition, it is proposed that the availability of more soluble phase (β-
TCP in Mg-HA) may have influenced the higher rates of Mg release. Different rates of 
solubility from different phases of calcium phosphate can suggest the possibility of tuning and 
fabricating “engineered” particles with controlled rates of releases of different agents released 
from different phases.  
6.5 Antimicrobial activity 
The results proved that there is a direct relationship between the release profile in each sample 
and the observed antibacterial activity. The observed antibacterial activity can be attributed 
solely to the presence of the cations in the powder as all the samples were compared with a 
control sample of non-substituted HA. Based on the defined concentration of each cation in the 
solid and liquid phase, it was concluded that the observed antibacterial activity to the 
concentration of cation in the medium assuming other parameters remained unchanged. Using 
this principal, it is possible to predict the final antibacterial activity against these bacterial 
strains by knowing the amounts of each cations in the starting reaction medium.  
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6.6 Cell experiments  
For any newly developed biomaterial formulation, it is critical to measure its performance 
against selected biological activity screenings to ensure it is safe and compatible in principal. 
The biological response of the prepared material was measured by how the cation concentration 
affects the cell proliferation and cell differentiation responses in selected cell line. While cell 
proliferation was increased in the lower ranges of cation concentration, it was negatively 
affected at higher ratio samples where the expected concentration of cation in liquid phase was 
exceeding the cation’s cytotoxicity level. Similar results were obtained for osteoblast 
differentiation as at higher ratios of Mg-HA, negative results were observed. 
We suggested that biocompatibility may be affected with the change in crystal properties of the 
powder which highlights how different parameters may be interrelated and impact the success 
of a biomaterial. 
6.7 Recommendation for future work  
Using extra analytical techniques for material characterisation can provide further 
understanding of the final powder and how the calcium phosphate and its chemical and crystal 
properties may change by addition of cations. In particular, solid NMR can help to define the 
new and existing molecular bonds at greater detail. 
Mechanical properties of the bulk material and parameters like compressive and tension 
strength and strain, porosity and density can be useful to predict the in situ behaviour and how 
they are changed with different formulations. Also release profile and solubility can be 
evaluated under simulated conditions which there is circulated medium similar to what occurs 
in the body.  
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Also, elemental analysis assays at the surface of material (like EDS) can determine the extent 
of the surface adsorption of cations on powder and differentiate it from the chemicals that are 
incorporated within the crystal lattice.  
Furthermore, new formulations can be used by mixing different ratios of cations at selected 
optimum concentration and generate a hybrid formulation with possibly inventive properties.  
To better define antibacterial activity, other pathogenic bacterial strains can be used against 
these powders. Using the prepared hybrid material as discussed earlier may be able to control 
various bacterial strains in particular the strains which are becoming more resistant to common 
antibiotics. 
Using more detailed biological assessments, such as mineralisation and gene expression can 
also help to understand the behaviour of the material in the body and provide a better picture 
its overall success. 
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